UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

☒	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, ~~2022~~2023

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-36245

RiceBran Technologies

(Exact name of registrant as specified in its charter)

California	87-0673375
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
25420 Kuykendahl Rd., Suite B300 Tomball, TX	77375
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (281) 675-2421

Securities registered under Section 12(b) of the Exchange Act: None

Title of each class Trading Symbol Name of each exchange on which registered Common Stock, no par value per share RIBT The NASDAQ Capital Market

Securities registered under Section 12(g) of the Exchange Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ ~~Accelerated filer ☐~~ Non-accelerated filer ☒ Accelerated filer ☐ Smaller reporting company ☒ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark if the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended). ~~Yes~~YES ☐ No NO ☒

As of June 30, ~~2022~~2023, the aggregate market value of our common stock held by non-affiliates was $3410.34 million calculated by using the closing price of the common stock on such date on NASDAQ Capital Market of $61.7011 per share.

As of March 1629, ~~2023~~2024, there were 610,~~384~~002,~~334~~ 902 shares of our common stock, no par value per share, outstanding.

Documents incorporated by reference: Portions of the registrant’s Definitive Proxy Statement for its annual meeting of shareholders, which Definitive Proxy Statement will be filed with the Commission not later than 120 days after the registrant’s fiscal year ended December 31, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K.None

Auditor Firm PCAOB ID: 49 Auditor Name: RSM US LLP Auditor Location: Houston, Texas

Auditor Firm PCAOB ID:	100	Auditor Name:	Withum Smith+Brown, PC	Auditor Location:	Whippany, New Jersey

Auditor Firm PCAOB ID:	49	Auditor Name:	RSM US LLP	Auditor Location:	Houston, Texas

Table of Contents

FORM 10-K

INDEX

PART I			Page
	Item 1.	Business	4
	Item 1A.	Risk Factors	86
	Item 1B.	Unresolved Staff Comments	1412
	Item 2.	Properties	14
	Item 1C.	Cybersecurity	13
	Item 3.	Legal Proceedings	14
	Item 2.	Properties	13
	Item 4.	Mine Safety Disclosures	14
	Item 3.	Legal Proceedings	13
	Item 4.	Mine Safety Disclosures	13
PART II
	Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	1514
	Item 6.	Reserved	1514
	Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
	Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	17
	Item 8.	Financial Statements and Supplementary Data	17
	Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	4143
	Item 9A.	Controls and Procedures	4144
	Item 9B.	Other Information	4244
	Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	4244
PART III
	Item 10.	Directors, Executive Officers and Corporate Governance	4245
	Item 11.	Executive Compensation	4249
	Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	4254
	Item 13.	Certain Relationships and Related Transactions, and Director Independence	4255
	Item 14.	Principal Accountant Fees and Services	4255
PART IV
	Item 15.	Exhibits and Financial Statement Schedules	4256
Signatures			4762

Table of Contents

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K includes forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions. Words such as “believes,” “anticipates,” “expects,” “estimates,” “intends,” “plans,” “projects,” “will,” “may” and similar expressions are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements are not guarantees of future performance and concern matters that could subsequently differ materially from those described in the forward-looking statements. Future events and actual results could differ materially from those discussed in this Annual Report. These risks and uncertainties include those described in “Risk Factors” and elsewhere in this Annual Report. Except as required by law, we undertake no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this Annual Report. We do not endorse any projections regarding future performance that may be made by third parties.

Unless the context requires otherwise, references to “we,” “us,” “our” and the “Company” refer to RiceBran Technologies, and its consolidated subsidiaries.

Table of Contents

PART I

ITEM 1. BUSINESS

Overview

Our Company

We are a specialty ingredient ~~and~~company ~~milling~~focused ~~company~~on ~~that~~the ~~produces~~development, ~~nutritional~~production, and ~~functional~~marketing ~~ingredients~~of products derived from ~~rice~~traditional and ~~other~~ancient small ~~and ancient~~ grains. ~~for~~We ~~the~~create ~~nutraceutical,~~and ~~healthy~~produce ~~food,~~products ~~companion~~utilizing ~~animal~~proprietary ~~and~~processes ~~equine~~to ~~feed~~deliver ~~categories.~~improved ~~Notably~~nutrition, weease ~~are~~of ause, ~~market~~and ~~leader~~extended inshelf-life, ~~North~~while ~~America~~addressing inconsumer ~~converting~~demand ~~raw~~for ~~rice~~all ~~bran~~natural, ~~into~~non-GMO ~~stabilized rice bran (SRB)~~ and ~~high~~organic ~~value SRB derivative~~ products ~~including:~~.

● RiBalance, a complete rice bran nutritional package derived from further processing SRB;

● RiSolubles, a highly nutritious, carbohydrate and lipid rich fraction of RiBalance;

● RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and

● our family of ProRyza products, which includes derivatives composed of protein and protein/fiber blends.

We have developed our products by optimizing proprietary processes. Our products are healthy, natural, and non-genetically modified ingredients that are hypoallergenic and gluten free for use in baked goods, cereals, coatings, health foods, high-end animal nutrition, and animal health. Our customer include food and animal nutrition manufacturers, wholesalers and retailers, both domestic and international.

We incorporated under the laws of the State of California in 2000. From July 2003 until October 2012, our corporate name was “NutraCea.” In October 2012, we changed our name to “RiceBran Technologies”. In 2018, we moved our corporate headquarters to Texas, from Arizona.

We ~~produce~~own ~~SRB~~and atoperate ~~four~~a ~~locations:~~grain ~~two~~mill ~~raw~~and ~~rice~~processing ~~bran~~facility ~~stabilization facilities located within supplier-owned rice mills~~ in ~~Arbuckle~~East ~~and~~Grand ~~West Sacramento~~Forks, ~~California,~~Minnesota ~~one~~operated ~~company-owned~~by ~~rice~~MGI ~~bran~~Grain, ~~stabilization~~Incorporated ~~facility in Mermentau~~(MGI), ~~Louisiana,~~acquired ~~and our wholly owned rice mill~~ in ~~Wynne, Arkansas~~2019.

WeOn ~~further~~June ~~process~~23, ~~SRB~~2023, ~~into~~we ~~high-value~~completed ~~SRB~~the ~~derivatives~~sale atof our ~~Dillon,~~assets ~~Montana~~related ~~facility~~to ~~using~~our ~~proprietary~~stabilized ~~equipment~~rice bran business (SRB Business) for $1.8 million in cash and ~~technology~~the assumption of $1.7 ~~Our~~million ~~primary~~of ~~products~~real ~~include:~~estate ~~RiSolubles,~~operating ~~RiFiber~~lease and other liabilities. The sale agreement contains customary representations, ~~RiBalance~~warranties, inand ~~both~~covenants. ~~organic~~The SRB Business was a specialty ingredient company that produced nutritional and ~~conventional~~functional ~~formats~~ingredients derived from raw rice bran for the nutraceutical, healthy food, companion animal and ~~our~~equine ~~ProRyza~~feed ~~family~~categories ofto convert raw rice bran into stabilized rice bran (SRB) and high-value SRB derivative products.

WeOn ~~own~~December ~~and~~1, ~~operate~~2023, ~~two~~an ~~specialty~~entity ~~mills:~~owned aby ~~rice~~Cable ~~mill~~Car ~~and~~Capital ~~bran stabilization facility in Wynne~~LLC, ~~Arkansas~~Funicular ~~operated be Golden Ridge Rice Mills~~Funds, ~~Inc.~~LP (~~Golden Ridge~~Funicular), ~~acquired~~purchased in$0.4 ~~2018;~~million ~~and~~of ashares ~~grain~~of ~~mill~~common ~~and~~stock ~~processing~~of ~~facility~~the inCompany ~~East~~and ~~Grand~~lent ~~Forks,~~the ~~Minnesota~~Company ~~operated~~$4.1 ~~by MGI Grain, Incorporated (MGI), acquired in 2019~~million.

~~Stabilized~~On ~~RiceBran~~January 25, 2024, we sold our rice mill facility in Wynne, Arkansas operated by Golden Ridge Rice Mills, Inc. (~~SRB~~Golden Ridge), that was acquired and owned and operated since 2018. Golden Ridge specialized in producing #1 and #2 Grade U.S. premium long and medium white rice milled to United States Department of Agriculture (USDA) standards. Golden Ridge also produced brown rice, brewers rice, and brokens.

AsOur ~~the~~MGI ~~leading~~grain ~~supplier~~mill ofand ~~SRB,~~processing wefacility ~~believe~~in ~~our~~East ~~greatest~~Grand ~~market~~Forks, ~~opportunities~~Minnesota ~~are~~specializes in ~~the~~processing ~~food~~barley, ~~ingredient~~oats, and ~~animal~~mustard ~~nutrition~~and ~~markets.~~provides ~~Nutritionally~~us ~~balanced,~~a ~~minimally~~presence ~~processed,~~in ~~gluten~~a ~~free,~~key ~~non-GMO~~production ~~and~~region ~~clean-label~~in ~~food~~the ~~and~~U.S. ~~animal~~MGI’s ~~feed~~facility ~~ingredients~~is ~~are~~an inAmerican ~~high~~Institute ~~demand,~~of ~~and~~Baking we(AIB) ~~are~~certified ~~strategically~~barley ~~positioned~~pearling tofacility, ~~take~~Hazard ~~advantage~~Analysis ofCritical ~~this~~Control ~~growing~~Point (HACCP) and ~~sustainable~~SQF ~~market opportunity~~certified.

Food Ingredients

Our SRB and SRB derivative products are nutritional and beneficial food products that contain a unique combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants that enhance the nutritional value of popular consumer products. Our products replace ingredients like soy protein isolate, soy protein concentrate, modified food starch, pea protein, mustard flour and yeast at a significantly reduced cost. Foods that are ideally suited for the addition of our SRB to their products include processed meats, cereals, snacks, beverages, baked goods, breading, and batters.

Table of Contents

Animal Nutrition

Our SRB is marketed as a feed ingredient in the United States and international animal nutrition markets, and we will continue to pursue sales opportunities with attractive margins in those markets. SRB is currently used as an equine feed ingredient as it has been shown to provide health benefits for show and performance horses. We believe that there are also numerous market opportunities for utilizing SRB in the production of food for companion animals. We have multiple engagements with customers in the companion animal market, and we are aggressively pursuing other opportunities.

Rice Bran

Rice is the staple food for over half of the world’s population, especially in some of the world’s most populous countries. Asia accounts for roughly 90% of global rice production and China is the world’s number one rice producer. Globally, the United States ranks 12th in rice production with approximately 1% of the global total.

After harvest, individual rice kernels are stored in common receiving locations such as farm silos for future delivery to grain dryers or area rice mills. At this stage, large quantities of individual rice kernels are collectively called “paddy rice,” or “rough” rice. In this form, the rice kernel is fully enveloped by the rice hull, which serves as a protective cover, shielding the inner rice kernel from damage.

After storage and drying, paddy rice is cleaned of foreign material (scalping, de-stoning and aspiration). The paddy husker then uses differential speed rubber rollers to remove the hulls from rough rice. Aspiration carries off the loosened hulls, and the normal brown rice kernels (caryopsis) are separated from the unhusked kernels which are returned to the paddy husker.

Once husked, the outer brown layers of bran are removed from the inner white starch endosperm by an abrasive or frictional milling process producing a milled white rice kernel. After milling, white rice is typically sorted by size to remove broken kernels from whole kernels, and by color to remove discolored kernels. Further processing may also be used to polish the white rice for a smooth surface.

Raw rice bran collected from the milling process is composed of rice germ and several sub-layers (pericarp, testa, nucellus and aleurone) surrounding the white starchy endosperm. Commercial rice bran makes up approximately 10% of rough rice by weight. Rice germ, an especially nutrient rich material, makes up approximately 10% of commercial rice bran by weight.

In the milling process the oils present in raw rice bran come into contact with native lipase enzymes that are naturally present in the rice kernel which initiate a rapid enzymatic hydrolysis of the oil, converting oils (triglycerides) into monoglycerides, diglycerides and free fatty acids (FFA). As the FFA content builds in raw rice bran, the bran becomes unpalatable and off flavors (rancidity) develop.

If left unchecked, enzymatic degradation at room temperatures can increase the FFA levels to 5-8% within 24 hours continuing at a rate of approximately 4-5% per day thereafter. Rice bran stabilization deactivates the native enzymes to prevent the increase of FFA otherwise caused by lipase enzyme activity. Proper stabilization is critical in the preservation of the nutritional value of the bran.

Historically, there have been a number of attempts to develop rice bran stabilization techniques, including the use of chemicals, microwave heating or variations of existing extrusion technology. Many of these approaches have had limited success in part because they have produced rice bran with limited shelf life or with significant degradation of nutrients.

Rice Bran Stabilization

We stabilize rice bran with proprietary processes to create a combination of temperature, pressure and other conditions necessary to thoroughly deactivate enzymes without significantly damaging the structure or nutrient content of the raw rice bran, leaving the higher value compounds in bran, such as oils, proteins and phytonutrients undamaged and are available for utilization.

Our stabilizers are located in close proximity to the rice mills where we source raw bran so that the raw bran can be delivered quickly. We maintain exact process conditions within a prescribed pressure/temperature regime and have the ability to purge our equipment of material in the event of power failure or interruption of the flow of fresh bran into the system.

Once stabilized, SRB leaving our system is then discharged onto cooling units specifically designed to control air pressure and humidity. Once cooled, SRB can be loaded into bulk hopper trucks for large volume customers or sent by pneumatic conveyor to a bagging unit for packaging into various size bags or 2,000-pound sacks.

We operate stabilizers of our own design which we believe offer certain advantages. Each stabilizer processes approximately 2,000 pounds of bran per hour and has a capacity to produce over 7,200 tons of SRB per year. Stabilization production capacity can be doubled, tripled or further multiplied by installing additional units sharing a common conveyor and stage system.

Table of Contents

SRB can be further processed to produce fractions enriched in one or more macronutrients, including proteins, fibers, lipids and micronutrients such as vitamins, minerals and phytosterols, among others. In these processes, SRB is put into an aqueous slurry, treated with one or more enzymes, centrifugally separated and the fractions are dried.

SRB Attributes

Rice bran is free of all major allergens and is a valuable source of protein with a balanced amino acid profile for food ingredient products and is rich in healthy oil, vitamins, antioxidants, dietary fiber and other nutrients. The approximate composition and caloric content of our SRB is as follows:

Fat (oil)	18-23%
Protein	12-16%
Total Dietary Fiber	20-30%
Moisture	4-8%
Ash	6-14%
Calories	3.2 kcal/gram

Because SRB contains approximately 18-23% oil, it has a favorable fatty acid composition and excellent heat stability which makes it an attractive ingredient for a wide variety of applications.

Specialty Milling

Rice Mill

Our Golden Ridge rice mill and bran stabilization facility is located on nearly 32 acres in Wynne, Arkansas. Golden Ridge provides a presence in the largest rice-producing state and a cost-efficient source of SRB close to customers in the Midwest and Eastern U.S. Golden Ridge produces U.S. No. 1 and U.S. No. 2 Grade U.S. premium long and medium white rice milled to USDA standards. Golden Ridge adheres to standard operating procedures and passed all the prerequisite audits required to meet Good Manufacturing Practice (GMP) standards and Safe Quality Food (SQF) certifications.

Barley and Oats Mill

Our MGI grain mill and processing facility in East Grand Forks, Minnesota specializes in processing barley, oats, and mustard. MGI provides us a presence in a key production region in the U.S. and a complimentary portfolio of ingredients purchased by substantially the same buyers as our rice products. MGI’s facility is an American Institute of Baking (AIB) certified barley pearling facility, Hazard Analysis Critical Control Point (HACCP) and SQF certified.

Intellectual Property

Our stabilization processes are an adaptation of standard food processing technology applied to rice bran. We have chosen to treat our methods and processes as a trade secret and not to pursue process or process equipment patents on the original processes. As we develop improvements, we intend to periodically review whether we should seek patent protection for them. We believe that certain unique products, and their biological effects, resulting from our SRB may be patentable in the future.

Market Opportunity

There is an expanding market for minimally processed plant-based ingredients that provide dense and balanced nutrition as well as high functionality while being non-GMO, gluten and allergen free. Regulatory requirements to add front-of-label warnings on food items and increasing demand from consumers for less processed ingredients is driving a shift to cleaner ingredients. We anticipate further adoption of our ingredients by food companies as a result, with a corresponding transition among high-end animal nutrition companies.

Our Customers

We use almost entirely internal sales staff, ~~outside independent sales representatives and third-party distributors~~ to market our portfolio of products to customers domestically and internationally. In ~~2022~~2023 and ~~2021~~2022, three customers accounted for 2948.24% and 3244.40% of our revenues from continuing operations. We continue to focus efforts on diversification of our customer base to mitigate the concentration of customers.

Table of Contents

Government Regulations

Our operations are subject to federal, foreign, state and local government laws and regulations, including those relating to zoning, workplace safety and accommodations for the disabled, and our relationships with our employees are subject to regulations, including minimum wage requirements, anti-discrimination laws, overtime and working conditions and citizenship requirements.

In both our U.S. and foreign markets, we are affected by extensive laws, governmental regulations, administrative determinations, court decisions and similar constraints. Such laws, regulations and other constraints exist at the federal, state and local levels in the U.S., and at all levels of government in foreign jurisdictions, including to the formulation, manufacturing, packaging, labeling, distribution, sale and storage of our products. We are also subject to regulations regarding product claims and advertising.

Table of Contents

The formulation, manufacturing, packaging, labeling, advertising, distribution and sale of our products are subject to regulation by one or more federal agencies, including the Food & Drug Administration (FDA), the Federal Trade Commission (FTC) and the USDA. We are also regulated by various states and local agencies where our products are manufactured and/or sold, as well as a host of agencies outside the U.S. Among other matters, the FDA and FTC are concerned with product safety and claims made with respect to a product’s ability to provide health-related benefits. The FDA, under the Federal Food, Drug and Cosmetic Act (FDCA), regulates the formulation, manufacturing, packaging, labeling, distribution and sale of food and food ingredients, while the FTC regulates their advertising.

Federal agencies, including the FDA and the FTC, have a variety of enforcement remedies, including investigations, issuing warning letters and cease-and-desist orders, requiring corrective labeling or advertising, requiring consumer redress such as requiring that a company offer to repurchase products previously sold, seeking injunctive relief or product seizures, imposing civil penalties or commencing criminal prosecution. Certain state agencies have similar authority. These federal and state agencies have in the past used these remedies in regulating participants in the food and food ingredient industries, including the imposition of civil penalties.

The FDA Food Safety Modernization Act (FSMA), enacted January 4, 2011, amended the FDCA to significantly enhance the FDA’s authority over various aspects of food regulation. The FSMA granted the FDA mandatory recall authority when the FDA determines there is a reasonable probability that a food is adulterated or misbranded and that the use of, or exposure to, the food will cause serious adverse health consequences or death to humans or animals. One of the more significant changes under FSMA is the requirement of hazard analysis and risk-based preventive controls (HARPC) for all human and animal food processing facilities. We are committed to FSMA compliance and are SQF certified at ~~all~~ our ~~facilities~~facility.

Any substance that is intentionally added to food is a food additive and is subject to premarket review and approval by the FDA, unless the substance is generally recognized, among qualified experts, as having been adequately shown to be safe under the conditions of its intended use, or unless the use of the substance is otherwise excluded from the definition of a food additive. When an additive is proposed for use in a meat, its safety, technical function and conditions of use must also be evaluated by the USDA. Because the USDA retains jurisdiction over meat products and food ingredients intended for use in meats, the use of our SRB meat enhancers is regulated by this agency. SRB has USDA approval for use in certain meat products.

Animal feed ingredients are regulated by the FDA at the federal level and by the individual states. ~~Our SRB is defined for animal use as heat stabilized rice bran for use as a feed ingredient.~~

Competition

~~Recently~~Our major competitors include producers of barley, weoats ~~have~~and ~~seen~~mustard. ~~increased~~We ~~competition~~compete ~~from~~with other companies that ~~have~~offer ~~invested~~products ~~significant~~that ~~resources~~incorporate tocereal ~~develop~~grains ~~technologies~~as ~~for~~well ~~stabilizing~~as ~~and~~other ~~processing~~companies ~~rice~~that ~~bran~~offer alternative food ingredients. Many consumers may consider such products to be a replacement for our products. We believe that weincreased ~~have~~competition ~~proprietary~~negatively ~~technologies~~impacted ~~and~~our ~~processes~~financial ~~for~~results ~~stabilizing~~in ~~rice~~2023, ~~bran~~especially in our prior SRB Business, asand ~~well~~is aslikely ~~significant~~to ~~brand~~continue ~~recognition~~to impact us negatively in the ~~animal~~foreseeable ~~feed~~future. ~~and~~Our ~~food~~results ~~ingredient~~of ~~sectors~~operations ~~both~~in ~~domestically~~2023 ~~and~~were ~~internationally.~~impacted Weby ~~also~~competition ~~believe~~from companies that we have ~~industry-leading~~invested ~~manufacturing~~significant ~~facilities~~resources to develop technologies for stabilizing and processing rice bran. ~~However~~During 2023, we ~~believe~~also ~~that~~faced ~~increased~~ competition ~~negatively~~from ~~impacted~~producers ~~our~~of ~~financial~~isolated ~~results~~soy inprotein, ~~2022~~wheat bran and isoat ~~likely~~bran toand ~~continue~~from tocompanies ~~impact~~that usoffer ~~negatively in~~products ~~the~~incorporating ~~foreseeable~~stabilized ~~future~~rice bran.

We are also aware of several new producers of rice-based animal nutrition and food ingredient products in the United States, Europe and Asia. We believe that our major competitors include producers of isolated soy protein, wheat bran and oat bran, particularly in the food ingredients market segment. We compete with other companies that offer products incorporating SRB as well as companies that offer other food ingredients. Many consumers may consider such products to be a replacement for our products.

Human Capital

We employ a skilled workforce within a broad range of functions. As of December 31, ~~2022~~2023, we had 9435 employees. Our employees are located throughout the United States to serve our business operations. From year to year, we experience normal variable labor fluctuation at our production ~~facilities~~facility.

Table of Contents

We attract and retain our workforce through a dynamic and inclusive culture by providing a safe work environment, flexible work arrangements, and competitive pay and benefits, including access to personal health advocates offering independent guidance. We believe that we have positive relationships with our employees and have deployed programs that advance employee engagement, communication, and feedback. None of our employees are covered by collective bargaining agreements.

Available Information

We maintain an Internet website at the following address: www.ricebrantech.com. We make available on or through our Internet website certain reports and amendments to those reports that we file with the Securities and Exchange Commission (SEC) in accordance with the Securities Exchange Act of 1934 (Exchange Act). These include our annual reports on Form 10-K, our quarterly reports on Form 10-Q, our current reports on Form 8-K and the reports of beneficial ownership. We make this information available on our website free of charge as soon as reasonably practicable after we electronically file the information with, or furnish it to, the SEC. The contents of our website are not incorporated by reference in this report on Form 10-K and shall not be deemed “filed” under the Exchange Act.

Table of Contents

ITEM 1A. RISK FACTORS

Our operations and financial results are subject to various risks and uncertainties, including those described below, which could adversely affect our business, financial condition, results of operations, cash flows and the trading price of our common stock. Investors or potential investors in our stock should carefully consider the risks described below.

RISK FACTORS

Risks Relating to Our Business

We have not yet achieved annual positive cash flows.

Our net cash used in operating activities from continuing operations was $32.92 million in ~~2022~~2023 and $43.28 million in ~~2021~~2022. We may not be able to achieve revenue growth, profitability or positive cash flow, on either a quarterly or annual basis, and that profitability, if achieved, may not be sustained. If we are unable to achieve or sustain profitability, we may not be financially viable in the future and may have to curtail, suspend, or cease operations, restructure existing operations to attempt to ensure future viability, or pursue other alternatives such as pursuing dissolution and liquidation, seeking to merge with another company, selling all or substantially all of our assets or raising additional capital through equity or debt financings. Because of our recurring losses and negative cash flows from operations, the audit report of our independent registered public accountants on our consolidated financial statements contains an explanatory paragraph stating that there is substantial doubt about our ability to continue as a going concern.

We depend primarily on the sale of a limited number of products milled in a single facility, and the failure to diversify our product offering could materially harm our business and our operating results.

Historically, we depended in large part on revenue derived from sales of SRB to a few key customers. Following the sale of our SRB Business and our Golden Ridge facility in June 2023 and January 2024, respectively, we no longer receive revenue from the sale of SRB and derive revenue from the sale of barley, oats and mustard produced in one facility. Given the recent divestitures of our business, the consequent reduction in our product revenue diversification could adversely affect our profitability potential and could materially and adversely affect our business, operations and cash flows by making us more vulnerable to, among other things:

●

Fluctuations in the prices of and demand for the products we manufacture;

●

Construction in the supply of raw materials;

●

Droughts, floods and other adverse growing conditions impacting barley, oats and mustard;

●

Fires, floods, explosions, accidents and adverse weather conditions that could damage our grain mill;

●

Disruption in transportation;

●

Regulatory changes affecting our milling operations or other aspects of our business;

●

General economic disruption; and

●

Changes in consumer tastes

We have generated significant losses since our inception in 2000, and losses in the future could cause the trading price of our stock to decline or have a material adverse effect on our financial condition, cash flow, and ability to pay our debts as they become due.

Through December 31, ~~2022~~2023, we have incurred an accumulated deficit in excess of $~~316~~ 333 million. We may not be able to achieve profitability or maintain profitable operations if achieved. If our losses continue, our liquidity may continue to be severely impaired, our stock price may fall and our shareholders may lose all or a significant portion of their investment. If we are not able to attain profitability in the near future our financial condition could deteriorate further which could have a material adverse impact on our business and prospects and result in a significant or complete loss of shareholder investment. Further, we may be unable to pay our debt obligations as they become due, which include obligations to secured creditors.

We may need to raise additional funds in the future to achieve our business objectives and to satisfy our cash obligations, which would dilute the ownership of our existing shareholders and possibly subordinate certain of their rights to the rights of new investors.

We may need to raise additional funds through debt or equity financings to complete our business objectives. We also may choose to raise additional funds in debt or equity financings if they are available to us on reasonable terms to increase our working capital, strengthen our financial position or to make acquisitions. Our board of directors has the ability, without seeking shareholder approval, to issue convertible debt and additional shares of common stock or preferred stock that is convertible into common stock for such consideration as the board of directors may consider sufficient, which may be at a discount to the market price. Any sales of additional equity or convertible debt securities could result in dilution of the equity interests of our existing shareholders, which could be substantial. Additionally, if we issue shares of preferred stock or convertible debt to raise funds, the holders of those securities might be entitled to various preferential rights over the holders of our common stock, including repayment of their investment, and possibly additional amounts, before any payments could be made to holders of our common stock in connection with an acquisition of us. Such preferred shares, if authorized, might be granted rights and preferences that would be senior to, or otherwise adversely affect, the rights and the value of our common stock. Also, new investors may require that we and certain of our shareholders enter into voting arrangements that give them additional voting control or representation on our board of directors. We have a limited number of authorized and unissued (and unreserved) shares, which limits our ability to raise additional funds through such debt or equity financings. Our shareholders would need to approve any increase in the number of authorized shares. If we determine that such an increase is desirable, it is possible our shareholders will not approve the increase.

Table of Contents

Our outstanding debt is subject to terms that may adversely affect our operations and financial condition.

We entered into a factoring agreement in October 2019. The factoring agreement provides for a $7.0 million credit facility which we may draw upon to the extent we have qualifying accounts receivable as defined in the agreement. The lender has the right to demand repayment of advances under the facility at any time, and amounts owed under the agreement are secured by our personal property assets. If the lender demands repayment and we fail to make such repayment, or if we cause or permit any other event of default as defined in the agreement or fail to comply with covenants set forth in the agreement (including restrictions on incurring other debt under unsecured loans), we would be subject to additional expenses or possible foreclosure on our assets that secure our obligations under the agreement. Such results could have a material adverse effect on our operations and financial condition.

We ~~received~~have ~~$1.8~~identified ~~million~~material onweaknesses ~~an SBA Paycheck Protection Program (PPP) loan~~ in ~~April~~our ~~2020~~internal ascontrol ~~provided~~over ~~for~~financial ~~in the Coronavirus Aid~~reporting, ~~Relief~~ and ~~Economic~~if ~~Security~~we ~~Act,~~are ~~enacted~~unable ~~into~~to ~~U.S.~~achieve ~~law in March 2020. The outstanding principal~~ and ~~related~~maintain ~~accrued~~effective ~~interest~~internal oncontrol ~~our~~over ~~PPP~~financial ~~loan were completely forgiven in January 2021. The SBA may audit any PPP loan at its discretion through January 2027~~reporting, ~~six years~~ ~~after~~investors ~~the~~could ~~date~~lose ~~the~~confidence ~~SBA~~in ~~forgave~~our ~~the~~consolidated ~~loan.~~financial ~~The~~statements ~~SBA may review any or all of the following when auditing a PPP loan: whether the borrower qualified for the PPP loan, whether the PPP loan amount was appropriately calculated~~ and ~~the~~our ~~proceeds used for allowable purposes~~Company, ~~and~~which ~~whether the loan forgiveness amount was appropriately determined. We~~ could behave ~~deemed~~a ~~ineligible~~material ~~for~~adverse ~~the~~effect ~~PPP loan received in 2020 upon audit by the SBA. We believe the SBA’s stated intention is to focus its reviews~~ on ~~borrowers with loans greater than $2 million, thereby mitigating~~ our ~~future~~business ~~risk of an audit. The SBA continues to develop~~ and ~~issue~~our ~~new~~stock ~~and updated guidance regarding required borrower certifications and requirements for forgiveness of loans made under the program~~price.

AsIn the course of ~~March~~preparing 16the financial statements for the fiscal year ended December 31, 2023, our management determined that we have $2material weaknesses in our internal control over financial reporting, which relate to management’s review controls over the documentation and review of the required dual approval for the posting of journal entries and the processing and review of inventory costing.5 ~~million~~We ~~outstanding~~had onconsistent turnover within the accounting department that led to the Company having a ~~mortgage~~lack ~~promissory~~of ~~note.~~sufficient ~~The~~number ~~note~~of isqualified ~~secured~~personnel byto ~~our~~maintain ~~real~~proper ~~property~~controls ~~located~~over infinancial ~~Arkansas~~reporting. IfAs wea ~~fail~~result toof ~~make~~these ~~repayment~~material weaknesses, we ~~would~~have beinitiated ~~subject~~and will continue to implement remediation measures including, but not limited to: hiring additional ~~expenses~~accounting orstaff ~~possible~~and ~~foreclosure~~the onnecessary customization of the ~~assets~~Company’s accounting system to provide the documentation for the required dual approval for the posting of journal entries. As a result, the Company believes that ~~secure~~it ~~our~~has ~~obligations~~adequate resources to address accounting and reporting requirements under U.S. GAAP and SEC reporting standards and to implement the ~~agreement~~appropriate internal controls. ~~Such~~If ~~results~~we fail to fully remediate these material weaknesses or fail to maintain effective internal controls in the future, it could ~~have~~result in a material ~~adverse~~misstatement ~~effect~~of our consolidated financial statements that would not be prevented or detected on ~~our~~a ~~operations~~timely ~~and~~basis, which could cause investors to lose confidence in our financial ~~condition~~information or cause the trading price of our common stock to decline.

Inflation could adversely impact our ability to control operating expenses and capital costs, increase our level of indebtedness and adversely impact our customer base.

We could be adversely impacted by inflationary pressures in the underlying economy. Most notably, we have a considerable amount of debt for which the interest rate is indexed to market costs of borrowing, which could increase in an inflationary environment. Should our cost of borrowing rise significantly as a result of inflation, we may not be able to service this debt in a timely manner and/or may be forced to default on some of these obligations. Similarly, we have entered into agreements to purchase raw materials and to sell finished goods. Some of the agreements to purchase raw materials are indexed to an underlying commodity price index. Should the cost of raw materials rise faster than we are able to raise the prices of our finished goods, it could have a negative impact on our gross profits which may cause the price of our common stock to decline.

If we are unable to maintain effective internal control over financial reporting, investors could lose confidence in our consolidated financial statements and our Company, which could have a material adverse effect on our business and our stock price.

We are required to maintain adequate internal control over financial reporting and to evaluate the effectiveness of our internal controls in accordance with the framework established by Internal Control - Integrated Framework (2013) published by the Committee of Sponsoring Organizations of the Treadway Commission. If we fail to maintain effective internal controls in the future, this could result in a material misstatement of our consolidated financial statements that would not be prevented or detected on a timely basis, which could cause investors to lose confidence in our financial information or cause the trading price of our common stock to decline.

There are significant market risks associated with our business.

Our business plan and strategies are based on certain assumptions regarding the size of the ~~rice, rice bran,~~ barley and oat markets, our anticipated share of these markets, the estimated price and acceptance of our products and other factors. These assumptions are based on our best estimates; however, our assessments may not prove to be correct. Any future success may depend upon factors including changes in governmental regulation, increased levels of competition, including the entry of additional competitors and increased success by existing competitors, changes in general economic conditions, increases in operating costs including costs of ~~rice bran,~~ production, supplies, personnel, equipment, and reduced margins caused by competitive pressures. Many of these factors are beyond our control.

Effects of COVID-19 pandemic and other health epidemics and outbreaks, including economic, regulatory, legal, workforce and cyber security risks, could adversely impact our financial condition, results of operations and cash flows.

The COVID-19 pandemic has adversely affected the business and financial markets of many countries, disrupted global supply chains, and created significant volatility in the financial markets. In addition, the pandemic has resulted in travel restrictions, business closures and the institution of quarantining and other restrictions on movement in communities. With widespread availability of vaccines, the U.S. Centers for Disease Control and Prevention has revised its guidance, travel restrictions have started to lift and businesses have reopened. However, the COVID-19 pandemic continues to evolve and the extent to which our business and results of operations are impacted will depend on various factors beyond our control, such as duration, severity and sustained geographic resurgence of the virus, the emergence of new variants, and the success of actions to contain the virus and its variants or treat its impact. The pandemic could adversely affect the demand for our products, and it poses the risk that we, or our customers, suppliers, and other business partners may be disrupted or prevented from conducting business for an uncertain period of time. The extent to which this would impact our financial results is unknown as it is dependent on future developments, which are highly uncertain and cannot be predicted. As such, it is difficult to estimate the exact magnitude of the COVID-19 pandemic on our business.

Table of Contents

We have not had, and we do not expect any of our facilities to be closed subject to government-mandated closures, and we have informed our customers that we anticipate operating throughout the COVID-19 outbreak. Disruption in the supply chain of raw materials used to produce our products as a result of the COVID-19 outbreak, has not caused us to close any of our facilities, and to date, our employees have been reporting to work, either remotely or in-person without any material change in attendance or productivity. However, we cannot ensure that the COVID-19 outbreak will not cause disruptions to our business in the future.

We depend on a limited number of customers and their ability to meet their obligations.

In ~~2022~~2023, three customers accounted for 2948.24% of revenues and the top ten customers accounted for 5475.41% of revenues. As of December 31, ~~2022~~2023, the customers with the highest ten balances accounted for 6386.71% of accounts receivable.

Table of Contents

We are dependent upon the continued growth, viability and financial stability of our customers. We expect to continue to depend upon a relatively small number of customers for a significant percentage of our revenues. Consolidation among our customers may reduce our number of customers or result in a concentration of credit risk with respect to outstanding accounts receivable. We consider the financial strength of our customers, the remoteness of the possible risk that a default event will occur, the potential benefits to our future growth and development, possible actions to reduce the likelihood of a default event, and the benefits from the transaction, before entering into a large credit limit with a customer. Although we analyze these factors, the ultimate collection of the obligation from the customer may not occur. Although we continue to expand our customer base in an attempt to mitigate the concentration of credit risk, writing off of an accounts receivable balance could have an adverse effect on our results of operations. Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash equivalents and trade receivables. Historically, we have not experienced any loss of our cash and cash equivalents, but we have experienced losses to our trade receivables. A significant reduction in sales to any of our significant customers could have a material adverse effect on our results of operations.

We may encounter difficulties in maintaining relationships with distributors and customers while enforcing our credit policies.

We define credit risk as the risk of loss from obligors or counterparty default. Our credit risks arise from both distributors and customers. Many of these risks and uncertainties are beyond our control. Our ability to forecast future trends and spot shifts in consumer patterns or behavior even before they occur are vital for success in today’s economy. In managing risk, our objective is to protect our profitability, but also to protect, to the extent we can, our ongoing relationships with our distributors and customers. However, as part of our credit risk policies, we occasionally must, among other things, cancel, reduce credit limits and place cash-only requirements for certain questionable accounts. These credit risk policies may negatively impact our relationships with our distributors and customers, which could adversely affect our results of operations.

Our ability to generate sales is dependent upon our ability to continue our ongoing marketing efforts to raise awareness of our products and ~~benefits~~their ~~of rice bran products generally~~benefits.

We are dependent on our ability to market products to animal food producers, food manufacturers, mass merchandisers, health food retailers and to other companies for use in their products. We must increase the level of awareness and benefits of ~~rice~~our ~~bran~~ products to be used in food and food ingredients in general and our products in particular. We will be required to devote substantial management and financial resources to these marketing and advertising efforts and such efforts may not be successful.

Our ability to adapt to sudden increases in demand for our ingredient products is limited by an adequate supply of feedstock.

Our ability to manufacture SRB is currently limited to the production capability of our equipment located at our two suppliers’ rice mills in California, our own plant located adjacent to our supplier in Mermentau, Louisiana and our rice mill in Wynne, Arkansas. At these facilities and our value-added product plant in Dillon, Montana, we currently are capable of producing enough finished products to meet current demand. If demand for our products were to increase dramatically in the future, we would need additional production capacity, which may take time and may expose us to additional long-term operating costs.

Adverse economic, weather, or other conditions may impact the price and supply of our feedstocks.

If economic or weather conditions, for example drought ~~conditions in California~~ or ~~flooding in Arkansas and Louisiana, adversely affect the amount of rice planted or harvested, the cost of rice bran products that we use may increase. Drought or~~ excessive moisture can ~~have~~adversely ~~similar~~affect ~~impacts on~~ the timing and number of acres planted to barley and oats in Minnesota, North Dakota, and Manitoba ~~as well~~. We are not always able to immediately pass cost increases to our customers. Therefore, cost increases could have an adverse effect on our results of operations.

We face competition from producers of ~~bran,~~ grains and other alternative ingredients with similar benefits ~~as our rice brans~~.

Competition in our targeted industries, including food ingredients, animal feed supplements and companion pet food ingredients is vigorous, with many businesses engaged in the various industries. Many of our competitors have established reputations for successfully developing and marketing their products, including products that incorporate ~~bran from other~~ cereal grains and other alternative ingredients that are widely recognized as providing similar benefits ~~as rice bran~~. In addition, many of our competitors have greater financial, managerial and technical resources than we do. If we are not successful in competing in these markets, we may not be able to attain our business objectives.

108

Table of Contents

We are affected by extensive laws, governmental regulations, administrative determinations, court decisions and similar constraints both domestically and abroad and our failure to comply with these laws, regulations and constraints could lead to the imposition of significant penalties or claims, which could harm our financial condition and operating results.

In both the U.S. and foreign markets, the formulation, manufacturing, packaging, labeling, distribution, sale and storage of our products are affected by extensive laws, governmental regulations, administrative determinations, court decisions and similar constraints. Such laws, regulations and other constraints may exist at the federal, state or local levels in the United States and at all levels of government in foreign jurisdictions. We are subject to regulation by one or more federal agencies including the U.S. Food and Drug Administration (FDA), the U.S. Federal Trade Commission and the U.S. Department of Agriculture (USDA), state and local authorities and foreign governmental agencies. In addition, the adoption of new regulations or changes in the interpretations of existing regulations may result in significant compliance costs or discontinuation of product sales and may negatively impact the marketing of our products, resulting in significant loss of sales revenues. Our failure to comply with these current and new regulations could lead to the imposition of significant penalties or claims, limit the production or marketing of any non-compliant products or advertising and could negatively impact our business.

Our warehousing and manufacturing facilities are subject to risks that may negatively affect our business and operations.

Our ability to make, store, and move our products is important to our success. Disruption to our manufacturing capabilities or to our storage capabilities, due to damage to our facilities or equipment, inability or delay in replacing parts or equipment, weather, natural disaster, fire, terrorism, pandemic, or other factors, could impair our ability to manufacture or distribute our products. If we fail to mitigate the possible impact of such events, or effectively manage them if they occur, they could adversely affect our business and results of operations. Such events could also require additional resources to restore our supply chain.

Our facilities are subject to laws and regulations administered by the FDA, USDA, the Occupational Safety and Health Administration, and other federal, state, and local governmental agencies relating to the production, storage, distribution, quality, and safety of food products and the health and safety of our employees. Our failure to comply with such laws and regulations could subject us to lawsuits, administrative penalties, and civil remedies, including fines, injunctions, and recalls of our products. Changes in such laws or regulations that impose additional requirements on us could increase the cost of operating our facilities, causing our results of operations to be adversely affected.

We may be subject to product liability claims and product recalls.

We sell food and nutritional products for animal and human consumption, which involves risks such as product contamination or spoilage, product tampering and other adulteration of food products. We may be subject to liability if the consumption of any of our products causes injury, illness or death. We maintain a product liability policy for $5.0 million per year in the aggregate. In addition, we may voluntarily recall products in the event of contamination or damage. A significant product liability judgment or a widespread product recall may cause a material adverse effect on our financial condition. Even if a product liability claim is unsuccessful, there may be negative publicity surrounding any assertion that our products caused illness or injury which could adversely affect our reputation with existing and potential customers.

Many of the risks of our business have only limited insurance coverage and many of our business risks are uninsurable.

Our business operations are subject to potential product liability, environmental, fire, employee, manufacturing, shipping and other risks. Although we have insurance to cover some of these risks, the amount of this insurance is limited and includes numerous exceptions and limitations to coverage. In the event we were to suffer a significant uninsured claim, our financial condition would be materially and adversely affected.

Our success depends in part on our ability to obtain, enforce and protect our licenses and other intellectual property rights for our products and technology.

Our success is dependent upon our ability to protect and enforce the trade secrets and trademarks that we have and to develop and obtain new patents and trademarks for future processes, machinery, compounds and products that we develop. The process of seeking patent protection may be long and expensive, and patents might not be issued or not be broad enough in scope. We may not be able to protect our technology adequately, and our competition may be able to develop similar technology that does not infringe or encroach upon any of our rights.

119

Table of Contents

There currently are no claims or lawsuits pending or threatened against us regarding possible infringement claims, but infringement claims by third parties, or claims for indemnification resulting from infringement claims, could be asserted in the future or that such assertions, if proven to be accurate, could have a material adverse effect on our business, financial condition and results of operations. In the future, litigation may be necessary to protect our trade secrets or know-how or to defend against claimed infringement of the rights of others and to determine the scope and validity of the proprietary rights of others. Any litigation could result in substantial cost and diversion of our efforts and other resources, which could have a material adverse effect on our financial condition and results of operations. Adverse determinations in any litigation could result in the loss of our proprietary rights, subjecting us to significant liabilities to third parties, require us to seek licenses from third parties or prevent us from manufacturing or selling our systems, any of which could have a material adverse effect on our financial condition and results of operations. A license under a third party’s intellectual property rights might not be available to us on reasonable terms, if at all.

We are dependent on key employees.

Our success depends upon the efforts of our top management team and certain other key employees, including the efforts of our executive chairman, ~~chief financial officer,~~ and the ~~other~~mill ~~members of the senior~~ leadership ~~team~~teams. Although we have written employment agreements with some of these employees, such individuals could die, become disabled, retire, or resign. In addition, our success is dependent upon our ability to attract and retain key management persons for positions relating to the marketing and distribution of our products. We may not be able to recruit and employ such executives at times and on terms acceptable to us. Also, volatility, lack of positive performance in our stock price and changes in our overall compensation program, including our equity incentive program, may adversely affect our ability to retain such key employees.

Our officers and directors have limited liability and have indemnification rights.

Our articles of incorporation and bylaws provide that we may indemnify our officers and directors against losses sustained or liabilities incurred which arise from any transaction in that officer’s or director’s respective managerial capacity, unless that officer or director violates a duty of loyalty, did not act in good faith, engaged in intentional misconduct or knowingly violated the law, approved an improper dividend or derived an improper benefit from the transaction.

Risks Relating to Our Stock

Our common stock was delisted from Nasdaq, which may adversely affect our stock price and the liquidity of our stock and could impact our ability to obtain financing could be impaired.

Trading in the Company’s common stock was suspended at the open of business on November 8, 2023 removing the Company’s securities from listing and registration on Nasdaq. We have transferred the quotation of our common stock to the over-the-counter markets operated by OTC Markets Group Inc. The shares of the Company’s common stock are currently trading under the symbol of “RIBT” on OTC Pink Market.

The delisting of our common stock from Nasdaq may negatively impact our Company and holders of our common stock, including the willingness of investors to hold our common stock because of the resulting decreased price, liquidity and trading of our common stock, limited availability of price quotations and reduced news and analyst coverage. There can be no guarantee that a broker will continue to make a market in our common stock and that trading will continue on the OTC Pink Market. The delisting from Nasdaq may further adversely impact the perception of our financial condition, cause reputational harm with investors, our employees and business partners, and limit our access to debt and equity financing.

Our stock price is volatile.

The market price of our common stock has fluctuated significantly in the past and may continue to fluctuate significantly in the future. The market price of the common stock may continue to fluctuate in response to a number of factors, including:

●

fluctuations in our quarterly or annual operating results;

● ~~fluctuations~~asset insales ~~the~~and ~~cost of raw rice bran or the other feedstocks for our business~~refinancings;

●

fluctuations in the cost of feedstocks for our business;

●

developments in our relationships with customers and suppliers;

●

our ability to obtain financing;

●

announcements of new products or product enhancements by us or our competitors;

●

announcements of technological innovations or new systems or enhancements used by us or our competitors;

●

the loss of services of one or more of our executive officers or other key employees;

Table of Contents

●

developments in our or our competitors’ intellectual property rights;

●

adverse effects to our operating results due to the impairment of goodwill;

●

failure to meet the expectation of securities analysts or the public;

●

general economic and market conditions;

●

our ability to expand our operations, domestically and internationally;

●

the amount and timing of expenditures related to any expansion;

●

litigation involving us, our industry or both;

●

actual or anticipated changes in expectations by investors or analysts regarding our performance; and

●

price and volume fluctuations in the overall stock market from time to time.

In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been brought against that company. Our stock price is volatile and in prior years we have been the target of shareholder litigation. Any shareholder litigation brought against us in the future could result in substantial costs and divert our management’s attention and resources from our business.

Table of Contents

We have significant “equity overhang” which could adversely affect the market price of our common stock and impair our ability to raise additional capital through the sale of equity securities.

As of ~~March~~December 1631, 2023, 69,~~384~~513,~~334~~341 shares of common stock were outstanding, 24,~~349~~501,~~083~~858 shares of common stock were issuable upon exercise of our outstanding stock options and warrants, 14,235 shares of common stock were issuable upon conversion of preferred stock and ~~682~~490,~~204~~061 shares of common stock issuable upon vesting of restricted stock units. The possibility that substantial amounts of our common stock may be sold by investors or the perception that such sales could occur, often called “equity overhang,” could adversely affect the market price of our common stock and could impair our ability to raise additional capital through the sale of equity securities in the future. The issuance of the additional shares upon an increase in our authorized shares of common stock would significantly increase the amount of our common stock outstanding and the amount of the equity overhang.

The authorization and issuance of preferred stock may have an adverse effect on the rights of holders of our common stock.

Our Board, without further action or vote by holders of our common stock, has the right to establish the terms, preference, rights and restrictions and issue shares of preferred stock. Any series of preferred stock could be issued with terms, rights, preferences and restrictions that could adversely affect the rights of holders of our common stock and thereby reduce the value of our common stock. The designation and issuance of preferred stock favorable to current management or shareholders could make it more difficult to gain control of our board of directors or remove our current management and may be used to defeat hostile bids for control which might provide shareholders with premiums for their shares. We have designated and issued five series of preferred stock that no longer remain outstanding. In addition, in February 2017, we designated a seventh series of preferred stock, Series G. As of March 16, 2023, 150 shares of Series G preferred stock remain outstanding. We may issue additional series of preferred stock in the future.

If we fail to comply with the continuing listing standards ~~of The NASDAQ Capital Market~~, our securities could be delisted, which could affect the market price of our common stock and reduce our ability to raise capital.

Our common stock is currently listed on the ~~NASDAQ~~OTC ~~Capital~~Pink Market under the symbol “RIBT”. For our common stock to continue to be listed on the NASDAQ Capital Market, we must meet the current NASDAQ Capital Market continued listing requirements, including maintaining a minimum of $2.5 million in shareholders’ equity and maintaining a minimum common stock bid price of $1.00. If we were unable to meet these requirements, including, but not limited to, requirements to obtain shareholder approval of a transaction other than a public offering involving the sale or issuance equal to 20% or more of our common stock at a price that is less than the market value of our common stock, our common stock could be delisted from the NASDAQ Capital Market.

There can be no assurance that we will be able to maintain compliance with the continued listing requirements for ~~Nasdaq~~the OTC Pink Market. If we fail to maintain compliance with any such continued listing requirement, there can also be no assurance that we will be able to regain compliance with any such continued listing requirement in the future ~~or that our common stock will not be delisted from NASDAQ Capital Market in the future~~.

If our securities were to be delisted from the NASDAQ Capital Market, our securities could continue to trade on the over-the-counter bulletin board following any delisting from the NASDAQ Capital Market, or on the Pink Sheets, as the case may be. Any such delisting of our securities could have an adverse effect on the market price of, and the efficiency of the trading market for our securities, not only in terms of the number of shares that can be bought and sold at a given price, but also through delays in the timing of transactions and less coverage of us by securities analysts, if any. Also, if in the future we were to determine that we need to seek additional equity capital, it could have an adverse effect on our ability to raise capital in the public or private equity markets. 11

Table of Contents

General Risks

An “ownership change” could limit our ability to utilize our net operating loss (NOL) carryforwards and other tax attributes, which could result in increased future tax liability to us. We have entered into a rights agreement (Rights Agreement) to reduce the likelihood of an “ownership change” occurring in the future.

We have significant U.S. federal and state NOL carryforwards. Federal tax laws impose restrictions on the utilization of NOL carryforwards and other tax attributes in the event of an “ownership change” as defined by Section 382 of the Internal Revenue Code of 1986, as amended (Tax Code). A corporation generally will experience an “ownership change” if the percentage of the corporation’s stock owned by its “5-percent shareholders,” as defined in Section 382 of the Tax Code (Section 382), increases by more than 50 percentage points over their lowest ownership percentage within the “testing period” as defined in Section 382, which is generally a rolling three-year period. Under Section 382, if a corporation undergoes an “ownership change,” such corporation’s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income may be limited. Future changes in our stock ownership, which may be outside of our control, may trigger an “ownership change.” If an “ownership change” occurs in the future, utilization of our NOL carryforwards or other tax attributes may be limited, which could potentially result in increased future tax liability to us.

Accordingly, we have adopted the Rights Agreement. The Rights Agreement is designed to reduce the likelihood that we will experience an “ownership change” under Section 382 by discouraging any person or group of persons from acquiring beneficial ownership of 4.95% or more of the shares of our common stock then outstanding or from acquiring additional shares of our common stock. Although the Rights Agreement is intended to reduce the likelihood of an “ownership change” that could adversely affect the utilization of our NOL carryforwards and other tax attributes, we cannot provide assurance that these restrictions on transferability will prevent all transfers that could result in such an “ownership change”.

We must comply with our contractual obligations.

We have numerous ongoing contractual obligations under various purchase, sale, supply, production and other agreements which govern our business operations. While we seek to always comply with these obligations, we may not be able to comply with the terms of all contracts during all periods of time, especially if there are significant changes in market conditions or our financial condition. If we are unable to comply with our material contractual obligations, there likely would be a material adverse effect on our financial condition and results of operations.

Table of Contents

Compliance with corporate governance and public disclosure regulations may result in additional expenses.

In order to comply with laws, regulations and standards relating to corporate governance and public disclosure, including the framework established by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) entitled “Internal Control - Integrated Framework”, and other regulations issued by the SEC, such as Dodd-Frank, we may need to invest substantial resources to comply with these evolving standards, and this investment would result in increased general and administrative expenses and a diversion of management time and attention from revenue-generating activities to compliance activities.

Breaches of our information system security measures could disrupt our internal operations.

We are dependent upon information technology for the distribution of information internally and to our customers and suppliers. This information technology is subject to theft, damage or interruption from a variety of sources, including but not limited to malicious computer viruses, security breaches and defects in design. Security breaches may result from employees’ failure to observe internal control protocols designed to protect the security of our network and the information on it, or solely from external intrusion despite our best efforts to protect our network and the information on it. Various measures have been implemented to manage our risks related to information system and network disruptions, but a system failure or breach of these measures could negatively impact our operations and financial results.

Our inability to successfully recover from a disaster or other business continuity problem could cause material financial loss, regulatory actions, reputational harm or legal liability.

Should we experience a local or regional disaster or other business continuity problem, such as a terrorist attack, pandemic, security breach, power loss, telecommunications failure, earthquake, hurricane or other natural or man-made disaster, our continued success will depend, in part, on the availability of key personnel, and the proper functioning of computer, telecommunication and other related systems and operations. Further, we could potentially lose customer data or experience adverse interruptions to our operations in a disaster recovery scenario, which could result in material financial loss, regulatory action, reputational harm or legal liability.

ITEM 1B. UNRESOLVED STAFF COMMENTS

Not applicable.

Table of Contents

ITEM 1C. CYBERSECURITY

Risk Management and Strategy

We employ a risk management framework to identify, assess, monitor, and test cyber risk and controls, and perform comprehensive due diligence and ongoing oversight of third-party relationships, including vendors. We have made and will continue to make ongoing investments in developing and enhancing our security processes and controls and in maintaining our technology infrastructure, including the maintenance of a business continuity and disaster recovery program, which is tested on a regular basis. We have also implemented processes to help identify, assess and manage cybersecurity risks associated with our use of a third-party service provider. We also provide regular education and training to our employees and contractors on cybersecurity and the protection of our information systems in order to mitigate risk associated with protection against threats to the confidentiality, availability, and integrity of our information systems. We do not believe that risks from cybersecurity threats of which we are currently aware, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition. See Item 1A – Risk Factors above for additional information on risks related to cyber-attacks.

Governance

Together with the Board’s standing committees, the Company’s Board of Directors is responsible for ensuring that material risks, including material cybersecurity risks, are identified and managed appropriately. The Board and its committees regularly review material operational, financial, cybersecurity, compensation and compliance risks with management. For example, the Audit Committee oversees the Company’s consultation with outside parties with an expertise in cybersecurity that we engage and retain to review and assess our information security program. The Board also receives regular updates concerning our information security and cyber risk strategy, cyber defense initiatives, cyber event preparedness, and cybersecurity risk assessments.

ITEM 2. PROPERTIES

We use ~~and~~our ~~maintain~~owned ~~various~~facility ~~facilities~~ for manufacturing, warehousing and distribution. ~~These facilities consist of both owned and leased properties.~~ The following table summarizes the properties currently used to conduct our operations ~~as of December 31, 2022~~:

Location Status Primary Use West Sacramento, California Leased Warehousing Mermentau, Louisiana Owned Manufacturing Lake Charles, Louisiana Building – owned Warehousing Lake Charles, Louisiana Land – leased Warehousing Dillon, Montana Owned Manufacturing Wynne, Arkansas Owned Manufacturing East Grand Forks, Minnesota Owned Manufacturing

We believe that ~~all~~ our ~~facilities~~facility ~~are~~is in good operating condition and the machinery and equipment is well-maintained. We believe the ~~facilities~~facility ~~are~~is suitable for ~~their~~its intended purposes and have capacities adequate for current operations.

Our wholly owned rice mill in Wynne, Arkansas, (Golden Ridge), carries a mortgage agreement with a lender pursuant to a promissory note, originally date July 2020, and modified in January 2023 (see Note 9 to the accompanying consolidated financial statements for further discussion of the promissory note).

ITEM 3. LEGAL PROCEEDINGS

We currently are not a party to any material litigation or other material legal proceedings. From time to time, we may be subject to legal proceedings and claims in the ordinary course of business.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

1413

Table of Contents

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Price Range of Common Stock

Our common stock trades on the ~~NASDAQ~~OTC ~~Capital~~Pink Market under the symbol “RIBT.” Our CUSIP No. is 762831303. Any over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.

Holders

As of March 1629, ~~2023~~2024, there were approximately ~~224~~222 holders of record of our common stock.

Dividends

We have never declared or paid any cash dividends on our common stock. We currently anticipate that we will retain ~~all~~any future earnings for the expansion and operation of our business and do not anticipate paying cash dividends in the near future.

Recent Sales of Unregistered Securities

During the quarter ended December 31, ~~2022~~2023, we issued the securities described below without registration under the Securities Act. The description below does not include issuances that were disclosed previously on Current Reports on Form 8-K. Unless otherwise indicated below, the securities were issued pursuant to the private placement exemption provided by Section 4(a)(2) of the Securities Act of 1933, as amended. All issuances below were made without any public solicitation, to a limited number of sophisticated persons and were acquired for investment purposes only.

On December 311, ~~2022~~2023, we issued ~~600~~2,222,222 shares of common stock to aan ~~service~~entity ~~provider,~~owned ~~that~~by isCable ~~not~~Car aCapital ~~natural person~~LLC, asFunicular ~~compensation~~Funds, ~~for~~LP ~~service~~(Funicular), ~~provided.~~at ~~The~~a ~~shares~~purchase ~~were~~price ~~valued~~equal atto an$0.18 ~~aggregate~~per ~~of $2,100~~share.

On December 31, 2023, we issued 600 shares of common stock to a service provider, that is not a natural person, as compensation for service provided. The shares were valued at an aggregate of $2,100.

Share Repurchases

None

ITEM 6. RESERVED

Table of Contents

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

~~Results~~Basis of ~~Operations~~Presentation and Going Concern

~~Revenues~~The ~~were~~Company ~~$41.6~~has ~~million~~incurred inlosses ~~2022,~~and angenerated ~~increase~~negative ofcash ~~$10.5~~flows ~~million, or 33.7%, compared to $31.1 million in 2021. The increase was due to strong growth~~ from ~~our MGI and Golden Ridge milling~~ operations, assince ~~well~~its ~~as growth in core SRB sales, offset in part by lower sales of value-add SRB derivative products~~inception. ~~The~~As ~~primary driver~~ of ~~growth~~December ~~for~~31, ~~all~~2023, ~~three of~~ the ~~expanding~~Company ~~businesses~~had ~~was~~an ~~higher~~accumulated ~~volumes~~deficit ~~resulting~~of ~~from improved sales and operations~~$333.3 million ~~The decrease in value-add SRB derivative sales stemmed from multiple factors, including increased competition from new market entrants~~ and ~~production~~cash ~~issues with our organic products due to poor quality feedstock~~ and ~~the~~cash ~~necessity~~equivalents ~~for~~of ~~enzyme~~$1.1 ~~changes~~million.

~~Gross~~Our ~~loss~~history ~~was $0.8 million in 2022, compared to gross profit~~ of ~~$0.4~~operating ~~million~~losses inand ~~2021.~~negative ~~The~~operating ~~$1.2~~cash ~~million~~flows ~~decrease~~from incontinuing ~~gross~~operations ~~profit~~raises insubstantial ~~the~~doubt ~~was~~about ~~attributable primarily to lower gross profits from~~ our ~~value-added~~ability ~~SRB derivative products and,~~ to acontinue ~~lesser~~as ~~extent, lower margins from core SRB sales, offset in part by~~ a ~~significant~~going ~~reduction~~concern inwithin ~~gross~~one ~~loss~~year from ~~our~~the ~~specialty~~date ~~milling~~of ~~facilities~~this filing. ~~Most~~Due ~~notably,~~to ~~Golden~~these ~~Ridge~~historical ~~generated~~losses ~~its~~and ~~first~~negative ~~positive operating~~ cash flows, ~~from~~management ~~milling~~has ~~operations~~considered invarious ~~the~~strategic ~~fourth~~alternatives. ~~quarter~~Specifically, ofwe ~~2022~~recently ~~following~~completed ~~the~~a ~~implementation~~refinancing ofin ~~our~~December ~~new operating agreement with Gander Foods~~2023, ~~LLC,~~as ~~which~~further ~~commenced~~described ~~October 1, 2022~~below.

~~Selling~~On ~~general~~December ~~and~~1, ~~administrative~~2023, ~~(SG&A)~~an ~~expenses~~entity ~~were~~owned ~~$6.6~~by ~~million~~Cable inCar ~~2022,~~Capital ~~a decline of $0.5 million~~LLC, orFunicular ~~6.5%~~Funds, ~~compared~~LP ~~to $7.1 million in 2021. The reduction was achieved despite higher wage rates and insurance premiums~~(Funicular), ~~due~~purchased ~~to reductions in director compensation and efforts to drive other efficiencies. We further reduced SG&A by~~ $0.14 million ~~with~~of ashares ~~sublet~~ of ~~our~~common ~~corporate~~stock ~~headquarters.~~of ~~The sublet began in~~ the ~~third~~Company ~~quarter of 2022~~ and ~~ends~~lent in the ~~fourth~~Company ~~quarter~~$4.1 ~~of 2023~~million.

Related to this financing, Funicular was also granted warrants to purchase up to 5.0 million shares of common stock of the Company. If Funicular exercised all its warrants, it would own 49.8% of the Company. The Company also exchanged existing warrants with other investors to purchase an aggregate 2.2 million shares of common stock of the Company for an aggregate of approximately 0.6 million shares of common stock of the Company and new warrants to purchase 1.2 million shares of common stock of the Company.

With the proceeds of this financing, the Company repaid its $1.5 million mortgage note (see Note 9) and will use the remaining balance to fund its current and future general working capital and operating, investing, and financing cash flow needs.

On January 25, 2024, the Company sold Golden Ridge for $2.15 million. As a result of the sale, the Company has streamlined its business and balance sheet, eliminating unprofitable operations.

The Company also believes additional cash can be secured through other debt or structured equity financing, if necessary. However, there can be no assurance that equity or debt financing will be available to the Company should it need it or, if available, that the terms will be satisfactory to the Company and not dilutive to existing shareholders. The Company’s failure to raise capital as and when needed could have significant negative consequences for its business, financial condition, and results of consolidated operations.

On June 23, 2023, we completed the sale of assets related to the production of stabilized rice bran and the processing of stabilized rice bran into stabilized rice bran derivatives at facilities located in West Sacramento, California, Mermentau, Louisiana, Lake Charles, Louisiana and Dillon, Montana (the SRB Business). The SRB Business’s results are presented as discontinued operations in our consolidated statements of operations and are excluded from continuing operations for all periods presented. See Note 3 in the Notes to Consolidated Financial Statements for further discussion of our discontinued operations.

For the year ended December 31, 2023, our continuing operations included the results of operating our rice mill located in Wynne, Arkansas (Golden Ridge) and our barley and oats mill located in East Grand Forks, Minnesota (MGI). Subsequently, on January 26, 2024, we completed the sale of our Golden Ridge rice mill and the assets exclusively related to our production of No. 1 and No. 2 Grade U.S. premium long and medium white rice and SRB products at the Golden Ridge facility for $2.15 million.

Following the sales of the SRB Business and Golden Ridge, we derive revenues from sales of barley, oats and mustard produced at our grain mill and processing facility in East Grand Forks, Minnesota. As a result of these transactions (which are by nature non-recurring) our future results of operations may differ materially from our past results.

Results of Continuing Operations

Revenues from continuing operations were $22.6 million in 2023, a decrease of $4.0 million, or 15.0%, compared to $26.6 million in 2022. This decrease was equally split between our MGI and Golden Ridge milling operations. At MGI, the decrease was about equally split among the four quarters primarily due to lower commodity prices during the year. The Golden Ridge decrease mainly occurred in the fourth quarter and was primarily due to unavoidable business disruption during its sale process that concluded with the sale of the mill on January 25, 2024.

Despite this decrease in revenue, the 2023 gross loss from continuing operations improved $0.4 million over 2022 primarily due to better matching of raw material commodity and sales prices.

Selling general and administrative (SG&A) expenses from continuing operations were $5.9 million in 2023, an increase of $0.5 million, or 9.3% compared to $5.4 million in 2022. This increase was primarily due to increased legal costs as we continue to explore strategic alternatives.

Loss from continuing operations in 2023 was $8.6 million, or $1.22 per share, compared to a loss from continuing operations of $6.7 million, or $1.21 per share, in 2022. This increase was primarily due to a $1.5 million impairment charge recorded in the fourth quarter on the property and equipment at Golden Ridge related to the sale of these assets on January 25, 2024.

Net loss in 2023 was $17.6 million, or $2.51 per share, compared to a net loss of $7.9 million, or $1.42 per share in 2022. This $9.7 million increase was primarily due to the $8.6 million loss on the sale of our SRB in June 2023 and the $1.5 million impairment charge noted above offset by $0.4 million of net savings driven by not having SRB and its related losses in the second half of 2023.

Liquidity, Going Concern and Capital Resources

The Company has incurred losses and generated negative cash flows from operations since its inception. As of December 31, 2023, the Company had an accumulated deficit of $333.3 million, shareholders’ deficit of $3.0 million and cash and cash equivalents of $1.1 million. In our continuing operations, we used $2.2 million in operating cash during 2023, compared to $3.8 million of operating cash in 2022. We also funded $0.7 million of capital expenditures in 2023, compared to $0.2 million in in the prior year. These capital expenditures relate primarily to equipment at our MGI facility.

Our history of operating losses and negative operating cash flows from continuing operations raises substantial doubt about our ability to continue as a going concern within one year from the date of this filing. Due to these historical losses and negative cash flows, management has considered various strategic alternatives. Specifically, we recently completed a refinancing in December 2023, as further described below.

Table of Contents

WeOn ~~recognized~~December ~~a gain of $0.~~1, ~~million in 2022 on the involuntary conversion of assets when we finalized our insurance claim for hurricane damage that occurred in August 2020 to our Lake Charles~~2023, ~~Louisiana property. In 2021~~Funicular, wepurchased ~~recorded a~~ $30.94 million ~~non-cash,~~of ~~non-tax-deductible~~shares ~~impairment~~of ~~charge~~common ~~equal~~stock toof the ~~entire~~Company ~~amount~~and oflent ~~our goodwill (as discussed further in Note 7 to~~ the ~~accompanying~~Company ~~consolidated~~$4.1 ~~financial statements)~~million.

~~Operating~~Related ~~loss~~to this financing, Funicular was ~~$7.2~~also ~~million~~granted inwarrants ~~2022,~~to ~~compared~~purchase up to an5.0 ~~operating~~million ~~loss~~shares of ~~$10~~common stock of the Company.6 ~~million~~If inFunicular ~~2021~~exercised all its warrants, asit would own 49.8% of the ~~decline~~Company. inThe ~~gross~~Company ~~profits~~also ~~were~~exchanged ~~offset~~existing bywarrants ~~the~~with ~~improvement~~other ininvestors ~~SG&A,~~to ~~the~~purchase ~~gain~~an onaggregate ~~involuntary~~2.2 ~~conversion~~million ~~and~~shares of common stock of the ~~impact~~Company for an aggregate of approximately 0.6 million shares of common stock of the ~~2021~~Company ~~goodwill~~and ~~impairment~~new warrants to purchase 1.2 million shares of common stock of the Company.

InWith ~~2021~~the proceeds of this financing, wethe ~~recognized~~Company arepaid its $1.85 million ~~gain~~mortgage onnote ~~extinguishment~~and ofwill ~~our~~use ~~Small~~the ~~Business~~remaining ~~Administration~~balance ~~Paycheck~~to ~~Protection~~fund ~~Program~~its ~~loan~~current ~~(see~~and ~~Note~~future 14general toworking ~~the~~capital ~~accompanying~~and ~~consolidated~~operating, ~~financial~~investing, ~~statements~~and ~~for~~financing ~~further~~cash ~~discussion~~flow ~~of the loan)~~needs.

~~Net~~On ~~loss~~January ~~in 2022 was $7.8 million~~25, ~~or $1.41 per share~~2024, ~~compared~~the toCompany asold ~~net~~Golden ~~loss~~Ridge offor $82.915 million~~, or $1~~.87 ~~per~~As ~~share,~~a inresult ~~2021.~~of ~~The $3.3 million decline in operating loss was offset by~~ the ~~$0.2 million change in fair value of derivative liability~~sale, the ~~$0.2~~Company ~~million~~has ~~increase~~streamlined inits ~~interest~~business and ~~other~~balance ~~expense due to higher average outstanding debt~~sheet, ~~and~~eliminating ~~the~~unprofitable ~~impact of the 2021 $1~~operations.~~8 million gain on the PPP loan extinguishment.~~

~~Liquidity~~The Company also believes additional cash can be secured through other debt or structured equity financing, ~~Going~~if ~~Concern~~necessary. However, there can be no assurance that equity or debt financing will be available to the Company should it need it or, if available, that the terms will be satisfactory to the Company and ~~Capital~~not ~~Resources~~dilutive to existing shareholders. The Company’s failure to raise capital as and when needed could have significant negative consequences for its business, financial condition, and results of consolidated operations.

We had $3.9 million in cash and equivalents as of December 31, 2022, a decline of $1.9 million from $5.8 million on December 31, 2021. Cash used in operating activities in 2022 was $3.9 million compared to $4.2 million in 2021, driven principally by an increase in net losses. Cash used in investing activities in 2022 was $0.5 million, which consisted of $0.6 million in capital expenditures offset by $0.1 million in insurance proceeds. Cash from financing activities in the 2022 was $2.5 million, which included $1.3 million from the sale of common stock and warrants, net of cash offering costs, and a $0.9 million over-advance on our factoring facility (see Note 9 to the accompanying consolidated financial statements for further discussion of the over-advance).

Management believes that despite the multi-year history of operating losses and negative operating cash flows from continuing operations, there is no substantial doubt about our ability to continue as a going concern within one year after the date that these financial statements included in this Annual Report are issued. Factors alleviating this concern include $3.9 million in cash and cash equivalents as of December 31, 2022, the recent improvement in profitability of our milling business, and our ability to procure additional capital if needed through a variety of sources, most notably through the disposition, or borrowing against, of one of our owned facilities.

On March 30, 2020, we entered into a sales agreement with respect to an at-the-market (ATM) offering program, under which we may offer and sell shares of our common stock having an aggregate offering price of up to $6.0 million, which we currently have $2.8 million remaining. Under the terms of the securities purchase agreement related to a September 2021 offering, we are prohibited from entering into an agreement to effect any at-the-market issuance until September 13, 2023. Under the terms of the securities purchase agreement related to the October offerings, we are generally prohibited from entering into an agreement to effect an offering of our common stock or common stock equivalents until May 20, 2023, or a variable rate transaction, as defined in the agreement, until October 20, 2023.

Critical Accounting Policies

The accompanying consolidated financial statements have been prepared in U.S. Dollars and in accordance with accounting principles generally accepted in the United States (GAAP). The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. These estimates and assumptions are affected by the application of our accounting policies. Our significant accounting policies are described in Note 21 to the accompanying consolidated financial statements. Critical accounting estimates are those that require application of management’s most difficult, subjective or complex judgments, often as a result of matters that are inherently uncertain and may change in subsequent periods. While we apply our judgment based on assumptions believed to be reasonable under the circumstances, actual results could vary from these assumptions. It is possible that materially different amounts would be reported using different assumptions. The following is a description of what we consider to be our most significant critical accounting policies.

Inventories – We state inventories at the lower of cost or net realizable value. We employ a full absorption procedure using standard cost techniques for most of our operations. The standards are customarily reviewed and adjusted so that they are materially consistent with actual purchase and production costs. We make provisions for potentially obsolete or slow-moving inventory based upon our analysis of inventory levels, historical obsolescence and future sales forecasts. We write-off inventory determined to be obsolete immediately.

Property and Equipment – Property and equipment are stated at cost less accumulated depreciation. We compute depreciation on the straight-line basis and recognize it over the estimated useful lives of the assets. We expense maintenance and repairs as incurred and capitalize renewals and betterments. We include gains or losses on the sale of property and equipment in net income (loss).

Impairment of Long-lived Assets – We review our long-lived assets, such as property and equipment and right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We recognize an impairment loss when the undiscounted future cash flows estimated to be generated by the asset to be held and used are not sufficient to recover the unamortized balance of the asset. The impairment loss is the difference between the carrying value and the estimated fair value. We determine the estimated fair value based on either the discounted future cash flows or other appropriate fair value methods with the amount of any such deficiency charged to operations in the current year. Estimates of future cash flows are based on many factors, including current operating results, expected market trends and competitive influences. We report assets to be disposed of by sale at the lower of the carrying amount or fair value, less estimated costs to sell.

Intangible Assets – We amortize recognized intangible assets over the useful lives of the assets unless that life is determined to be indefinite. All of our intangible assets are finite lived. We evaluate the remaining useful life of an intangible asset each reporting period to determine whether events or circumstances may indicate that a revision to the useful life is warranted to reflect the remaining expected use of the asset. If an intangible asset’s useful life is determined to be finite, but the precise length of that life is not known, the intangible asset is amortized over our best estimate of the asset’s useful life in a manner that reflects the pattern in which the asset’s economic benefits are consumed or expected to be realized. We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We recognize an impairment loss when the undiscounted future cash flows estimated to be generated by the asset to be held and used are not sufficient to recover the unamortized balance of the asset. Our primary intangible asset is a customer relationship intangible which derives its value from future cash flows expected from the acquired customers. Changes in the actual or estimated future cash flows of these customers could result in a material adjustment to amortization expense, an impairment loss, or both. Estimates of future cash flows are based on many factors, including current cash flows, expected market trends and competitive influences.

Table of Contents

Impairment of Long-lived Assets – We review our long-lived assets, such as property and equipment and right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We recognize an impairment loss when the undiscounted future cash flows estimated to be generated by the asset to be held and used are not sufficient to recover the unamortized balance of the asset. The impairment loss is the difference between the carrying value and the estimated fair value. We determine the estimated fair value based on either the discounted future cash flows or other appropriate fair value methods with the amount of any such deficiency charged to operations in the current year. Estimates of future cash flows are based on many factors, including current operating results, expected market trends and competitive influences. We report assets to be disposed of by sale at the lower of the carrying amount or fair value, less estimated costs to sell.

Intangible Assets – We amortize recognized intangible assets over the useful lives of the assets unless that life is determined to be indefinite. All of our intangible assets are finite lived. We evaluate the remaining useful life of an intangible asset each reporting period to determine whether events or circumstances may indicate that a revision to the useful life is warranted to reflect the remaining expected use of the asset. If an intangible asset’s useful life is determined to be finite, but the precise length of that life is not known, the intangible asset is amortized over our best estimate of the asset’s useful life in a manner that reflects the pattern in which the asset’s economic benefits are consumed or expected to be realized. We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We recognized an impairment loss when the undiscounted future cash flows estimated to be generated by the asset to be held and used are not sufficient to recover the unamortized balance of the asset. Our primary intangible asset is a customer relationship intangible which derives its value from future cash flows expected from the acquired customers. Changes in the actual or estimated future cash flows of these customers could result in a material adjustment to amortization expense, an impairment loss, or both. Estimates of future cash flows are based on many factors, including current cash flows, expected market trends and competitive influences.

Revenue Recognition – We account for a contract with a customer when the written contract is committed, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of collection. Substantially all of our revenue is derived by fulfilling customer orders for the purchase of our products under contracts which contain a single performance obligation, to supply continually defined quantities of product at fixed prices. We account for shipping and handling activities that occur after the customer has obtained control of a good as a fulfillment cost rather than as an additional promised service. We recognize revenue at the point in time that control of the ordered product(s) is transferred to the customer, which is upon delivery to the customer, or its designee at our location, a customer location or other customer-designated delivery point. For substantially all of our contracts, control of the ordered product(s) transfers at our location. Amounts invoiced to customers for shipping and handling are reported as revenues and the related costs incurred to deliver product to the customer are reported as cost of goods sold.

We measure revenue as the amount of consideration we expect to receive in exchange for fulfilling product orders. Incidental items that are immaterial in the context of the contract are recognized as expense. Our contracts do not include a significant financing component. Our contracts may include terms that could cause variability in the transaction price, including, for example, rebates and volume discounts, or other forms of contingent revenue. The amount of consideration we expect to receive and revenue we recognize includes estimates of variable consideration, including costs for rebates and discounts. If the consideration promised in a contract includes a variable amount, we estimate the amount to which we expect to be entitled using either the expected value or most likely amount method. Changes in judgments and estimates regarding probability of collection and variable consideration might result in a change in the timing or amount of revenue recognized.

We capitalize the incremental costs of obtaining a revenue contract and amortized those costs on a straight-line basis over the expected customer relationship period if we expect to recover those costs. As a practical expedient, we expense costs to obtain a contract as incurred if the amortization period would have been a year or less. Typically, costs to incur revenue contracts are not significant.

Discontinued Operations - A discontinued operation may include a component or a group of components of our operations. A disposal of a component or a group of components is reported in discontinued operations if the disposal represents a strategic shift that has or will have a major effect on our operations and financial results when the following occurs: (1) a component (or group of components) meets the criteria to be classified as held for sale; (2) the component or group of components is disposed of by sale; or (3) the component or group of components is disposed of other than by sale (for example, by abandonment or in a distribution to owners in a spin-off). For any component classified as held for sale or disposed of by sale or other than by sale, qualifying for presentation as a discontinued operation, we report the results of operations of the discontinued operations (including any gain or loss recognized on the disposal or loss recognized on classification as held for sale of a discontinued operation), less applicable income taxes (benefit), as a separate component in the consolidated statement of operations for current and all prior periods presented.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Directors of RiceBran Technologies

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of RiceBran Technologies and its subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations, changes in shareholders’ equity and cash flows for the years then ended, and the related notes to the consolidated financial statements (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of RiceBran Technologies:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheet of RiceBran Technologies and Subsidiaries (the “Company”) as of December 31, 2023, and the related consolidated statements of operations, changes in shareholders’ (deficit) equity, and cash flows for the year then ended, and the related notes to the consolidated financial statements (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

Going Concern

The accompanying financial statements have been prepared assuming that the entity will continue as a going concern. As discussed in Note 2 to the financial statements, the entity has an accumulated deficit at December 31, 2023 and, since inception, has suffered significant operating losses and negative cash flows from operations that raise substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the ~~Company~~entity’s financial statements based on our ~~audits~~audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our ~~audits~~audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our ~~audits~~audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the ~~Company~~entity’s internal control over financial reporting. Accordingly, we express no such opinion.

Our ~~audits~~audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our ~~audits~~audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our ~~audits~~audit ~~provide~~provides a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that ~~was~~were communicated or required to be communicated to the audit committee and that: (1) ~~relates~~relate to accounts or disclosures that are material to the financial statements and (2) involved ~~our~~ especially challenging, subjective, or complex judgments. The communication of ~~the~~ critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate ~~opinions~~opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Long-Lived Asset Impairment

As described in Notes 6 and 7 to the financial statements, the Company’s net consolidated property and equipment and intangible assets balances were $14,207,000 and $380,000, respectively, at December 31, 2022. As further described in Note 2 to the financial statements, the Company reviews long-lived assets, including property and equipment and intangible assets for impairment whenever events or changes in circumstances indicate that the caring amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the assets. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount exceeds the fair value of the asset. Based on events occurring during the year ended December 31, 2022, management performed an impairment assessment to test long-lived assets for impairment. The results of this assessment indicated that estimated undiscounted future cash flows exceed the carrying amount of the assets. The Company’s impairment assessment required management to make significant estimates and assumptions related to a number of factors, including forecasts of revenue growth rates and cash flows.

We identified the long-lived asset impairment assessment as a critical audit matter because changes in certain significant assumptions management used in the impairment analysis, including revenue growth rates and operating margins could have a significant impact on the analysis. Auditing these assumptions involved a high degree of auditor judgment and subjectivity and increased audit effort.

~~Table~~Asset ofImpairment ~~Contents~~

As described in Notes 6 and 7 to the financial statements, the Company’s net consolidated property and equipment and intangible assets balances were $4,238,000 and $270,000, respectively, at December 31, 2023. As further described in Note 1 to the financial statements, the Company reviews long-lived assets, including property and equipment and intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the assets. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount exceeds the fair value of the asset. Based on events occurring during the year ended December 31, 2023, management performed an impairment assessment to test long-lived assets for impairment. The results of this assessment indicated that assets were impaired and an impairment expense of approximately $1,542,000 was recorded. The Company’s impairment assessment required management to make significant estimates and assumptions related to a number of factors, including forecasts of revenue and cash flows.

We identified the long-lived asset impairment assessment as a critical audit matter because changes in certain significant assumptions management used in the impairment analysis, including projected revenues and operating margins could have a significant impact on the analysis. Auditing these assumptions involved a high degree of auditor judgment and subjectivity and increased audit effort.

Our audit procedures related to the Company’s long-lived asset impairment assessment included the following, among others:

● We obtained an understanding of the relevant controls related to the development of forecasted revenue ~~growth rates~~ and operating margins

● We tested the reasonableness of management’s process for determining the forecasts of revenue ~~growth rates~~ and operating margins

● We tested the reasonableness of management’s assumptions of forecasted revenue ~~growth rates~~ and operating margins by comparing management’s prior forecast to historical results for the Company ~~comparing the projections for consistency to the Company’s strategic plans and initiatives and comparing the projections to industry forecasts~~

● We evaluated whether the estimates ~~of revenue growth rates and cash flows~~ were consistent with evidence obtained in other areas of the audit.

/s/ WithumSmith+Brown, PC

We have served as RiceBran Technologies’ auditor since 2023.

Whippany, New Jersey

March 29, 2024

PCAOB ID Number 100

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Directors of RiceBran Technologies:

Opinion on the Financial Statements

We have audited, before the effects of the adjustments to retrospectively apply discontinued operations, as discussed in Note 3, the accompanying consolidated balance sheet of RiceBran Technologies and its subsidiaries (the Company) as of December 31, 2022, the related consolidated statements of operations, changes in shareholders’ (deficit) equity and cash flows for the year ended December 31, 2022, and the related notes to the consolidated financial statements (collectively, the financial statements). The 2022 financial statements before the effects of the adjustment described in Note 3 are not presented herein. In our opinion, before the effects of the adjustments to retrospectively apply discontinued operations, as discussed in Note 3, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

We were not engaged to audit, review, or apply any procedures to retrospectively apply discontinued operations, as discussed in Note 3, and accordingly, we do not express an opinion or any other form of assurance about whether such adjustments are appropriate and have been properly applied. Those adjustments were audited by other auditors.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ RSM US LLP

We ~~have~~ served as the Company’s auditor ~~since~~ from 2018 to 2023.

Houston, Texas

March 16, 2023

19 20

Table of Contents

RiceBran Technologies

Consolidated Balance Sheets

December 31, ~~2022~~2023 and ~~2021~~2022

(in thousands, except share amounts)

	2022			2021
	2023			2022
ASSETS
Current assets:
Cash and cash equivalents	$	31,~~941~~139		$	53,~~825~~941
Accounts receivable, net of allowance for doubtful accounts of $27 and $18		3,703			4,136
Accounts receivable, net of allowance for credit losses of $32 and $27		2,824			3,703
Inventories		~~2,378~~543			~~2,444~~465
Other current assets		~~1,046~~308			~~810~~735
Total current assets		11,068			13,215
Current assets held for sale		-			2,224
Property and equipment, net		14,207			15,444
Total current assets		4,814			11,068
Operating lease right-of-use assets		1,778			2,127
Property and equipment, net		4,238			6,020
Intangible assets		380			527
Operating lease right-of-use assets		-			77
Total assets	$	27,433		$	31,313
Intangible assets		270			380
LIABILITIES AND SHAREHOLDERS' EQUITY
Long-term assets held for sale		-			9,888
Total assets	$	9,322		$	27,433
LIABILITIES AND SHAREHOLDERS' (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	1,~~232~~549		$	~~826~~1,232
Commodities payable		12,~~546~~466			1,~~702~~546
Accrued salary, wages and benefits		~~696~~316			~~787~~489
Accrued expenses		1,124			683
Accrued legal		1,985			595
Operating lease liabilities, current portion		391			382
Accrued expenses		434			500
Due under bank line of credit		1,832			-
Operating lease liabilities, current portion		-			107
Due under factoring agreement		3,150			3,379
Due under bank line of credit		-			1,832
Due under insurance premium finance agreements		185			128
Due under factoring agreement		1,866			3,150
Finance lease liabilities, current portion		125			86
Due under insurance premium finance agreements		75			185
Long-term debt, current portion		996			1,183
Finance lease liabilities, current portion		132			113
Total current liabilities		11,364			9,156
Long-term debt, current portion		137			988
Operating lease liabilities, less current portion		1,557			1,948
Current liabilities held for sale		-			540
Finance lease liabilities, less current portion		325			100
Total current liabilities		8,960			11,277
Long-term debt, less current portion		1,296			1,356
Finance lease liabilities, less current portion		402			320
Derivative warrant liability		69			258
Long-term debt, less current portion		2,960			836
Total liabilities		14,524			12,818
Derivative warrant liability		-			69
Long-term liabilities held for sale		-			2,022
Total liabilities		12,322			14,524
Commitments and contingencies
Shareholders' equity:
Shareholders' (deficit) equity:
Preferred stock, 20,000,000 shares authorized: Series G, convertible, 3,000 shares authorized, stated value $150, 150 shares, issued and outstanding		75			75
Common stock, no par value, 15,000,000 shares authorized, 6,309,509 shares and 5,158,967 shares, issued and outstanding		328,551			326,279
Common stock, no par value, 15,000,000 shares authorized, 9,513,341 shares and 6,309,509 shares, issued and outstanding		330,202			328,551
Accumulated deficit		(~~315~~333,~~717~~277	)		(~~307~~315,~~859~~717	)
Total shareholders' equity		12,909			18,495
Total shareholders' (deficit) equity		(3,000	)		12,909
Total liabilities and shareholders' equity	$	27,433		$	31,313
Total liabilities and shareholders' (deficit) equity	$	9,322		$	27,433

See Notes to Consolidated Financial Statements

2021

Table of Contents

RiceBran Technologies

Consolidated Statements of Operations

Years Ended December 31, ~~2022~~2023 and ~~2021~~2022

(in thousands, except share and per share amounts)

	2022			2021
	2023			2022
Revenues	$	4122,~~617~~649		$	3126,~~131~~647
Cost of goods sold		4223,~~376~~060			3027,~~689~~410
Gross profit (loss)		(759	)		442
Gross loss		(411	)		(763	)
Selling, general and administrative expenses		65,~~690~~944			75,~~087~~397
Impairment of goodwill		-			3,915
Property and equipment impairment		1,542			-
Loss (gain) on involuntary conversion of property and equipment		(147	)		6
Loss from continuing operations before other income (expense)		(7,897	)		(6,160	)
Operating loss		(7,302	)		(10,566	)
Interest expense		(672	)		(516	)
Other income (expense):
Interest income		25			22
Interest expense		(572	)		(463	)
Change in fair value of derivative warrant liability		69			189
Interest income		22			1
Other income		266			7
Change in fair value of derivative warrant liability		189			389
Other expense		(330	)		(183	)
Gain on extinguishment of PPP Loan		-			1,792
Loss from continuing operations before income taxes		(8,539	)		(6,641	)
Other income		7			4
Income tax expense		(12	)		(19	)
Other expense		(183	)		(85	)
Loss from continuing operations		(8,551	)		(6,660	)
Loss before income taxes		(7,839	)		(8,928	)
Loss from discontinued operations		(9,009	)		(1,198	)
Income tax expense		(19	)		(21	)
Net loss	$	(17,560	)	$	(7,858	)
Net loss	$	(7,858	)	$	(8,949	)
Basic and diluted loss per common share:
Loss per common share:
Continuing operations	$	(1.22	)	$	(1.21	)
Basic	$	(1.42	)	$	(1.87	)
Discontinued operations	$	(1.29	)	$	(0.21	)
Diluted	$	(1.42	)	$	(1.87	)
	$	(2.51	)	$	(1.42	)
Weighted average number of shares outstanding:
Basic		56,~~514~~992,~~671~~358			45,~~773~~514,~~895~~671
Diluted		56,~~514~~992,~~671~~358			45,~~773~~514,~~895~~671

See Notes to Consolidated Financial Statements

2122

Table of Contents

RiceBran Technologies

Consolidated Statements of Changes in Shareholders’ (Deficit) Equity

Years Ended December 31, ~~2022~~2023 and ~~2021~~2022

(in thousands, except share amounts)

	Shares
						Preferred			Common		Accumulated
	Series G			Common		Stock			Stock		Deficit			(Deficit) Equity
Balance, January 1, 2021		225			4,523,809	$	112		$	322,218	$	(298,910	)	$	23,420
Balance, January 1, 2022		150			5,158,967	$	75		$	326,279	$	(307,859	)	$	18,495
Sales of common stock, net of costs					306,240		-			2,721		-			2,721
Common stock awards under equity incentive plans		-			70,858		-			1,114		-			1,114
Exercise of common stock warrants		-			248,543		-			171		-			171
Common stock issued to vendors		-			2,400		-			18		-			18
Conversion of preferred stock into common stock		(75	)		7,117		(37	)		37		-			-
Net loss		-			-		-			-		(8,949	)		(8,949	)
Balance, December 31, 2021		150			5,158,967		75			326,279		(307,859	)		18,495
Sales of common stock and common stock warrants, net of costs		-			675,000		-			986		-			986
Common stock awards under equity incentive plans		-			137,695		-			1,261		-			1,261
Exercise of common stock warrant		-			325,000		-			-		-			-
Common stock issued to vendors		-			2,400		-			10		-			10
Stock units issued to vendors		-			-		-			15		-			15
Other		-			10,447		-			-		-			-
Net loss		-			-		-			-		(7,858	)		(7,858	)
Balance, December 31, 2022		150			6,309,509	$	75		$	328,551	$	(315,717	)	$	12,909
Sales of common stock and common stock warrants, net of costs		-			2,851,032		-			1,155		-			1,155
Common stock awards under equity incentive plans		-			290,935		-			412		-			412
Common stock issued to vendors		-			2,400		-			80		-			80
Stock units issued to vendors		-			59,465		-			4		-			4
Net loss		-			-		-			-		(17,560	)		(17,560	)
Balance, December 31, 2023		150			9,513,341	$	75		$	330,202	$	(333,277	)	$	(3,000	)

See Notes to Consolidated Financial Statements

2223

Table of Contents

RiceBran Technologies

Consolidated Statements of Cash Flows

Years Ended December 31, ~~2022~~2023 and ~~2021~~2022

(in thousands)

	2022			2021
	2023			2022
Cash flow from operating activities:
Net loss	$	(717,~~858~~560	)	$	(87,~~949~~858	)
Loss from discontinued operations		(9,009	)		(1,198	)
Loss from continuing operations		(8,551	)		(6,660	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		~~2,103~~929			~~2,397~~866
Amortization		~~147~~110			~~195~~147
Stock and share-based compensation		~~1,286~~496			1,~~132~~204
Change in fair value of derivative warrant liability		(~~189~~69	)		(~~389~~189	)
Impairment of goodwill		-			3,915
Impairment of Golden Ridge assets		1,542			-
Loss (gain) on disposition and involuntary conversion of property and equipment		(147	)		6
Other		-			11
Gain on extinguishment of PPP loan		-			(1,792	)
Provision for bad debts		64			15
Accretion of interest		24			83
Other		(33	)		-
Changes in operating assets and liabilities:
Accounts receivable		~~369~~879			~~(1,332~~369	)
Inventories		66(78	)		~~(566~~309	)
Accounts payable and accrued expenses		~~624~~1,470			~~280~~433
Commodities payable		~~(156~~921	)		~~876~~(156	)
Other		~~(236~~144	)		(69129	)
Net cash used in operating activities		(3,936	)		(4,198	)
Net cash used in operating activities of continuing operations		(2,207	)		(3,795	)
Net cash used in operating activities of discontinued operations		(211	)		(141	)
Net cash used in operating activities		(2,418	)		(3,936	)
Cash flows from investing activities:
Purchases of property and equipment		(~~563~~689	)		(~~1,440~~225	)
Proceeds from insurance on involuntary conversion		109			639
Net cash used in investing activities of continuing operations		(689	)		(225	)
Proceeds from sale of property and equipment		-			3
Net cash provided by (used in) investing activities of discontinued operations		1,679			(229	)
Net cash used in investing activities		(454	)		(798	)
Net cash provided by (used in) investing activities		990			(454	)
Cash flows from financing activities:
Advances on factoring agreement		3826,~~117~~002			3138,~~038~~117
Payments on factoring agreement		(3827,~~346~~286	)		(2938,~~519~~346	)
Advances on bank line of credit		~~3,867~~37			-2,789
Payments on bank line of credit		(21,~~035~~869	)		-
Advances on insurance premium finance agreements		927			962
Advances on long-term debt and finance lease agreements		3,863			-
Payments on insurance premium finance agreements		(870	)		(960	)
Payments of long-term debt and finance lease liabilities		(2,061	)		(1,286	)
Advances on long-term debt, net of issuance costs		900			1,167
Proceeds from issuances of common stock and warrants, net of cash issuance costs		400			1,256
Payments of long-term debt and finance lease liabilities		(1,310	)		(665	)
Net cash provided by (used in) financing activities of continuing operations		(914	)		2,530
Proceeds from issuances of common stock and warrants, net of cash issuance costs		1,256			3,364
Net cash used in financing activities of discontinued operations		(460	)		(24	)
Proceeds from common stock warrant exercises		-			171
Net cash provided by (used in) financing activities		(1,374	)		2,506
Net cash provided by financing activities		2,506			5,558
Net change in cash and cash equivalents	$	(2,802	)	$	(1,884	)
Net change in cash and cash equivalents	$	(1,884	)	$	562
Cash and cash equivalents, beginning of period		3,941			5,825
Cash and cash equivalents, beginning of period		5,825			5,263
Cash and cash equivalents, end of period		1,139			3,941
Cash and cash equivalents, end of period		3,941			5,825
Net change in cash and cash equivalents	$	(2,802	)	$	(1,884	)
Net change in cash and cash equivalents and restricted cash	$	(1,884	)	$	562
Supplemental disclosures:
Cash paid for interest	$	548		$	354
Cash paid for income taxes	$	26		$	18

See Notes to Consolidated Financial Statements

2324

Table of Contents

~~RiceBran~~NOTE ~~Technologies~~1. BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Notes to Consolidated Financial Statements

NOTE 1. LIQUIDITY AND MANAGEMENT’S PLAN

Our multi-year history of operating losses and negative operating cash flows from continuing operations raised substantial doubt about our ability to continue as a going concern before consideration of management’s plans, however after consideration of management’s plans and the factors below, we believe substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued has been alleviated. The factors that alleviated the substantial doubt are summarized below:

Cash Reserves - As of December 31, 2022, we had $3.9 million in cash and cash equivalents.

Improving Operating Cash Flows - We expect an improvement in operating cash flows in 2023 due to the full year impact of two 2022 events: (i) effective October 1, 2022, we transitioned sourcing and selling activities for our Arkansas mill (Golden Ridge) to Gander Foods, LLC, a service provider with local expertise, and (ii) we made major capital investments in capacity expansion at our Minnesota mill (MGI) during 2022. Golden Ridge has been a significant source of operating losses for us since its acquisition in 2018, however it made its first positive quarterly contribution to operating cash flows in the fourth quarter of 2022 as a result of the transition to the service provider. MGI, which has been consistently profitable since its acquisition in 2019, saw a significant increase in sales and profit contribution in the fourth quarter of 2022 due to the additional capacity coming online in the third quarter of 2022. The transition of Golden Ridge to positive operating cash flows and expansion in MGI’s contribution to operating cash flows, together with (i) the steps we have taken to lower our run rate for selling and general administrative expenses and (ii) recovery of our SRB derivatives business, should provide us with a pathway to improved operating cash flows in 2023.

Access to Equity Funding - We could raise additional capital from offerings of equity, including common equity and equivalents once the restrictions discussed in Note 10 lapse in September 2023. We successfully completed equity raises in both 2022 and 2021 as further described in Note 10.

Ability to Leverage and/or Sell Real Property - We have been able to supplement liquidity by borrowing against our real property located in Wynne, Arkansas. We also own our facilities in Mermentau, Louisiana, Dillon, Montana, and North Grand Forks, Minnesota, with no existing liens. We could sell or mortgage these facilities to provide additional liquidity.

Strategic Review Process - In light of our challenges in achieving our operating and financial targets in 2022, we are currently undergoing a strategic review of all the possible alternatives to generate improved returns to our shareholders.

NOTE 2. BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business

We are a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. We create and produce products utilizing proprietary processes to deliver improved nutrition, ease of use, and extended shelf-life, while addressing consumer demand for all natural, non-GMO and organic products.

Notably, we convert raw rice bran into stabilized rice bran (SRB), and high value-added derivative products including: RiBalance, a rice bran nutritional package derived from SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a fiber rich insoluble derivative of RiBalance and ProRyza, a rice bran protein-based product.

SRB is an additive used in human and animal foods. SRB has certain attractions compared to additives based on the by-products of other agricultural commodities, such as corn, soybeans, wheat, and yeast. Our SRB and SRB derivatives are healthy, natural, hypoallergenic, gluten free, and non-genetically modified ingredients used in a variety of applications.

We produce SRB from four locations: two facilities located within supplier-owned rice mills in California; and two company-owned facility in the Louisiana and Arkansas delta region. We produce SRB derivatives at our Dillon, Montana, facility and we operate two specialty milling facilities, a rice mill in Arkansas, Golden Ridge, and a barley and oats mill in Minnesota, MGI.

Segment Reporting

Given the integrated nature of the products we produce and the ~~facilities~~facility in which we produce them, we have one reporting unit and one operating segment, as defined in applicable accounting guidance, specialty ingredients.

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

Recent Accounting Guidance

Recent accounting standards not yet adopted

The following discusses the accounting standard(s) not yet adopted that will, or are expected to, result in a significant change in practice and/or have a significant financial impact on our financial position, results of operations or cash flows.

In ~~June~~December ~~2016~~2023, the FASB issued ~~guidance~~ ASU ~~No. 2016~~2023-~~13 Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments which changes the accounting for credit losses for certain instruments~~09, ~~including~~Improvement ~~trade receivables, from an incurred loss method~~ to aIncome ~~current~~Tax ~~expected~~Disclosures, ~~loss~~which ~~method.~~requires ~~The~~disclosure ~~measurement~~ of ~~expected~~disaggregated ~~credit~~income ~~losses~~taxes ~~is based on relevant information about past events~~paid, ~~including~~prescribes ~~historical~~standard ~~experience,~~categories ~~current~~for ~~conditions,~~the ~~and~~components ~~reasonable~~of ~~and~~the ~~supportable~~effective ~~forecasts.~~tax ~~The~~rate ~~guidance~~reconciliation, and ~~subsequent~~modifies ~~guidance~~other income tax-related todisclosures. ~~the~~ASU ~~topic,~~2023-09 is effective for ~~our~~fiscal ~~annual~~years ~~and interim periods~~ beginning inafter December ~~2023~~15, ~~and~~2024, may ~~must~~ be ~~adopted~~applied onprospectively aor ~~modified retrospective approach through cumulative-effect adjustment to retained earnings as of January 1~~retrospectively, ~~2023. Based on the nature of our current receivables~~ and ~~our~~allows ~~credit~~for ~~loss~~early ~~history,~~adoption. weThese dorequirements are not ~~expect~~expected ~~the adoption of the guidance~~ to have aan ~~significant~~ impact on our results of operations, financial position, or cash flows and will expand income tax disclosures.

Recently adopted accounting standards

In June 2016, the FASB issued guidance ASU No. 2016-13 Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments which changes the accounting for credit losses for certain instruments, including trade receivables, from an incurred loss method to a current expected loss method. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts. We adopted the guidance, and subsequent guidance related to the topic, effective January 1, 2023. Adoption of the standard had no significant impact on our results of operations, financial position, or cash flows as of January 1, 2023.

Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation – The accompanying consolidated financial statements have been prepared in U.S. dollars and in accordance with accounting principles generally accepted in the United States (GAAP). The accompanying consolidated financial statements include the accounts of RiceBran Technologies and all subsidiaries in which we have a controlling interest. All significant inter-company balances are eliminated in consolidation.

Use of Estimates – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the reporting period. Because of the uncertainty inherent in such estimates, actual results could differ from those estimates.

Reclassifications – Certain reclassifications have been made to amounts reported for the prior year to achieve consistent presentation with the current year. Such reclassifications had no impact on previously reported net loss or shareholders’ equity. 25

Table of Contents

Reclassifications – Certain reclassifications have been made to amounts reported for the prior year for discontinued operations to achieve consistent presentation with the current year. Such reclassifications had no impact on previously reported net loss or shareholders’ equity. See Note 3 in the Notes to Consolidated Financial Statements for further discussion of our discontinued operations.

Cash and Cash Equivalents – We consider all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. In all periods presented, we maintained our cash and cash equivalents with major banks. We maintain cash in bank accounts in amounts which at times may exceed federally insured limits. At times we invest in money market funds which are also not federally insured. We have not experienced any losses on such accounts.

Accounts Receivable and Allowance for ~~Doubtful~~Credit ~~Accounts~~Losses – Accounts receivable represent amounts receivable on trade accounts. The allowance for doubtful accounts is based on our assessment of the collectability of customer accounts and the aging of accounts receivable. We analyze the aging of customer accounts, customer concentrations, customer creditworthiness, current economic trends and changes in our customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts. From period to period, differences in judgments or estimates utilized may result in material differences in the amount and timing of the provision for doubtful accounts. We periodically evaluate our credit policy to ensure that customers are worthy of terms and support our business plans. We generally do not require collateral.

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

Impairment of Long-lived Assets – We review our long-lived assets, such as property and equipment and right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We recognize an impairment loss when the undiscounted future cash flows estimated to be generated by the asset to be held and used are not sufficient to recover the unamortized balance of the asset. The impairment loss is the difference between the carrying value and the estimated fair value. We determine the estimated fair value based on either the discounted future cash flows or other appropriate fair value methods with the amount of any such deficiency charged to operations in the current year. Estimates of future cash flows are based on many factors, including current operating results, expected market trends and competitive influences. We report assets to be disposed of by sale at the lower of the carrying amount or fair value, less estimated costs to sell.

Intangible Assets – We amortize recognized intangible assets over the useful lives of the assets unless that life is determined to be indefinite. All of our intangible assets are finite lived. We evaluate the remaining useful life of an intangible asset each reporting period to determine whether events or circumstances may indicate that a revision to the useful life is warranted to reflect the remaining expected use of the asset. If an intangible asset’s useful life is determined to be finite, but the precise length of that life is not known, the intangible asset is amortized over our best estimate of the asset’s useful life in a manner that reflects the pattern in which the asset’s economic benefits are consumed or expected to be realized. We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We recognize an impairment loss when the undiscounted future cash flows estimated to be generated by the asset to be held and used are not sufficient to recover the unamortized balance of the asset. Our primary intangible asset is a customer relationship intangible which derives its value from future cash flows expected from the acquired customers. Changes in the actual or estimated future cash flows of these customers could result in a material adjustment to amortization expense, an impairment loss, or both. Estimates of future cash flows are based on many factors, including current cash flows, expected market trends and competitive influences.

Leases – We lease certain buildings, land and corporate office space under operating leases with monthly or annual rent payments. We lease certain machinery and equipment under finance leases with monthly rent payments. We determine if an arrangement is a lease at inception. We present operating lease assets as operating lease right-of-use assets and the related liabilities as operating lease liabilities in our consolidated balance sheets. We include finance lease right-of-use assets in property and equipment, net, and the related liabilities as finance lease liabilities in our consolidated balance sheets.

Table of Contents

We recognize right-of-use assets and lease liabilities based on the present value of the future minimum lease payments over the lease term, beginning at the commencement date, for leases exceeding a year. Minimum lease payments include the fixed lease components of the lease and any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Lease terms may include options to renew when it is reasonably certain that we will exercise that option. We combine lease and nonlease components and account for them as a single lease component. Certain leases contain rent escalation clauses, rent holidays, capital improvement funding or other lease concessions.

In determining our right-of-use assets and lease liabilities, we apply a discount rate to the minimum lease payments within each lease. When we cannot readily determine the discount rate implicit in a lease, we utilize our incremental borrowing rate, the rate of interest that we would incur to borrow, on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. To estimate the incremental borrowing rate, we reference a market yield curve consistent with our assessment of our credit quality.

We recognize operating lease expense related to the minimum lease payments on a straight-line basis over the lease term. For finance leases, we recognize amortization expense related to the minimum lease payments on a straight-line basis over the lease term while interest expense is recognized using the effective interest method. Expense related to variable lease payments that do not depend on a rate or index and short-term rentals, on leases with terms less than a year, are expensed as incurred.

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

Revenue Recognition – We account for a contract with a customer when the written contract is committed, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of collection. Substantially all of our revenue is derived by fulfilling customer orders for the purchase of our products under contracts which contain a single performance obligation, to supply continually defined quantities of product at fixed prices. We account for shipping and handling activities that occur after the customer has obtained control of a good as a fulfillment cost rather than as an additional promised service. We recognize revenue at the point in time that control of the ordered product(s) is transferred to the customer, which is upon delivery to the customer, or its designee at our location, a customer location or other customer-designated delivery point. For substantially all of our contracts, control of the ordered product(s) transfers at our location. We report amounts invoiced to customers for shipping and handling are reported as revenues and the related costs incurred to deliver product to the customer are reported as cost of goods sold.

We measure revenue as the amount of consideration we expect to receive in exchange for fulfilling product orders. Incidental items that are immaterial in the context of the contract are recognized as expense. Our contracts do not include a significant financing component. Our contracts may include terms that could cause variability in the transaction price, including, for example, rebates and volume discounts, or other forms of contingent revenue. The amount of consideration we expect to receive and revenue we recognize includes estimates of variable consideration, including costs for rebates and discounts. If the consideration promised in a contract includes a variable amount, we estimate the amount to which we expect to be entitled using either the expected value or most likely amount method. Changes in judgments and estimates regarding probability of collection and variable consideration might result in a change in the timing or amount of revenue recognized.

Discontinued Operations - A discontinued operation may include a component or a group of components of our operations. A disposal of a component or a group of components is reported in discontinued operations if the disposal represents a strategic shift that has or will have a major effect on our operations and financial results when the following occurs: (1) a component (or group of components) meets the criteria to be classified as held for sale; (2) the component or group of components is disposed of by sale; or (3) the component or group of components is disposed of other than by sale (for example, by abandonment or in a distribution to owners in a spin-off). For any component classified as held for sale or disposed of by sale or other than by sale, qualifying for presentation as a discontinued operation, we report the results of operations of the discontinued operations (including any gain or loss recognized on the disposal or loss recognized on classification as held for sale of a discontinued operation), less applicable income taxes (benefit), as a separate component in the consolidated statement of operations for current and all prior periods presented.

Selling, General and Administrative Expenses – Selling, general and administrative expenses include salaries and wages, bonuses and incentives, share-based compensation expense, employee-related expenses, facility-related expenses, marketing and advertising expense, depreciation of non-operating property and equipment, professional fees, amortization of intangible assets, provisions for losses on accounts receivable and other operating expenses.

Table of Contents

Share-Based Compensation – For awards of nonvested common stock and common stock units to employees and directors, share-based compensation is measured based on the fair value of our common stock on the date of grant and the corresponding expense is recognized over the period during which the holder is required to provide service in exchange for the award. Compensation expense related to service-based awards are recognized on a straight-line basis over the requisite service period for the award. In the event we require no specific future performance, the entire amount of compensation is recognized immediately.

We have outstanding common stock options as of December 31, ~~2022~~2023 and ~~2021~~2022. ~~We have not granted any stock options since 2020.~~ Share-based compensation expense for common stock options granted to employees and directors was calculated at the grant date using the Black-Scholes-Merton valuation model and is expensed on a straight-line basis over the service period of the award. The Black-Scholes-Merton option pricing model required us to estimate key assumptions such as expected life, volatility, risk-free interest rates and dividend yield to determine the fair value of share-based awards, based on both historical information and management’s judgment regarding market factors and trends.

We recognize forfeitures of employee and director awards as they occur. In the event an employee or director terminates service prior to the vesting of an award, we reverse the entire amount of previously recognized compensation expense related to the award.

Share-based compensation for awards to ~~nonemployees~~non-employees is calculated as of the grant date, taking into consideration the probability of satisfaction of performance conditions, in a manner consistent with awards to employees. The expense associated with share-based awards for service is recognized over the term of service. In the event services are terminated early or we require no specific future performance, the entire amount of unrecognized compensation is expensed. The expense associated with share-based awards made in exchange for goods is generally attributed to expense in the same manner as if the vendor had been paid in cash.

Income Taxes – We account for income taxes by recording a deferred tax asset or liability for the recognition of future deductible or taxable amounts and operating loss and tax credit carryforwards. We recognize a deferred tax expense or benefit as a result of timing differences between the recognition of assets and liabilities for financial reporting and tax purposes.

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which temporary differences are expected to be recovered or settled. We recognized deferred tax assets for deductible temporary differences and operating loss and tax credit carryforwards. When necessary, we establish a valuation allowance to reduce that deferred tax asset if it is more likely than not that the related tax benefits will not be realized. The realization of deferred tax assets can be affected by, among other things, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the length of statutory carryforward periods, our experience with utilizing operating losses and tax credit carryforwards by jurisdiction, and tax planning alternatives that may be available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that may be different from current estimates of the tax liabilities. If our estimate of tax liabilities proves to be less than the ultimate assessment, an additional charge to expense would result. If payment of these amounts ultimately proves to be less than the recorded amounts, the reversal of the liabilities may result in income tax benefits being recognized in the period when it is determined that the liabilities are no longer necessary.

We recognize interest and penalties related to uncertain tax positions, if any, in selling, general and administrative expenses.

Derivative Warrant Liability – We have an outstanding warrant agreement that provides for cash settlement of the warrant in certain circumstances. We account for this warrant as a liability instrument. This warrant is carried at fair value as a derivative warrant liability in our consolidated balance sheets at the end of each reporting period and any resultant changes in fair value are recorded in the consolidated statements of operations in other income (expense) as change in fair value of derivative warrant liability.

Fair Value – Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Certain assets and liabilities may be presented in the financial statements at fair value. Assets and liabilities measured at fair value on a non-recurring basis may include property and equipment.

We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:

● Level 1 – inputs include quoted prices for identical instruments and are the most observable.

● Level 2 – inputs include quoted prices for similar assets and observable inputs such as interest rates, currency exchange rates and yield curves.

● Level 3 – inputs are not observable in the market and include management’s judgments about the assumptions market participants would use in pricing the asset or liability.

NOTE 32. ~~CASH~~GOING CONCERN AND ~~CASH~~MANAGEMENT’S ~~EQUIVALENTS~~PLAN

AsThe ~~of December~~Company ~~31,~~has ~~2022,~~incurred welosses ~~had~~and ~~$2.7~~generated ~~million~~negative of cash ~~and~~flows ~~cash~~from ~~equivalents~~operations ~~invested~~since inits ~~a money market fund with net assets invested in U~~inception.S. ~~Dollar~~As ~~denominated money market securities~~ of December ~~domestic~~31, ~~and foreign issuers~~2023, ~~U.S.~~the ~~Government~~Company ~~securities~~had ~~and~~an ~~repurchase~~accumulated ~~agreements.~~deficit ~~We consider all liquid investments with original maturities~~ of ~~three~~$333.3 million ~~months~~and orcash ~~less~~and atcash ~~the~~equivalents ~~time~~ of ~~purchase~~$1.1 ~~to be cash equivalents~~million.

WeOur ~~have~~history of operating losses and negative operating cash onflows ~~deposit~~from incontinuing ~~excess~~operations ofraises ~~federally~~substantial ~~insured~~doubt ~~limits~~about atour ability to continue as a ~~bank~~going concern within one year from the date of this filing. WeDue doto ~~not~~these ~~believe~~historical ~~that~~losses ~~maintaining~~and ~~substantially~~negative ~~all~~cash ~~such~~flows, ~~assets~~management ~~with~~has ~~the~~considered ~~bank~~various orstrategic ~~investing~~alternatives. inSpecifically, we recently completed a ~~liquid~~refinancing ~~mutual~~in December ~~fund~~2023, ~~represent~~as ~~material~~further ~~risks~~described below.

NOTE 4. ACCOUNTS RECEIVABLE AND REVENUES

We classify amounts billed as accounts receivable on our consolidated balance sheets and require payment on a short-term basis. Invoices are generally issued at the point control transfers and substantially all of our invoices are due within 30 days or less, however certain customers have terms of up to 120 days. For substantially all of our contracts, control of the ordered product(s) transfers at our location. Periodically, we require payment prior to the point in time we recognize revenue. We classify amounts received from customers prior to revenue recognition on a contract as customer prepayments liability on our consolidated balance sheets. We typically apply customer prepayments to an invoice within 30 days of the prepayment. Revenues in 2022 and 2021 include $0.1 million, or less, in unearned revenue as of the end of the prior year.

Table of Contents

~~RiceBran~~On December ~~Technologies~~1, 2023, an entity owned by Cable Car Capital LLC, Funicular Funds, LP (Funicular), purchased $0.4 million of shares of common stock of the Company and lent the Company $4.1 million.

~~Notes~~Related to ~~Consolidated~~this ~~Financial~~financing, ~~Statements~~Funicular was also granted warrants to purchase up to 5.0 million shares of common stock of the Company. If Funicular exercised all its warrants, it would own 49.8% of the Company. The Company also exchanged existing warrants with other investors to purchase an aggregate 2.2 million shares of common stock of the Company for an aggregate of approximately 0.6 million shares of common stock of the Company and new warrants to purchase 1.2 million shares of common stock of the Company.

On January 25, 2024, the Company sold Golden Ridge for $2.15 million. As a result of the sale, the Company has streamlined its business and balance sheet, eliminating unprofitable operations.

The Company also believes additional cash can be secured through other debt or structured equity financing, if necessary. However, there can be no assurance that equity or debt financing will be available to the Company should it need it or, if available, that the terms will be satisfactory to the Company and not dilutive to existing shareholders. The Company’s failure to raise capital as and when needed could have significant negative consequences for its business, financial condition, and results of consolidated operations.

NOTE 3. DISCONTINUED OPERATIONS

We continuously assess the composition of our portfolio to ensure it is aligned with our strategic objectives and positioned to maximize return to our shareholders. On June 23, 2023, we completed the sale of our assets related to the SRB Business for $1.8 million in cash and the assumption of $1.7 million of real estate operating leases and other liabilities. The sale agreement contained customary representations, warranties, and covenants.

The proceeds, net of expenses, of $1.4 million, and the net carrying value of the SRB Business assets and liabilities assumed as of the date of sale at $10.0 million resulted in our recognition of a loss on sale of $8.6 million. The loss on sale includes no provision for income taxes as it is anticipated the tax benefit for the expected tax loss on disposition will not be realized based on our current U.S. valuation allowance position.

In consideration of the Lender’s (as defined below) consent to the sale and release of securities interests and liens on SRB Business assets, we paid a portion of the amount outstanding on our mortgage promissory note, not exclusively related to the SRB Business, from proceeds of the sale. In addition, we paid liabilities for accumulated paid time off to the employees of the SRB Business. The following table summarizes the distribution of proceeds (in thousands).

Purchase price	$	1,800
Expenses as of June 30, 2023		(375	)
Net proceeds	$	1,425

Repayment of mortgage promissory note	$	450
Payment of paid time off liabilities		215
	$	665

Table of Contents

The following table summarizes the carrying amounts of the SRB Business as of June 23, 2023, the date of sale (in thousands).

Inventories	$	2,252
Other current assets		185
Property and equipment		7,710
Operating lease right of use assets		1,566
Total assets		11,713

Accrued expenses		9
Operating lease liabilities		1,668
Finance lease liabilities		12
Long-term debt		14
Total liabilities		1,703
Net assets sold	$	10,010

The buyer of the SRB business did not acquire accounts receivable generated by the operation of the SRB Business assets and generally did not assume any accounts payable or accrued expenses related to the operation of the SRB Business through the June 23, 2023, date of sale.

We determined that the disposal met the criteria for presentation as discontinued operations in the second quarter of 2023. Accordingly, SRB Business results are presented as discontinued operations in our consolidated statements of operations and are excluded from continuing operations for all periods presented. In addition, the SRB Business assets and liabilities are classified as held for sale in our consolidated balance sheets for December 31, 2022. The operations of the SRB Business are included in our results through the June 23, 2023, date of sale. The following two tables represent activity up to the date of the sale.

The following table summarizes the major line items included in loss from discontinued operations related to the SRB Business and divestiture (in thousands).

	December 31
	2023			2022
Revenues	$	6,857		$	14,970
Cost of goods sold		(6,796	)		(14,966	)
Selling, general and administrative expenses		(457	)		(1,293	)
Interest expense		(28	)		(56	)
Loss from operations of discontinued operations		(424	)		(1,345	)
Gain (loss) on sale		(8,585	)		147
Loss from discontinued operations	$	(9,009	)	$	(1,198	)

Depreciation included in cost of goods sold	$	646		$	1,238
Capital expenditures	$	111		$	964

The following table summarizes the major line items included in cash flows from discontinued operations related to the SRB Business and divestiture (in thousands).

	December 31
	2023			2022

Net cash used in operating activities	$	(211	)	$	(141	)
Net cash provided by (used in) investing activities		1,679			(229	)
Net cash used in financing activities		(460	)		(24	)
Net cash provided by (used in) discontinued operations		1,008			(394	)

Table of Contents

In the year ended December 31, 2023, net cash provided by investing activities in the table above is presented in our consolidated statements of cash flows in net cash provided by investing activities of discontinued operations and includes the $1.4 million net proceeds from the sale of the SRB Business. In the year ended December 31, 2023, net cash used in financing activities in the table above is presented in our consolidated statements of cash flows used in financing activities of discontinued operations and includes the $0.5 million repayment of our mortgage promissory note from the initial proceeds from the sale.

The following table summarizes the carrying amounts of major classes of SRB Business assets and liabilities classified as held for sale as of December 31, 2022 (in thousands).

Inventories	$	1,913
Other current assets		311
Property and equipment		8,187
Operating lease right of use assets		1,701
Total assets held for sale	$	12,112

Accrued expenses, including paid time off liabilities of employees of the SRB business	$	236
Operating lease liabilities		1,841
Finance lease liabilities		17
Long-term debt, including $450 of mortgage promissory note, not exclusively related to the SRB business		468
Total liabilities held for sale	$	2,562

NOTE 4. ACCOUNTS RECEIVABLE AND REVENUES

We classify amounts billed as accounts receivable on our consolidated balance sheets and require payment on a short-term basis. Invoices are generally issued at the point control transfers and substantially all of our invoices are due within 30 days or less, however certain customers have terms of up to 120 days. For substantially all of our contracts, control of the ordered product(s) transfers at our location. Periodically, we require payment prior to the point in time we recognize revenue. We classify amounts received from customers prior to revenue recognition on a contract as customer prepayments liability on our consolidated balance sheets. We typically apply customer prepayments to an invoice within 30 days of the prepayment. The accounts receivable balance as of January 1, 2022, was $2.4 million.

Our accounts receivable potentially subject us to significant concentrations of credit risk. Revenues and accounts receivable from significant customers (customers with revenue or accounts receivable in excess of 10% of consolidated totals) are stated below as a percent of consolidated totals.

	Customer
	A			B			C
% of revenue, 2022		14.0	%		8.5	%		6.8	%
% of revenue, 2023		26	%		13	%		10	%
% of revenue, 2021		11.9	%		0.3	%		11.4	%
% of revenue, 2022		20	%		13	%		11	%
% of accounts receivable, as of December 31, 2022		11.6	%		18.6	%		0.2	%
% of accounts receivable, as of December 31, 2023		32	%		11	%		10	%
% of accounts receivable, as of December 31, 2021		17.2	%		0.0	%		9.0	%
% of accounts receivable, as of December 31, 2022		12	%		19	%		9	%

The following table presents disaggregated revenues ~~by geographic area shipped to~~ (in thousands).

	2022		2021
	2023		2022
United States	$	40,267	$	29,637
Long Grain Rice and Bran	$	15,723	$	16,957
Other countries		1,350		1,494
Barley and Oats		6,296		8,306
Revenues	$	41,617	$	31,131
Feed and Other		630		1,384
Revenues	$	22,649	$	26,647

Table of Contents

NOTE 5. INVENTORIES

The following table details the components of inventories (in thousands).

	December 31
	2022		2021
	2023		2022
Finished goods	$	~~1,737~~123	$	~~1,560~~228
Raw materials		~~423~~393		~~718~~212
Packaging		~~218~~27		~~166~~25
Inventories	$	~~2,378~~543	$	~~2,444~~465

NOTE 6. PROPERTY AND EQUIPMENT

The following table details the components of property and equipment (amounts in thousands).

	December 31
	2022		2021		Estimated Useful Lives (Years)
	2023		2022		Estimated Useful Lives (in years)
Land	$	~~730~~493	$	~~730~~493
Furniture and fixtures		~~259~~-		~~265~~71	5	-7	10-	10
Plant		101,~~095~~902		103,~~457~~440	20	-20	~~40 or life of lease~~-	40 or life of lease
Computer and software		~~450~~27		~~452~~382	3	-3	5-	5
Leasehold improvements		~~1,838~~-		~~1,828~~152	4	-5	~~15 or life of lease~~-	6 or life of lease
Machinery and equipment		156,~~703~~423		155,~~115~~758	5	-5	15-	15
Property and equipment, cost		298,~~075~~845		2810,~~847~~296
Less accumulated depreciation		144,~~868~~607		134,~~403~~276
Property and equipment, net	$	144,~~207~~238	$	156,~~444~~020

~~Amounts~~NOTE ~~payable for property and equipment included in accounts payable totaled $0~~7.1 ~~million~~INTANGIBLE at December 31, 2022, and $0.2 million at December 31, 2021. Assets which had not yet been placed in service, included in property and equipment, totaled $1.2 million at December 31, 2022, and $0.9 million at December 31, 2021.ASSETS

29 Intangible assets consist of the following (in thousands).

Table of Contents

			December 31, 2023						December 31, 2022
	Estimated Useful Life		Gross Carrying Value		Accumulated Amortization		Net Carrying Value		Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Customer relationships		15	$	930	$	668	$	262	$	930	$	564	$	366
Trademarks		10		13		6		7		13		5		8
Non-compete agreement		5		22		21		1		22		16		6
Total intangible assets			$	965	$	695	$	270	$	965	$	585	$	380

RiceBran Technologies

Notes to Consolidated Financial Statements

NOTE 7. INTANGIBLE ASSETS AND GOODWILL

Intangible assets, excluding goodwill, consist of the following (in thousands).

			December 31, 2022						December 31, 2021
	Estimated Useful Life		Gross Carrying Value		Accumulated Amortization		Net Carrying Value		Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Customer relationships		15	$	930	$	564	$	366	$	930	$	423	$	507
Trademarks		10		13		5		8		13		3		10
Non-compete agreement		5		22		16		6		22		12		10
Total intangible assets			$	965	$	585	$	380	$	965	$	438	$	527

The customer relationship intangible is amortizing over the 15-year period of expected future economic benefit, in proportion to the discounted expected future cash flows used to estimate the value of the intangible at acquisition in 2019. It is amortizing at a more rapid rate in the earlier periods than in later periods. Other finite-lived intangible assets are amortizing on a straight-line basis.

As of December 31, ~~2022~~2023, the weighted-average remaining amortization period for intangibles ~~other than goodwill~~ is 98.9 years and future intangible amortization is expected to total the following (in thousands):

2023	$	111
2024	$	80
2024		80
2025		58
2026		42
2027		31
Thereafter		58
2028		22
Total amortization	$	380
Thereafter		37
Total amortization	$	270

We performed our annual impairment testing of goodwill as of December 31, 2021. We estimated the fair value of our company by a discounted cash flow method, reconciled to our market capitalization. We determined the fair value of our equity, based on our market capitalization, was substantially below our carrying value. As a result, in 2021, we recorded a non-cash, non-tax-deductible impairment charge equal to the entire amount of our goodwill, $3.9 million. 32

Table of Contents

NOTE 8. LEASES

The components of lease expense and cash flows from leases (in thousands) follow.

	2022		2021
	2023		2022
Finance lease cost:
Amortization of right-of use assets, included in cost of goods sold	$	97145	$	8997
Interest on lease liabilities		2152		1121
Operating lease cost, included in selling, general and administrative expenses:
Fixed leases cost		515		515
Fixed lease cost		80		515
Variable lease cost		~~168~~61		~~149~~168
Short-term lease cost		85188		6185
Total lease cost	$	~~886~~526	$	~~825~~886
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from finance leases	$	2152	$	1121
Operating cash flows from operating leases	$	~~515~~80	$	515
Financing cash flows from finance leases	$	~~104~~150	$	96104

As of December 31, ~~2022~~2023, ~~variable~~we ~~lease payments~~ do not ~~depend~~believe onit ais ~~rate~~certain orthat ~~index.~~we Aswill ~~of December~~exercise ~~31,~~any ~~2022,~~lease ~~property~~renewal ~~and equipment, net, includes $0~~options.6 ~~million~~The ofremaining ~~finance~~terms ~~lease right-~~of~~-use-assets,~~ ~~with~~our anleases ~~original~~and ~~cost of $0.9 million. During 2022, we financed~~ the ~~purchase~~discount ofrates ~~$0.4~~used ~~million of property and equipment~~ in ~~noncash finance lease transactions. During 2021, we financed~~ the ~~purchase~~calculation of ~~$0.1~~the ~~million~~fair value of ~~property~~our ~~and~~leases ~~equipment~~as inof December ~~noncash~~31, ~~finance~~2023, ~~lease transactions~~follows.

	Finance Leases
Remaining leases terms (in years)		0.2	-	4.1
Weighted average remaining lease terms (in years)			3.7
Discount rates		2.8%	-	11.6%
Weighted average discount rate			9.6%

~~Table~~Maturities of ~~Contents~~ lease liabilities as of December 31, 2023, follows (in thousands).

RiceBran Technologies

	Finance
	Leases
2024	$	178
2025		167
2026		165
2027		126
2028		4
Total lease payments		640
Amounts representing interest		(106	)
Present value of lease obligations	$	534

Notes to Consolidated Financial Statements

As of December 31, 2022, we do not believe it is certain that we will exercise any lease renewal options. The remaining terms of our leases and the discount rates used in the calculation of the fair value of our leases as of December 31, 2022, follows.

	Operating Leases				Finance Leases
Remaining leases terms (in years)		0.8	-	10.2		0.3	-	4.8
Weighted average remaining lease terms (in years)				5.5				4.0
Discount rates		6.3%	-	9.0%		2.8%	-	10.4%
Weighted average discount rate				7.8%				8.2%

As of December 31, 2022, operating leases have maturities extending through 2032. Maturities of lease liabilities as of December 31, 2022, follows (in thousands).

	Operating			Finance
	Leases			Leases
2023	$	528		$	158
2024		429			117
2025		439			102
2026		451			99
2027		232			60
Thereafter		346			-
Total lease payments		2,425			536
Amounts representing interest		(477	)		(86	)
Present value of lease obligations	$	1,948		$	450

NOTE 9. DEBT

We finance certain amounts owed for annual insurance premiums under financing agreements. As of December 31, ~~2022~~2023, amounts due under insurance premium financing agreements are due in monthly installments of principal and interest through March 312024, ~~2023,~~ at an interest rate of 37.95% per year.

We also borrow under a factoring agreement with a lender (the Lender), which provides a $7.0 million credit facility. We may only borrow to the extent we have qualifying accounts receivable to use as collateral as defined in the agreement. The facility had an initial two-year term and automatically renews for successive annual periods until delivery of a proper termination notice. The facility term automatically extended to October 2023. We incur recurring fees under the agreement, including a funding fee of 0.5% above the prime rate, in no event to be less than 5.5%, on any advances, as well as a service fee on average net funds borrowed. The lender has a security interest in our personal property assets and the right to demand repayment of the advances at any time. 33

The Lender advanced us $0.9 million effective September 30, 2022 (the Over-advance), pending restructuring of our mortgage promissory note with the Lender. The Over-advance accrued interest at an annual rate which is the greater of 7.0% above the Lender's prime rate (14.5% at December 31 2022). and 10.3% until it was repaid in January 2023. As of December 31, 2022, the Over-advance is classified as long-term debt in our consolidated balance sheet as it was refinanced on a long-term basis in January 2023, as discussed below.

Additional information related to our factoring obligation (exclusive of the Over-advance) follows.

	2022			2021
Average borrowings outstanding (in thousands)	$	3,179		$	1,622
Amortization of debt issuance costs (in thousands)	$	-		$	75
Fees paid, as a percentage of average outstanding borrowings		5.8	%		6.2	%
Interest paid, as a percentage of average outstanding borrowings		7.0	%		6.4	%

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

Long-term debt consists of the following (in thousands).

	December 31,
	2022		2021
	2023		2022
Mortgage promissory note - Originally dated July 2020 and modified in December 2021 and January 2023. As modified, interest accrues at an annual rate which is the greater of 7.0% above the Lender's prime rate (14.5% at December 31, 2022) and 10.3%. Payable in monthly installments through January 2025. Face amount $2.5 million. Secured by certain real property in Wynne, Arkansas.	$	2,211	$	2,469
Mortgage promissory note - Dated December 1, 2023. Original principal $4.1 million. Interest accrues and compounds quarterly at 13.5% per year. At each quarterly interest payment date, the accrued and unpaid interest can be paid in cash or paid in-kind and has a December 1, 2028 maturity date.	$	2,968	$	-
Progress payment agreement - Dated August 2022. Original principal $37. Interest is payable monthly at the rate of 25.2% per year. Due on demand, until a finance lease is executed with the lender before that date for the related equipment.		39		-
Mortgage promissory note - Originally dated July 2020. As subsequently modified, interest accrued at an annual rate which is the greater of 7.0% above the Lender's prime rate (15.5% at September 30, 2023) and 10.3% and payable in monthly installments through January 2025. Face amount $2.5 million. Secured by certain real property in Arkansas. December 31, 2022, excludes $450 thousand allocated to discontinued operations.		-		1,761
Equipment note - Dated May 2021. Original principal $46. Due in monthly installments through June 2025. Interest accrues at the effective discount rate of 3.6% per year.		24		33
Equipment note - Dated May 2021. Original principal $46 thousand. Due in monthly installments through June 2025. Interest accrues at the effective discount rate of 3.6% per year.		15		24
Equipment note - Dated December 2019. Original principal $40. Due in monthly installments through December 2024. Interest accrues at the effective discount rate of 9.3% per year.		18		26
Equipment note - Dated June 2023. Original principal $144 thousand. Due in monthly installments through August 2025. Interest accrues at the effective discount rate of 14.0% per year.		114		-
Other				11
Progress payment agreement - Dated August 2022. Original principal $37 thousand. Interest was payable monthly at the rate of 25.2% per year until obligation was transferred to a finance lease in February 2023.		-		39
Total long-term debt, net	$	23,~~292~~097	$	21,~~539~~824

InOn December ~~2021~~1, 2023, we entered into ~~agreements with the Lender to effect~~ a ~~modification~~new ofsecured ~~the terms of our mortgage~~ promissory note. ~~This~~with ~~modification~~Funicular, ~~involved~~guaranteed ~~entering~~by ~~into~~its asubsidiaries ~~new~~Golden ~~mortgage~~Ridge ~~promissory~~and ~~note~~MGI, in the aggregate principal amount of $24.51 million, ~~with~~funded ~~terms~~on December as1, ~~indicated in the table above~~2023. WeA ~~received~~portion ~~$1.2~~of ~~million~~the inproceeds ~~cash~~ from the ~~lender~~note ~~and~~were ~~the~~used ~~lender applied the remainder of the principal~~ to ~~the~~pay ~~$1.3~~amounts ~~million~~owed ~~principal and interest then outstanding~~ under ~~our~~the ~~old~~previous mortgage promissory note. WeThe ~~recognized~~note nohas ~~gain~~a orstated ~~loss~~maturity ~~with~~date ~~the modification. At modification, the carrying amount~~ of December ~~the new note equaled the total of (i) the $~~1, 2028.3 ~~million~~Interest ~~carrying~~accrues ~~amount~~at ofa ~~the~~rate ~~old~~per ~~note~~annum ~~prior~~equal to ~~modification~~13.50%. ~~(ii)~~On ~~the~~each ~~$1.2~~quarterly ~~million~~interest ~~advanced~~payment bydate, the ~~lender~~accrued ~~at modification~~ and ~~(iii)~~unpaid ~~the~~interest ~~debt~~shall, ~~issuance~~at ~~costs associated with~~ the ~~modification.~~election ~~Under~~of the ~~terms~~Company ofin ~~the~~its ~~original~~sole ~~note~~discretion, ~~(i) interest~~be ~~accrued~~either atpaid anin ~~annual~~cash ~~rate~~or ~~which~~paid ~~was the greater of 11~~in-kind.0% ~~above~~In addition, the ~~1ender’s~~note ~~prime~~requires ~~rate~~payment ~~and~~of ~~14.3%~~a ~~and~~$50,000 ~~(ii)~~fee ~~principal~~on ~~and~~account ~~interest~~of ~~were~~costs ~~payable in monthly installments through May 2022~~ and aexpenses ~~final payment~~ of ~~$1.0~~Funicular, ~~million~~which fee was ~~due~~ in ~~June~~-kind ~~2022.~~at ~~This December~~the ~~2021~~Company’s ~~note~~election ~~was~~as ~~replaced~~per ~~with~~the ~~a new note in January 2023~~agreement.

In January 2023, we entered into agreements with the Lender to effect a modification of the terms of the ~~December~~ ~~2021~~mortgage promissory note. This modification involved us entering into a new mortgage promissory note in the principal amount of $2.5 million. We received $0.3 million in cash, and the ~~Lender~~lender applied the remainder of the new principal to the $1.3 million then outstanding on the ~~December~~ ~~2021~~prior ~~term~~mortgage promissory note and the $0.9 million Over-advance ~~on the factoring agreement~~. Under the terms of the January 2023 note, (i) interest ~~accrues~~accrued at the same rate as the prior note, an annual rate which is the greater of 7.0% above the 1ender’s prime rate and 10.3%, and (ii) principal and interest are payable in equal monthly installments through January 2025, under the January note. ~~The~~Prior ~~new~~to the January 2023 modification, principal and interest were payable in equal monthly installments through December 2023. The note is secured by a mortgage on our real property in Arkansas. The current portion of long-term debt on the consolidated balance sheet as of December 31, 2022, reflects the terms of the January 2023 modification.

~~Future~~We ~~principal~~borrow ~~maturities~~under ofa ~~long~~factoring agreement with a lender (the Lender), which provides a $7.0 million credit facility. We may only borrow to the extent we have qualifying accounts receivable to use as collateral as defined in the agreement. The facility had an initial two-year term ~~debt~~and ~~outstanding~~automatically atrenews for successive annual periods until delivery of a proper termination notice. The facility term automatically extended to ~~December~~October ~~31,~~2024. ~~2022,~~We ~~reflecting~~incur recurring fees under the ~~January~~ ~~2023~~agreement, ~~modification~~including a funding fee of 0.5% above the ~~mortgage~~prime ~~promissory~~rate, ~~note~~in no event to be less than 5.5%, ~~follow~~on (any advances, and a service fee on average net funds borrowed. The Lender has a security interest in ~~thousands)~~our assets and the right to demand repayment of the advances at any time.

2023	$	996
2024		1,194
2025		111
Principal maturities		2,301
Debt issuance costs		(9	)
Total long-term debt, net	$	2,292

The Lender also advanced us $0.9 million effective September 30, 2022 (the Over-advance), pending restructuring of our mortgage promissory note with the Lender. The Over-advance accrued interest at an annual rate which is the greater of 7.0% above the Lender's prime rate (14.5% at December 31, 2022) and 10.3% until it was repaid in January 2023. As of December 31, 2023, the Over-advance was classified as long-term debt in our consolidated balance sheet as it was refinanced on a long-term basis in January 2023, as discussed below.

Additional information related to our factoring obligation (exclusive of the Over-advance) follows (in thousands).

	2023			2022
Average borrowings outstanding (in thousands)	$	2,303		$	3,179
Fees paid, as a percentage of average outstanding borrowings		7.3	%		5.8	%
Interest paid, as a percentage of average outstanding borrowings		9.5	%		7.0	%

In 2023, we borrowed under a line of credit with a bank. The borrowing was secured by our cash on deposit with the bank and bore interest at prime. There were no stipulated repayment terms for the line as long as we maintained sufficient cash collateral. We repaid the amounts borrowed under the line of credit in full in April 2023. Our borrowings under the line of credit averaged $0.6 million and the average annual interest rate on borrowings was 6.7%.

Table of Contents

Future principal maturities of long-term debt outstanding at December 31, 2023, follow (in thousands).

2024	$	75
2025		54
2026		-
2027		-
2028		4,035
Principal maturities		4,164
Debt issuance costs		(1,067	)
Total long term debt, net	$	3,097

NOTE 10. EQUITY, SHARE-BASED COMPENSATION, WARRANTS AND SECURITIES OFFERINGS

In August 2022, our board of directors approved a 1 for 10 reverse split of our common stock. Our common stock began trading on a post-split basis on August 26, 2022. All share and per share information has been retrospectively adjusted for all prior periods presented giving retroactive effect to the reverse stock split. Such adjustments include calculations of our weighted average number of shares outstanding and loss per share, as well as disclosures regarding our share-based compensation and warrants.

Preferred Stock and Tax Benefits Preservation Plan (Rights Agreement)

Our board of directors, without further action or vote by holders of our common stock, has the right to establish the terms, preference, rights and restrictions and issue shares of preferred stock. We previously designated and issued six series of preferred stock of which no shares remain outstanding. In addition, we designated and issued a seventh series of preferred stock, Series G, of which 150 shares remain outstanding as of December 31, ~~2022~~2023.

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

The Series G preferred stock is non-voting and may be converted into shares of our common stock at the holders’ election at any time, subject to certain beneficial ownership limitations, at a ratio of 1 preferred share for 94.89915 shares of common stock. The Series G preferred stock is entitled to receive dividends if we pay dividends on our common stock, in which case the holders of the preferred stock are entitled to receive the amount and form of dividends that they would have received if they held the common stock that is issuable upon conversion of the Series G preferred stock. If we are liquidated or dissolved, the holders of Series G preferred stock are entitled to receive, before any amounts are paid in respect of our common stock, an amount per share of preferred stock equal to $1,000, plus any accrued but unpaid dividends thereon.

In July 2023, in connection with the Rights Agreement described below, we designated an eighth series of preferred stock, Series H Junior Participating Preferred Stock, no par value (Series H Preferred Shares). Series H Preferred shares will be entitled, if declared, to a preferential per share quarterly dividend payment equal to the greater of (i) $1.00 per share or (ii) an amount equal to 1,000 times the dividend declared per share of our common stock. Each share of Series H Preferred Stock entitles the holder to 1,000 votes on all matters submitted to a vote of our shareholders. In the event of any merger, consolidation or other transaction in which shares of common stock are converted or exchanged, each share of Series H Preferred Stock will be entitled to receive 1,000 times the amount received per one share of our common stock.

In July 2023, we entered into the Rights Agreement designed to reduce the likelihood that we will experience an “ownership change” under Section 382 of the Internal Revenue Code of 1986, as amended, by (i) discouraging any person or group of persons from becoming an “Acquiring Person”, which is defined in the Rights Agreement generally as a person or group of affiliated or associated persons that, at any time after the date of the Rights Agreement, has acquired, or obtained the right to acquire, beneficial ownership of 4.95% or more of the shares of our then-outstanding common stock and (ii) discouraging any existing shareholder currently beneficially holding 4.95% or more of the shares of our common stock from acquiring more shares of our common stock. In connection therewith, the board of directors of the company (the Board) declared a dividend of one preferred share purchase right (a Right) for each outstanding share of common stock to shareholders of record at the close of business on July 17, 2023. Each Right entitles the holder to purchase one one-thousandth of a share of our Series H Preferred Stock at a price of $6.00, subject to certain adjustments.

Table of Contents

The Rights will separate and begin trading separately from our common stock generally (i) when a person or group of affiliated or associated persons has become an Acquiring Person or (ii) following the commencement, or announcement of an intention to commence, a tender offer or exchange offer the consummation of which would result in any person becoming an Acquiring Person. If issued, each Right, other than Rights beneficially owned by the Acquiring Person (which will thereupon become void) will become exercisable for common stock having a value equal to two times the exercise price of the Right. Prior to exercise, a Right does not give its holder any dividend, voting or liquidation rights. If not otherwise redeemed, exchanged or terminated, the Rights will expire in July 2026, or at such later date as may be established by the Board.

Each share of Series H Preferred Stock will be entitled, when, as and if declared, to a preferential per share quarterly dividend payment equal to the greater of (i) $1.00 per share or (ii) an amount equal to 1,000 times the dividend declared per share of Common Stock. Each share of Series H Preferred Stock will entitle the holder thereof to 1,000 votes on all matters submitted to a vote of the shareholders of the Company. In the event of any merger, consolidation or other transaction in which shares of Common Stock are converted or exchanged, each share of Series H Preferred Stock will be entitled to receive 1,000 times the amount received per one share of Common Stock.

The Exercise Price payable, and the number of shares of Series H Preferred Stock or other securities or property issuable, upon exercise of the Rights are each subject to adjustment from time to time to prevent dilution (i) in the event of a stock dividend on, or a subdivision, combination or reclassification of, the Series H Preferred Stock, (ii) upon the grant to holders of the Series H Preferred Stock of certain rights or warrants to subscribe for or purchase Series H Preferred Stock or convertible securities at less than the then-current market price of the Series H Preferred Stock or (iii) upon the distribution to holders of the Series H Preferred Stock of evidences of indebtedness or assets (excluding regular periodic cash dividends or dividends payable in Series H Preferred Stock) or of subscription rights or warrants (other than those referred to above). The number of outstanding Rights and the number of one one-thousandths of a share of Series H Preferred Stock issuable upon exercise of each Right are also subject to adjustment in the event of a stock split, reverse stock split, stock dividends and other similar transactions involving the Common Stock.

In the event that any person or group of affiliated or associated persons becomes an Acquiring Person, each holder of a Right, other than the Rights beneficially owned by the Acquiring Person, affiliates and associates of the Acquiring Person and certain transferees thereof (which will thereupon become null and void), will thereafter have the right to receive, upon exercise of a Right, that number of shares of Common Stock having a market value of two times the Exercise Price.

In the event that, after a person or a group of affiliated or associated persons has become an Acquiring Person, the Company is acquired in a merger or other business combination transaction, or 50% or more of the Company’s assets or earning power are sold, proper provision will be made so that each holder of a Right will thereafter have the right to receive, upon the exercise thereof at the then-current exercise price of the Right, that number of shares of common stock of the acquiring company having a market value at the time of that transaction equal to two times the Exercise Price.

With certain exceptions, no adjustment in the Exercise Price will be required unless such adjustment would require an increase or decrease of at least one percent (1%) in the Exercise Price. No fractional shares of Series H Preferred Stock will be issued (other than fractions which are integral multiples of one one-thousandth of a share of Series H Preferred Stock, which may, at the election of the Company, be evidenced by depositary receipts) and, in lieu thereof, an adjustment in cash will be made based on the market price of the Series H Preferred Stock on the trading day immediately prior to the date of exercise.

Securities Offerings

In ~~October~~December ~~2022~~2023, we ~~issued~~entered ~~and~~into ~~sold~~a ~~675,000~~securities ~~shares~~purchase ofagreement ~~our~~(the ~~common~~Purchase ~~stock~~Agreement) ~~and~~with aFunicular, ~~prefunded~~pursuant ~~warrant~~to (which the ~~2022~~Company ~~Prefunded~~sold ~~Warrant~~and issued (i) ~~exercisable~~a ~~into~~secured ~~325,000~~promissory ~~shares~~note ofin ~~our~~the ~~common~~principal ~~stock~~amount ~~pursuant~~of to$4,000,000, ~~our~~as ~~effective~~more fully described under “~~shelf~~The Funicular Note” ~~registration~~below, ~~statement~~(ii) on2,222,222 ~~Form~~shares ~~S-3.~~(the ~~The~~Funicular ~~holder~~Shares) ~~exercised~~of the ~~2022~~Company’s ~~Prefunded~~common ~~Warrant~~stock, ~~with~~no anpar ~~exercise~~value ~~price~~(the ofCommon ~~$0.0001~~Stock), ~~per~~at ~~share~~a ~~(net~~purchase ofprice ~~the~~equal to $10.~~4999~~18 per share ~~prefunded~~and (iii) inwarrants ~~full~~(the inFunicular ~~2022.~~Warrants) Into apurchase ~~concurrent~~5,010,206 ~~private~~shares ~~placement,~~of weCommon ~~issued~~Stock ~~and~~(the ~~sold~~Funicular ~~warrants~~Warrant Shares), for ~~the~~an aggregate purchase upprice toof 2$4,000,000 ~~shares~~(collectively, ofthe ~~our~~Private ~~common~~Placement). ~~stock~~The atFunicular anWarrants ~~exercise~~will be exercisable at a price of $10.6018 per share, ~~which~~subject to adjustments as provided under the terms of the Funicular Warrants. The Funicular Warrants are exercisable inat any time on or after ~~April~~December 1, 2023, ~~and~~until ~~expire~~the ~~in October~~expiration ~~2025.~~thereof, ~~The~~provided ~~net~~that ~~proceeds~~the ~~from~~Company has a sufficient number of shares of authorized Common Stock under the ~~concurrent~~Company’s ~~offerings~~Restated and Amended Articles of $1Incorporation to permit such exercise.0 ~~million,~~The ~~after~~Funicular ~~deducting~~Warrants ~~placement~~have ~~agent~~a ~~fees~~term ~~and~~of ~~other~~five ~~offering~~years ~~expenses~~from the date of $0issuance.5 ~~million,~~In ~~were~~connection ~~allocated~~with tothe ~~equity.~~Private AsPlacement, ofon December 311, ~~2022~~2023, ~~$0.3~~the ~~million~~Company ofentered ~~these~~into ~~offering~~a ~~costs~~Registration ~~were~~Rights ~~unpaid~~Agreement with Funicular (the Registration RightsAgreement), pursuant to which the Company agreed to submit to or file with the U.S. WeSecurities ~~determined~~and Exchange Commission within 180 days after the ~~exercise~~Closing ~~price~~Date a registration statement registering the resale of the ~~2022~~Funicular ~~Prefunded~~Shares and the Funicular Warrant ~~was~~Shares ~~nominal~~(the ~~and~~Resale Registration Statement), and the Company agreed to use its reasonable best efforts to have the Resale Registration Statement declared effective as ~~such~~promptly as reasonably possible after the filing thereof. In certain circumstances, weFunicular ~~will~~can ~~consider~~demand the ~~shares~~Company’s ~~underlying~~assistance ~~that~~with ~~warrant~~underwritten toofferings and block trades, and Funicular will be ~~outstanding~~entitled ~~effective~~to certain piggyback registration rights. On ~~October~~December 201, ~~2022~~2023, ~~for~~ the ~~purposes~~Company ofentered ~~calculating~~into ~~basic~~a ~~earnings~~secured promissory note (~~loss~~the Funicular Note) ~~per~~in ~~share~~favor ~~(EPS).~~of WeFunicular ~~intend~~and guaranteed by its subsidiaries Golden Ridge and MGI, evidencing the loan made to ~~use~~the Company by Funicular in the ~~net~~aggregate ~~proceeds~~principal ~~from~~amount of $4 million, funded to the Company on ~~October~~December ~~2022~~1, ~~offerings~~2023, ~~for~~net ~~general~~of ~~corporate~~a ~~purposes,~~discount ~~which~~equal to 10% of the aggregate principal amount. The Funicular Note has a stated maturity date of ~~may~~December ~~include~~1, ~~funding~~2028. ~~capital~~Interest ~~expenditures~~accrues at a rate per annum equal to 13.50%. On each interest payment date, ~~working~~the ~~capital~~accrued and ~~repaying~~unpaid ~~indebtedness~~interest shall, at the election of the Company in its sole discretion, be either paid in cash or paid in-kind. In addition, wethe ~~issued~~Funicular ~~warrants~~Note ~~for~~requires ~~the~~payment ~~purchase~~ of upa ~~to 63~~$50,000 ~~shares~~fee on account of ~~our~~costs ~~common~~and ~~stock~~expenses toof ~~the~~Funicular, ~~placement~~which ~~agent~~fee was in-kind, at anthe ~~exercise~~Company’s ~~price~~election, within thirty days. The obligations under the Funicular Note are guaranteed by Golden Ridge and MGI and are secured by a security interest in the assets (other than certain excluded assets, the Collateral) of $1the Company, Golden Ridge and MGI, subject to the intercreditor agreement described below.~~875~~ ~~per~~The ~~share~~Funicular Note contains negative and restrictive covenants which ~~expire~~limit ~~in October~~the ~~2027~~ability of the Company, Golden Ridge and MGI to, among other things, transfer or otherwise dispose of the Collateral, incur indebtedness and create, incur, assume or allow liens on the Collateral or any real property owned by the Company, Golden Ridge or MGI.

In September 2021, we issued and sold 230,750 shares of common stock, a warrant for the purchase of up to 230,769 shares of common stock (Warrant A), and a prefunded warrant (the 2021 Prefunded Warrant) for the purchase of up to 230,786 shares of common stock pursuant to our effective “shelf” registration statement on Form S-3. The initial $10.00 per share exercise price of Warrant A was subject to adjustment in September 2022, and will be subject to adjustment again in September 2023, if 110% of the 5-day volume weighted average price of our common stock is less than the then-current exercise price. The 2021 Prefunded Warrant, which the holder exercised in full in 2021, had an exercise price of $0.001 (net of the $6.499 per share prefunded). We determined that the 2021 Prefunded Warrant qualified for equity accounting, however, Warrant A did not qualify for equity accounting because the holder may elect cash settlement of this warrant in the event of a change of control. As a result, we carry Warrant A as a liability at fair value in our consolidated balance sheets and the change in fair value of this warrant is recorded in our consolidated statements of operations. The net proceeds from the offering of $2.8 million, after deducting commissions and other cash offering expenses of $0.2 million were allocated to derivative warrant liability, in an amount equal to the $0.6 million estimated fair value of Warrant A as of September 13, 2021, with the remainder of the proceeds recorded in equity. We determined the exercise price of the Prefunded Warrant was nominal and, as such, considered the 230,786 shares initially underlying the 2021 Prefunded Warrant to be outstanding effective September 13, 2021, for the purposes of calculating basic EPS. We used the net proceeds from the September 2021 offering for general corporate purposes, which included funding capital expenditures and working capital and repaying indebtedness. 36

On March 30, 2020, we entered into an at market issuance (ATM) sales agreement with respect to an at-the-market offering program through B. Riley FBR, Inc, as sales agent. The issuances and sales of our common stock under the ATM sales agreement are made pursuant to our effective “shelf” registration statement on Form S-3. During 2021, we issued and sold 75,490 shares of common stock under an at market issuance sales agreement, at an average price of $8.00 per share. Proceeds from those 2021 sales of $0.5 million are recorded in equity, net of $0.1 million of stock issuance costs.

Under the terms of the securities purchase agreement related to the September 2021 offering, we are prohibited from entering into an agreement to effect any ATM issuance until September 13, 2023. Under the terms of the securities purchase agreement related to the October offerings, we are generally prohibited from entering into an agreement to effect an offering of our common stock or common stock equivalents until May 20, 2023, or a variable rate transaction, as defined in the agreement, until October 20, 2023.

Table of Contents

~~RiceBran~~In October ~~Technologies~~2022, we issued and sold 675,000 shares of our common stock and a prefunded warrant (the 2022 Prefunded Warrant) exercisable into 325,000 shares of our common stock pursuant to our effective “shelf” registration statement on Form S-3. The holder exercised the 2022 Prefunded Warrant with an exercise price of $0.0001 per share (net of the $1.4999 per share prefunded) in full in 2022. In a concurrent private placement, we issued and sold warrants for the purchase up to 2,000,000 shares of our common stock at an exercise price of $1.60 per share, which are exercisable in April 2023, and expire in October 2025. The net proceeds from the concurrent offerings of $1.0 million, after deducting placement agent fees and other offering expenses of $0.5 million, were allocated to equity. We determined the exercise price of the 2022 Prefunded Warrant was nominal and, as such, we will consider the shares underlying that warrant to be outstanding effective October 20, 2022, for the purposes of calculating basic earnings (loss) per share (EPS). We intend to use the net proceeds from the October 2022 offerings for general corporate purposes, which may include funding capital expenditures, working capital and repaying indebtedness. In addition, we issued warrants for the purchase of up to 63,000 shares of our common stock to the placement agent at an exercise price of $1.875 per share which expire in October 2027.

~~Notes~~In September 2021, we issued and sold 230,750 shares of common stock, a warrant for the purchase of up to ~~Consolidated~~230,769 ~~Financial~~shares ~~Statements~~of common stock (Series Warrant A), and a prefunded warrant (the 2021 Prefunded Warrant) for the purchase of up to 230,786 shares of common stock pursuant to our effective “shelf” registration statement on Form S-3. The initial $10.00 per share exercise price of Series Warrant A was subject to adjustment in September 2022, and will be subject to adjustment again in September 2023, if 110% of the 5-day volume weighted average price of our common stock is less than the then-current exercise price. The 2021 Prefunded Warrant, which the holder exercised in full in 2021, had an exercise price of $0.001 (net of the $6.499 per share prefunded). We determined that the 2021 Prefunded Warrant qualified for equity accounting, however, Series Warrant A did not qualify for equity accounting because the holder may elect cash settlement of this warrant in the event of a change of control. As a result, we carry Series Warrant A as a liability at fair value in our consolidated balance sheets and the change in fair value of this warrant is recorded in our consolidated statements of operations. The net proceeds from the offering of $2.8 million, after deducting commissions and other cash offering expenses of $0.2 million were allocated to derivative warrant liability, in an amount equal to the $0.6 million estimated fair value of Series Warrant A as of September 13, 2021, with the remainder of the proceeds recorded in equity. We determined the exercise price of the Prefunded Warrant was nominal and, as such, considered the 230,786 shares initially underlying the 2021 Prefunded Warrant to be outstanding effective September 13, 2021, for the purposes of calculating basic EPS. We used the net proceeds from the September 2021 offering for general corporate purposes, which included funding capital expenditures and working capital and repaying indebtedness.

Equity Incentive Plan

Our ~~board~~Board ~~of directors~~ adopted our Amended and Restated 2014 Equity Incentive Plan (the 2014 Plan) after shareholders approved the plan, and amendments thereto. On July 14, 2022, shareholders approved an increase in the number of shares of common stock authorized for issuance under the 2014 Plan of 600,000 shares. The total shares of common stock now authorized for issuance under the 2014 Plan is 1,230,000 shares. Under the terms of the plan, we may grant stock options, shares of common stock and share-based awards to officers, directors, employees or consultants providing services on such terms as are determined by the ~~board of directors~~Board. Our ~~board~~Board ~~of directors~~ administers the plan, determines vesting schedules on plan awards and may accelerate the vesting schedules for award recipients. The stock options granted under the 2014 Plan have terms of up to 10 years and vesting periods of up to 4 years. The restricted stock units granted under the plan vest over periods of up to 5 years. As of December 31, ~~2022~~2023, awards for the purchase of 1,~~088~~230,~~457~~000 shares of common stock have been granted and remain outstanding (common stock options, common stock and restricted stock units) and ~~141,543~~no available shares of common stock are reserved for future grants under the 2014 Plan.

~~Share-based compensation expenses related to employees and directors are included in selling, general and administrative expenses. Share-based compensation by type of award follows (in thousands).~~ 37

	2022		2021
Restricted stock units	$	1,160	$	866
Stock options		101		140
Common stock		-		108
Compensation expense related to common stock awards issued under equity incentive plan	$	1,261	$	1,114

Information regarding common stock issued under the 2014 Plan, including shares issued upon vesting of restricted stock units follows. All shares of common stock issued in 2022 or 2021 were vested as of the date issued.

	2022				2021
	Shares Issued		Weighted Average Grant Date Fair Value Per Share		Shares Issued		Weighted Average Grant Date Fair Value Per Share
Directors		34,875	$	6.71		13,608	$	7.95
Employees		89,307		5.75		57,250		5.52
Consultant		13,516		6.47		-
		137,698				70,858

In the period from January1, 2023 to March 16, 2023, we issued 68,693 shares of common stock upon the vesting of restricted stock units.

Table of Contents

~~RiceBran~~Share-based ~~Technologies~~compensation expenses related to employees and directors are included in selling, general and administrative expenses. Share-based compensation by type of award follows (in thousands).

Notes to Consolidated Financial Statements

	2023		2022
Restricted stock units	$	316	$	1,160
Stock options		96		101
Compensation expense related to common stock awards issued under equity incentive plan	$	412	$	1,261

Information regarding common stock issued under the 2014 Plan, including shares issued upon vesting of restricted stock units follows. All shares of common stock issued in 2023 or 2022 were vested as of the date issued.

	2023				2022
	Shares Issued		Weighted Average Grant Date Fair Value Per Share		Shares Issued		Weighted Average Grant Date Fair Value Per Share
Directors		104,249	$	1.11		34,875	$	6.71
Employees		186,686		4.16		89,307		5.75
Vendors		59,465		1.29		13,516		6.47
		350,400				137,698

Restricted Stock Units

We have outstanding (i) restricted stock units issued under the 2014 Plan (RSUs) to employees and directors and (ii) other restricted stock units issued to a service provider (SUs). Each RSU and SU represents a contingent right to receive one share of common stock. Summaries of nonvested and vested stock unit and activity follow.

	RSUs										SUs
	Number of Units			Unrecognized Compensation (in thousands)			Average Grant Date Fair Value per share		Weighted Average Expense Period (Years)		~~Number~~Numer of Units			Unrecognized Compensation (in thousands)			Average Grant Date Fair Value per share		Weighted Average Expense Period (Years)
Nonvested at January 1, 2021		149,540		$	730		$	4.88		1.4		-		$	-		$	-	$	-
Nonvested at January 1, 2022		126,603		$	658		$	5.20		0.9		-		$	-		$	-		-
Granted		82,469			796			9.65		1.0		-			-			-		-
Forfeited		(291	)		(3	)		10.31		0.7		-			-			-		-
Vested with service		(105,115	)		-					-		-			-			-		-
Expensed		-			(865	)	NA			-		-			-			-		-
Nonvested at December 31, 2021		126,603			658			5.20		0.9		-			-			-		-
Granted		527,871			1,680			3.18		2.7		160,000			216			1.35		3.0
Impact of Modification:												-			-			-		-
Before modification		(17,050	)		(150	)		8.77		0.6		-			-			-		-
After modification		17,050			64			3.73		-		-			-			-		-
Forfeited		(11,744	)		(68	)		5.77		1.1		-			-			-		-
Vested with Service		(275,912	)		-					-		-			-			-		-
Vested with service		(275,912	)		-					-		-			-			-		-
Expensed		-			(1,160	)	NA			-		-			(15	)	NA			-
Nonvested at December 31, 2022		366,818		$	1,024		$	2.79		2.8		160,000		$	201		$	1.26		2.7
Granted		316,845			186			0.59		-		6,132			5			0.74		-
Forfeited		(234,059	)		(892	)		3.81		1.3		-			-			-		-
Vested with Service		(449,104	)		-					-		(59,465	)		-			-		-
Expensed		-			(317	)	NA			-		-			(80	)	NA			-
Nonvested at December 31, 2023		500		$	1			1.28		0.2		106,667		$	126		$	1.18		1.8

	Number of RSUs
Vested at January 1, 2021		38,640
Vested with service		105,115
Issued at vesting		(57,250	)
Vested at December 31, 2021		86,505
Vested with service		275,912
Issued at vesting		(83,725	)
Issued at termination of service		(53,967	)
Vested at December 31, 2022		224,725

~~At December~~ Table ~~31, 2022, unvested RSUs had an intrinsic value~~ of $0.3 million. unvested SUs had an intrinsic value of $0.1 million, and vested RSUs had an intrinsic value of $0.2 million. As of December 31, 2022, the intrinsic value of all RSUs and SUs outstanding was $0.6 million, unrecognized compensation was $1.2 million and the remaining vesting period was 2.8 years. At December 31, 2022, issuance of 165,790 shares of common stock subject to the unvested RSUs and 224,725 shares of common stock subject to the vested RSUs, is deferred to the date the holder is no longer providing service to our company.Contents

	Number of RSUs
Vested at January 1, 2022		86,505
Vested with service		275,912
Issued at termination of service		(83,725	)
Issued at vesting		(53,967	)
Vested at December 31, 2022		224,725
Vested with service		508,569
Issued at vesting		(350,400	)
Vested at December 31, 2023		382,894

At December 31, 2023, unvested RSUs and SUs had an intrinsic value of less than $0.1 million, and vested RSUs had an intrinsic value of $0.1 million. As of December 31, 2023, the intrinsic value of all RSUs and SUs outstanding was $0.1 million, unrecognized compensation was $0.1 million and the remaining vesting period was 1.3 years. At December 31, 2023, issuance of 382,894 shares of common stock subject to the vested RSUs, is deferred to the date the holder is no longer providing service to our company.

We issued 160,000 SUs to a service provider in 2022, which the service provider elected to purchase with a $0.2 million cash signing fee. The SUs vest in three annual installments ending in September 2025 and we are expensing the fair value of the SUs over three years. The service provider may also earn performance-based cash compensation beginning October 1, 2022, if certain performance criteria are met. The performance compensation will be paid quarterly in an amount of cash which may then be used to purchase, at the election of the service provider, a number of fully vested SUs equal to (a) the performance compensation, divided by (b) the volume weighted average closing price of our common stock over the 90 consecutive trading days ending on the last day of the applicable performance period. The aggregate number of SUs purchased by the service provider, including the initial 160,000 SUs issued in 2022 may not exceed 1,000,000.

In 2022, we modified RSUs held by resigning directors and an employee such that the awards vested on the date of their termination of service. Prior to the modification, the resigning directors and employee would have forfeited the unvested RSUs on the date service terminated. As a result of the modifications, we adjusted cumulative expense on the RSUs to equal the fair value of the awards on the modification dates in accordance with applicable accounting guidance, as indicated in the table above.

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

Options

As of December 31, ~~2022~~2023 and ~~2021~~2022, we had outstanding options for the purchase of up 55114,~~424~~056 and 6455,~~396~~424 shares of common stock. We granted no100,000 stock options in ~~2022~~2023 and ~~2021~~no stock options in 2022. Stock options for the purchase of up to 841,~~972~~368 and 38,~~107~~972 shares of common stock forfeited or expired in ~~2022~~2023 and ~~2021~~2022. As of December 31, ~~2022~~2023, outstanding stock options had an intrinsic value of zero, a weighted average exercise price of $193.4266 per share, ~~a weighted average remaining vesting period of 1.1 years~~ and a weighted average contractual remaining term of 51.90 years. ~~As of December 31, 2022, unrecognized stock option compensation cost was $70 thousand. As of December 31, 2022, exercisable options had an intrinsic value of zero.~~

Unrecognized Compensation

As of December 31, ~~2022~~2023, the total amount of unrecognized compensation for all outstanding common stock awards, (options, RSUs and SUs was $10.31 million, and the remaining average expense period was 20.7 years (including unrecognized compensation on SUs of $0.21 million with a remaining average expense period of 21.78 years.)).

Warrants

The 2022 Prefunded Warrant was exercised in its entirety in 2022 and we issued 325,000 shares of common stock upon the cash exercises. The ~~2021 Prefunded Warrant was cashless exercised in its entirety in 2021 and we issued 230,750 shares of common stock upon the cashless exercises. The~~ initial $10.00 per share exercise price of Series Warrant A adjusted, pursuant to its original terms, to $2.72 per share in September 2022, and ~~will~~adjusted ~~be subject to adjustment~~ again in September 2023 to $0.57 per share, if 110% of the 5-day volume weighted average price of our common stock is less than the then-current exercise price.

On December 1, 2023, the Company consummated a transaction pursuant to an exchange agreement (the Cove Lane Exchange Agreement) with Cove Lane Master Fund LLC (Cove Lane) to exchange the existing Series A Warrant held by Cove Lane or its designees for 150,000 shares of Common Stock to be issued in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended (the Securities Act), upon the terms and conditions set forth in the Cove Lane Exchange Agreement.

On December 1, 2023, the Company consummated a transaction pursuant to an exchange agreement (the Sabby Exchange Agreement) with Sabby Volatility Warrant Master Fund, Ltd. (Sabby) to exchange the existing Common Stock Purchase Warrant held by Sabby or its designees for (i) 323,810 shares of Common Stock and (ii) warrants to purchase up to 1,200,000 shares of Common Stock (the Sabby Warrants) each to be issued in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act upon the terms and conditions set forth in the Sabby Exchange Agreement.

Table of Contents

The Sabby Warrants will be exercisable at a price of $0.2016 per share, subject to adjustments as provided under the terms of the Sabby Warrants. The Sabby Warrants are exercisable at any time on or after December 1, 2023, until the expiration thereof. The Sabby Warrants have a term of three years from the date of issuance.

On December 1, 2023, the Company consummated a transaction pursuant to an exchange agreement (the Hudson Bay Exchange Agreement and, collectively with the Cove Lane Exchange Agreement and the Sabby Exchange Agreement, the Exchange Agreements) with Hudson Bay Master Fund Ltd. (Hudson Bay) to exchange the existing Common Stock Purchase Warrant held by Hudson Bay or its designees for 155,000 shares of Common Stock to be issued in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act upon the terms and conditions set forth in the Hudson Bay Exchange Agreement.

Warrant activity, excluding activity related to prefunded warrants follows.

	2022							2021
	2023							2022
	Shares Under Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Shares Under Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
Outstanding at January 1		~~875~~2,~~067~~298,769		$	91.76		12.49		~~664~~875,~~592~~067		$	9.8276		1.14
Issued		24,~~063~~324,~~000~~802			10.6121		34.1		~~230~~2,~~769~~063,000		$	101.0061		53.01
Impact of Warrant A exercise price adjustment:
Before adjustment		~~230,769~~-			~~10.00~~-		~~4.0~~-		230,769		$	10.00		4.0
After adjustment		~~(230,769~~-	)		~~2.72~~-		~~4.0~~-		(230,769	)	$	2.72		4.0
Cash exercised									(17,794	)		9.60		0.8
Forfeited		(2,230,769	)		1.72		2.9
Expired		(~~639~~5,~~298~~000	)		920.6000		-		(2639,~~500~~298	)		529.5060		-
Outstanding at December 31		24,~~298~~387,~~769~~802		$	10.7621		24.91		~~875~~2,~~067~~298,769		$	91.76		12.49

The following table summarizes information related to exercisable and outstanding warrants as of December 31, ~~2022~~2023.

		Outstanding						~~Exercisable~~
Exercise Prices		Shares Under Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		~~Shares Under Warrants~~		~~Weighted Average Exercise Price~~		~~Weighted Average Remaining Contractual Life (Years)~~
$	10.6018		23,~~000~~124,~~000~~802	$	10.6018		24.89		-	$	-		-
$	10.8820		631,200,000		10.8820		41.8		-		-		-
$	21.7288		~~230~~63,~~769~~000		21.7288		3.78		~~230,769~~		~~2.72~~		~~3.7~~
$	20.00		5,000		20.00		0.1		5,000		20.00		0.1
			4,387,802	$	0.21		4.1
			2,298,769	$	1.76		2.9		235,769	$	3.09		3.6

36 40

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

NOTE 11. INCOME TAXES

Deferred tax asset (liability) is comprised of the following (in thousands):

	December 31
	2022				2021
	2023			2022
Net operating loss carryforwards	$	1417,~~264~~734		$	$14,264	~~13,385~~
Stock options and warrants		1,~~151~~090			1,151	~~832~~
Property and equipment		~~(46~~310	)		(46	16)
Intangible assets		~~875~~688			875	~~950~~
Capitalized expenses		~~117~~105			117	~~105~~
Other		~~655~~440			655	64
Operating right-of-use lease assets		~~(478~~-	)		-	~~(566~~	)
Operating right-of-use lease liabilities		~~645~~124			167	~~670~~
Net deferred tax assets		1720,~~183~~491			17,183	~~15,456~~
Less: Valuation allowance		(1720,~~183~~491	)		(17,183	~~(15,456~~)	)
Deferred tax asset (liability)	$	-		$	$-	-

We have determined it is more likely than not that our deferred tax assets will not be realized. Accordingly, we have provided a valuation allowance for deferred tax assets.

The following table summarizes the change in the valuation allowance (in thousands):

	2022			2021
	2023			2022
Valuation allowances, beginning of year	$	1517,~~456~~183		$	1215,~~421~~456
Net operating loss and other temporary differences		13,~~997~~974			21,~~926~~997
Expiration of net operating losses and limitations		(9033	)		-(90	)
Adjustment to deferred taxes		(~~197~~159	)		67(197	)
Impact of state tax rate change		22(404	)		4222
Other		(570	)		-(5	)
Valuation allowance, end of year	$	1720,~~183~~491		$	1517,~~456~~183

As of December 31, ~~2022~~2023, net operating loss (NOL) carryforwards for U.S. federal tax purposes totaled $5470.4 million. NOLs generated after December 31, 2017, do not expire. Federal NOLs of $9.9 million expire at various dates from ~~2023~~ 2036 through 2037 and the remainder do not expire. The Tax Cuts and Jobs Act (TCJA) limitation of 80% of taxable income is applied to NOLs generated in tax years beginning after December 31, 2017. NOL carryforwards for state tax purposes totaled $4647.0 5 million at December 31, ~~2022,~~2023. ~~and~~State NOLs of $45.6 million expire at various dates from ~~2023~~2024 through ~~2042~~2043 and the remainder do not expire.

Our ability to utilize previously accumulated NOL carryforwards is subject to substantial annual limitations due to the changes in ownership provisions of the Internal Revenue Code (IRC) of 1986, as amended, and similar state regulations. Prior to 2020, we experienced several ownership changes as defined in IRC Section 382(g). In general, the annual limitation is equal to the value of our stock immediately before the ownership change, multiplied by the long-term tax-exempt rate for the month in which the ownership change occurred. Any unused annual limitation may generally be carried over to later years until the NOL carryforwards expire. Accordingly, we have reduced our NOL in the table above to reflect these limitations.

We are subject to taxation in the U.S. federal jurisdiction and various state and local jurisdictions. We record liabilities for income tax contingencies based on our best estimate of the underlying exposures. We are open for audit by the IRS for years after ~~2018~~2019 and, generally, by U.S. state tax jurisdictions after ~~2017~~2018.

37 41

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

Reconciliations between the amounts computed by applying the U.S. federal statutory tax rate to loss before income taxes, and income tax expense (benefit) follows (in thousands):

	2022			2021
	2023			2022
Income tax benefit at federal statutory rate	$	(1,646	)	$	(1,875	)
Pre-tax income (loss)	$	(8,539	)	$	(6,641	)
Income tax benefit at federal statutory rate	$	(1,796	)	$	(1,646	)
Increase (decrease) resulting from:
State tax benefit, net of federal tax effect		(~~421~~189	)		(~~605~~421	)
Effect of change in state tax rate		~~(22~~404	)		(4222	)
Change in valuation allowance		13,~~727~~308			31,~~035~~727
Expirations of net operating losses and application of IRC 382 limitation		9033			-90
PPP loan forgiveness, nontaxable		-			(376	)
Fair value adjustments and others		(1,960	)		5
Change in fair value of derivative warrant liability, nontaxable		5			(81	)
Other nondeductible expenses		53			89
Other nondeductible expenses		89			32
Adjustments to deferreds		159			197
Adjustments to deferreds		197			(67	)
Income tax expense	$	12		$	19
Income tax expense	$	19		$	21

~~Based~~During onthe anyear ~~analysis of tax positions taken on income tax returns filed, we determined no material liabilities related to uncertain income tax positions existed as of~~ended December 31, ~~2022 or 2021. Although we believe the amounts reflected in our tax returns substantially comply with applicable U.S. federal~~2023, ~~state~~income ~~and local~~ tax ~~regulations,~~expense ~~the respective taxing authorities may take contrary positions based~~ on ~~their interpretation of~~ the ~~law.~~consolidated Astatement ~~tax~~of ~~position~~operations ~~successfully~~included ~~challenged~~$12 bythousand afrom ~~taxing~~minimum ~~authority~~state ~~could result in an adjustment to our provision or benefit for income~~ taxes inand ~~the~~franchise ~~period in which a final determination is made~~taxes.

Based on an analysis of tax positions taken on income tax returns filed, we determined no material liabilities related to uncertain income tax positions existed as of December 31, 2023 or 2022. Although we believe the amounts reflected in our tax returns substantially comply with applicable U.S. federal, state and local tax regulations, the respective taxing authorities may take contrary positions based on their interpretation of the law. A tax position successfully challenged by a taxing authority could result in an adjustment to our provision or benefit for income taxes in the period in which a final determination is made.

NOTE 12. INCOME (LOSS) PER SHARE (EPS)

Basic EPS is calculated under the two-class method under which all earnings (distributed and undistributed) are allocated to each class of common stock and participating securities based on their respective rights to receive dividends. Our outstanding convertible preferred stock are considered participating securities as the holders may participate in undistributed earnings with holders of common shares and are not obligated to share in our net losses.

Diluted EPS is computed by dividing the net income attributable to RiceBran Technologies common shareholders by the weighted average number of common shares outstanding during the period increased by the number of additional common shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive. The dilutive effects of outstanding options, warrants, nonvested shares of common stock and nonvested restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method. The dilutive effects of the outstanding preferred stock are calculated using the if-converted method.

Below are reconciliations of the numerators and denominators in the EPS computations.

	2022			2021
	2023			2022
NUMERATOR (in thousands):
Basic and diluted - net loss	$	(7,858	)	$	(8,949	)
Basic and diluted - loss from continuing operations	$	(8,551	)	$	(6,660	)
DENOMINATOR:
DENOMINATOR (in thousands):
Weighted average number of shares of shares of common stock outstanding		56,~~414~~746,~~079~~688			45,~~710~~414,~~567~~079
Weighted average number of shares of common stock underlying vested restricted stock units		~~100~~245,~~592~~670			63100,~~328~~592
Basic EPS - weighted average number of shares outstanding		56,~~514~~992,~~671~~358			45,~~773~~514,~~895~~671
Effect of dilutive securities outstanding		-			-
Diluted EPS - weighted average number of shares outstanding		56,~~514~~992,~~671~~358			45,~~773~~514,~~895~~671

No effects of potentially dilutive securities outstanding were included in the calculation of diluted EPS for ~~2022~~2023 and ~~2021~~2022, because to do so would be anti-dilutive due to our net loss. Potentially dilutive securities outstanding during ~~2022~~2023 and ~~2021~~2022 included our outstanding convertible preferred stock, options, warrants and nonvested restricted stock units. Those potentially dilutive securities, further described in Note 10, could potentially dilute EPS in the future.

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

NOTE 13. FAIR VALUE MEASUREMENT

The fair value of cash and cash equivalents, restricted cash, accounts and other receivables, accounts payable, commodities payable and short-term debt approximated their carrying value due to shorter maturities. As of December 31, ~~2022~~2023, the fair ~~value of our operating lease liabilities was approximately $0.2 million lower than their carrying~~ values, ~~based on current market rates for similar debt and leases with similar maturities (Level 3 measurements). As~~ of ~~December~~ ~~31, 2022, the fair values of~~ our long-term debt and finance lease liabilities approximated their carrying values, based on current market rates for similar debt and leases with similar maturities (Level 3 measurements).

Table of Contents

The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our consolidated balance sheets (in thousands):

	Level 1		Level 2		Level 3		Total
As of December 31, 2022:
Derivative warrant liability	$	-	$	-	$	69	$	69
Total liabilities at fair value	$	-	$	-	$	69	$	69
As of December 31, 2021:
Derivative warrant liability	$	-	$	-	$	258	$	258
Total liabilities at fair value	$	-	$	-	$	258	$	258

The following tables summarize the changes in level 3 items measured at fair value on a recurring basis (in thousands):

	Fair Value as of Beginning of Period		Total Realized and Unrealized Gains (Losses)			Issuance of New Instruments		Net Transfers (Into) Out of Level 3		Fair Value, at End of Period		Change in Unrealized Gains (Losses) on Instruments Still Held
2023:
Derivative warrant liability	$	69	$	(69	)	$	-	$	-	$	-	$	(69	)
Total Level 3 fair value	$	69	$	(69	)	$	-	$	-	$	-	$	(69	)
2022:
Derivative warrant liability	$	258	$	(189	)	$	-	$	-	$	69	$	(189	)
Total Level 3 fair value	$	258	$	(189	)	$	-	$	-	$	69	$	(189	)
2021:
Derivative warrant liability	$	-	$	-		$	647	$	-	$	258	$	(389	)
Total Level 3 fair value	$	-	$	-		$	647	$	-	$	258	$	(389	)

The derivative warrant liability in the tables above relates to Series Warrant A, discussed further in Note 10. Series Warrant A, ispreviously ~~carried~~held inby ~~our~~Cove ~~consolidated~~Lane, ~~balance~~was ~~sheets~~exchanged asfor ~~derivative~~150,000 ~~warrant~~shares ~~liability because the holder may elect cash settlement~~ of ~~the~~Common ~~warrant~~Stock inand ~~the~~is ~~event~~no oflonger acarried ~~change of control. We estimated the fair value of Warrant A using the Black-Scholes. Changes~~ in ~~the estimated fair value of Warrant A are included in other income (loss) in~~ our consolidated ~~statements~~balance ofsheets ~~operations.~~at December ~~The~~31, ~~following~~2023 ~~are~~as ~~the~~derivative ~~assumptions~~warrant ~~used in valuing Warrant A~~liability.

	December 31, 2022			December 31, 2021			September 30, 2021
Assumed exercise price, per share	$	2.72		$	10.00		$	10.00
Assumed volatility		92.2	%		69.5	%		71.0	%
Assumed risk free interest rate		4.3	%		0.8	%		0.4	%
Expected life of options (in years)		4.0			4.8			5.0
Expected dividends		-			-			-

The fair value of Warrant A approximates the cash settlement the holder could elect to be paid in the event of a change in control. At December 31, 2022, a $0.10 increase in our stock price would have resulted in an approximate $10 thousand increase in the Black Scholes fair value of Warrant A.

Table of Contents

RiceBran Technologies

Notes to Consolidated Financial Statements

NOTE 14. COMMITMENTS AND CONTINGENCIES

PPP Audit Contingency

In April 2020, we received $1.8 million on a Small Business Administration (SBA) Paycheck Protection Program (PPP) loan as provided for in the Coronavirus Aid, Relief and Economic Security Act, enacted into U.S. law in March 2020. Under certain conditions, the loan and accrued interest were forgivable, if we used the loan proceeds for maintaining workforce levels. We used the loan proceeds for maintaining workforce levels and the SBA forgave the entire loan and related accrued interest in January 2021. The SBA may audit any PPP loan at its discretion through January 2027, six years after the date the SBA forgave the loan. The SBA may review any or all of the following when auditing a PPP loan: whether the borrower qualified for the PPP loan, whether the PPP loan amount was appropriately calculated and the proceeds used for allowable purposes, and whether the loan forgiveness amount was appropriately determined. The SBA could deem us ineligible for the PPP loan received in 2020 upon audit by the SBA. We believe the SBA’s stated intention is to focus its reviews on borrowers with loans greater than $2 million, thereby mitigating our future risk of an audit. The SBA continues to develop and issue new and updated guidance regarding required borrower certifications and requirements for forgiveness of loans made under the program.

Employment Contracts and Severance Payments

In the normal course of business, we periodically enter into employment agreements which incorporate indemnification provisions. While the maximum amount to which we may be exposed under such agreements cannot be reasonably estimated, we maintain insurance coverage, which we believe will effectively mitigate our obligations under these indemnification provisions. No amounts have been recorded in our financial statements with respect to any obligations under such agreements.

We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control. In addition, vesting of outstanding nonvested equity grants would accelerate following a change in control.

Legal Matters

From time to time, we are involved in litigation incidental to the conduct of our business. These matters may relate to employment and labor claims, patent and intellectual property claims, claims of alleged non-compliance with contract provisions and claims related to alleged violations of laws and regulations. When applicable, we record accruals for contingencies when it is probable that a liability will be incurred, and the amount of loss can be reasonably estimated. Defense costs are expensed as incurred and are included in professional fees. While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits and other proceedings had or are expected to have a material effect on our financial position or results of operations in ~~2022~~2023 and ~~2021~~2022.

In January 2023, we received $0.3 million in restitution payments from a former employee. The payments were ordered by a federal court in 2012.

40 NOTE 15. SUBSEQUENT EVENT

~~Table~~On January of25, ~~Contents~~ 2024, we sold our Golden Ridge property and equipment for $2.15 million in cash. Related to this sale, on December 31, 2023 we recognized a $1.5 million impairment expense related to these assets.

PART II

(continued)

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

Table of Contents

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

An evaluation of the effectiveness of the design and operation of our “disclosure controls and procedures” (as such term is defined in Rule 13a and Rule15d-15(e)) under the Exchange Act was performed as of December 31, ~~2022~~2023, under the supervision and with the participation of our current management, including our current Executive Chairman, Interim Chief Financial Officer, and ~~Chief~~Interim ~~Accounting Officer~~Controller. Our disclosure controls and procedures have been designed to ensure that information we are required to disclose in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Executive Chairman and Interim Chief Financial Officer to allow timely decisions regarding required disclosures.

Based on this evaluation, our Executive Chairman and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2022.

Changes in Internal Control over Financial Reporting

~~There~~Except for as set forth below, there were no changes in our internal control over financial reporting that occurred during the year ended December 31, ~~2022~~2023, that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

Management Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934 (Exchange Act) and for the assessment of the effectiveness of internal control over financial reporting. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Our internal control over financial reporting includes those policies and procedures that:

(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention, or timely detection, of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

(iii) provide reasonable assurance regarding prevention, or timely detection, of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of current management, including our current Executive Chairman, Interim Chief Financial Officer, and ~~Chief~~Interim ~~Accounting Officer~~Controller, we conducted an assessment of the effectiveness of our internal control over financial reporting as of December 31, ~~2022~~2023. In making this assessment, management used the criteria set forth in the framework established by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) entitled “Internal Control - Integrated Framework (the 2013 Framework).” ~~Based on this analysis, our management concluded that as of December 31, 2022, our internal control over financial reporting was effective based upon the criteria set forth by the 2013 Framework.~~

41 Material Weaknesses

~~Table~~Our management concluded that as of ~~Contents~~ December 31, 2023, we did not maintain effective internal controls over financial reporting. Specifically, we identified material weaknesses over management’s review controls over the documentation and review of the required dual approval for the posting of journal entries and the processing and review of inventory costing.

The Company had consistent turnover within the accounting department in 2023, which led to not sustaining a sufficient number of qualified personnel to maintain the proper controls over financial reporting. This led to an overstatement in inventory due to the incorrect entry of purchase order quantities, which was detected by the Company’s independent auditors.

Management has initiated remediation measures including, but not limited to, hiring additional accounting staff and the necessary customization of the Company’s accounting system to provide the documentation for the required dual approval for the posting of journal entries. As a result, the Company believes that it has adequate resources to address accounting and reporting requirements under U.S. GAAP and SEC reporting standards and to implement the appropriate internal controls.

ITEM 9B. OTHER INFORMATION

None.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable.

Table of Contents

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The ~~information~~names ~~required by Item 10~~ of ~~Part III is incorporated by reference to~~ our ~~definitive~~directors ~~proxy~~and ~~statement,~~executive toofficers beand ~~filed~~certain ~~within~~information ~~120~~about ~~days~~them ofare ~~our~~set ~~fiscal~~forth ~~year end, or will be included in an amendment to this Form 10-K~~below.

Name	Age	Position

*Executive Officers*
Eric Tompkins*	62	Director and Executive Chairman
William J. Keneally	61	Interim Chief Financial Officer and Secretary

*Non-Employee Directors*
Brent D. Rosenthal (2)(3)*	51	Lead Independent Director
David I. Chemerow (1)(3)*	72	Director
James P. Flynn (1)(2)*	43	Director
Georgina Russell (1)(2)(3)*	47	Director

(1)	Current member of the Audit Committee.

(2)	Current member of the Compensation Committee.

(3)	Current member of the Nominating and Governance Committee.

*	Director nominee.

Executive Officers

Eric Tompkins has served as our director and executive chairman since June 2023, and has served as business unit leader of our milling operations since June 2021. Mr. Tompkins served as senior vice president of sales and business development from June 2020 to June 2021 and as senior vice president of business development from April 2019 to June 2020. Mr. Tompkins was president and chief executive officer of MGI Processing, LLC from March 2017 until we acquired that company in April 2019. He was director of sales for Ardent Mills from 2014 to 2017. From 1987 to 2014, Mr. Tompkins held various positions at Con Agra Brands, Inc. (NYSE: CAG), lastly as director of national account sales and initially in grain procurement and risk management. Mr. Tompkins graduated from the University of Colorado with a Bachelor of Arts in Economics and a Bachelor of Arts in International Affairs. He received his Master of International Management from the Thunderbird-American Graduate School of International Management. The Board believes that Mr. Tompkins’s extensive experience in commodities and milling, coupled with his history with our Company, are the attributes, skills, experiences and qualifications that allow Mr. Tompkins to make a valuable contribution as one of our directors.

William J. Keneally has served as our interim chief financial officer since April 2023 under a consulting services agreement with TechCXO, LLC; TechCXO Florida, LLC; TechCXO Tennessee, LLC and TechCXO Texas, LLC d/b/a CXO Partners. From March 2023 to the present and August 2018 to May 2022, Mr. Keneally has been a partner of TechCXO, LLC, a provider of C-suite executive services. From February 2020 to the present, Mr. Keneally has been founder and chief financial officer of Spades SBC whose mission is to significantly increase global planting and growing of trees so to mitigate client change efficiently and effectively. From June 2022 to February 2023, Mr. Keneally served as chief accounting officer of Flutterwave, Inc., a venture-backed, African-focused, payments and other solutions technology provider with approximately 50 global subsidiaries. From April 2013 to June 2015, Mr. Keneally served as chief financial officer of CTPartners Executive Search Inc. On November 12, 2015, the Court of Chancery of the State of Delaware appointed a receiver for CTPartners Executive Search Inc. Mr. Keneally is an inactive New York State certified public accountant and received his Bachelor of Business Administration – Accounting Concentration from the University of Notre Dame.

Non-Employee Directors

Brent D. Rosenthal has served as a director since July 2016 and as lead independent director since August 2020. Mr. Rosenthal was non-executive chairman of our Board from July 2016 to August 2020. Mr. Rosenthal is the founder of Mountain Hawk Capital Partners, LLC, an investment fund focused on small and micro-cap equities in the food and technology media telecom industries. Mr. Rosenthal also serves as lead director of the board of directors of Comscore, Inc (NASDAQ: SCOR), a digital data and analytics company, and on the board of directors of FLYHT Aerospace Solutions Ltd. (OTCX: FLYLF) and OmniLit Acquisition Corp. (NASDAQ: OLIT). Previously, Mr. Rosenthal was an advisor to the board of directors of Park City Group (NASDAQ: PCYG), a food safety and supply chain software company from 2015 to 2018. Mr. Rosenthal was a partner in affiliates of W.R. Huff Asset Management where he worked from 2002 to 2016. Mr. Rosenthal served on the board of directors of Rentrak Corporation (NASDAQ: RENT), a media measurement and advanced consumer targeting company, from 2008 to 2016 and as non-executive chairman of the board from 2011 to 2016. He also served on the boards of directors of four privately-held Hispanic food companies. Earlier in his career, Mr. Rosenthal was director of mergers and acquisitions for RSL Communications Ltd. and served emerging media companies for Deloitte. Mr. Rosenthal is an inactive certified public accountant. Mr. Rosenthal earned his Bachelor of Science in Accounting degree from Lehigh University and Master of Business Administration degree from the S.C. Johnson Graduate School of Management at Cornell University. The Board believes that Mr. Rosenthal’s experience investing in the food industry, independent board experience and business acumen are the attributes, skills, experiences and qualifications that allow Mr. Rosenthal to make a valuable contribution as one of our directors.

Table of Contents

David I. Chemerow has served as a director since October 2018. From August 2016 to September 2017, Mr. Chemerow served as the chief financial officer and treasurer of Comscore, Inc. and from January 2016 to August 2016, Mr. Chemerow served as the chief revenue officer of Comscore, Inc. Mr. Chemerow served as the chief operating officer and chief financial officer of Rentrak Corporation from October 2009 until Rentrak Corporation was merged into Comscore, Inc. in January 2016. Prior to 2009, Mr. Chemerow served in senior executive roles in several companies. Mr. Chemerow previously served as the non-executive chairman of the board of Playboy Enterprises, Inc. and is a member of the board of directors of Dunham’s Athleisure Corporation, a sporting goods retailer. Mr. Chemerow serves on the board of The Martha’s Vineyard Playhouse, a non-profit theatre. Mr. Chemerow is a graduate of Dartmouth College and holds a Master of Business Administration degree from The Amos Tuck School. The Board believes that Mr. Chemerow’s extensive experience, business knowledge and experience as chief operating officer and chief financial officer of several public companies are the attributes, skills, experiences and qualifications that allow Mr. Chemerow to make a valuable contribution as one of our directors.

James P. Flynn has served as a director since January 2024. Mr. Flynn is currently the Managing Member and Portfolio Manager of Nerium Capital LLC, an investment adviser he founded in 2021. He also currently serves on the Board of Directors of ARCA Biopharma (NASDAQ: ABIO), MEI Pharma (NASDAQ: MEIP), and Axiom Health (private). From 2019 to 2020, Mr. Flynn was exploring business opportunities, which ultimately led to the formation of Nerium Capital. From 2017 to 2018, Mr. Flynn worked as a therapeutics analyst at Aptigon Capital (a Citadel Company), an investment firm. Prior to that, from 2003 to 2017, Mr. Flynn served in various roles at Amici Capital, LLC, an investment firm, including healthcare portfolio manager (2008 to 2017). From 2002 to 2003, Mr. Flynn worked in the credit research/high yield group at Putnam Investments, an investment firm. He earned an S.B. degree in Management Science with a concentration in Finance and a minor in Economic Science from the Massachusetts Institute of Technology (MIT). Mr. Flynn is a Chartered Financial Analyst (CFA) Charterholder.

Georgina Russell has served as a director since January 2024. Ms. Russell is the Managing Partner of Chicane GP LLC and the Portfolio Manager of Chicane Opportunities Fund LP, roles she has held since January 2019. From January 2015 through December 2018, she was a Portfolio Manager at Willett Advisors, LLC (“Willett”) where she managed a long-term, concentrated fund of publicly traded securities. Prior to Willett, from April 2012 through July 2014, Ms. Russell was a Managing Director at Smithwood Advisers L.P. (“Smithwood”), a Los Angeles based investment advisory firm. Earlier in her career, Ms. Russell worked as an Analyst at Lonestar Capital Management, LLC in San Francisco, from January 2009 through April 2012. From August 2007 to December 2008, Ms. Russell did a first stint at Smithwood in their Hong Kong office. Before establishing her career in investing, Ms. Russell was a software engineer. She architected and authored cloud-based distributed systems. Ms. Russell was awarded three patents for her work. Ms. Russell graduated from the University of California, Berkeley in 1999 with a Bachelor of Arts degree with honors in Computer Science. She received an MBA with honors from The Wharton School at the University of Pennsylvania in 2007.

Board Leadership Structure

The Board believes our governance structure follows a successful leadership model under which our executive chairman also serves in a role as acting chief executive of the Company. The Board believes at present that the combined role of executive chairman and chief executive of the Company promotes united leadership and direction for the Company, which allows for a single, clear focus for management to execute the Company’s strategy and business plans. We recognize that different leadership models may work well for other companies at different times depending on individual circumstances, and we believe that the Company is well served by the combination of these roles as we seek to improve the performance of the Company and review our strategic alternatives. To enhance this approach and strengthen the oversight capabilities of the Board, we designated a lead independent director who is charged with working with the other independent directors in carrying out the strategic, governance, oversight and decision-making responsibilities of the Board.

Table of Contents

The Board does not have a policy, one way or the other, with respect to whether the same person should serve as both the chief executive officer and chairman of the Board or, if the roles are separate, whether the chairman should be selected from the non-employee directors or should be an employee. The Board believes that it should have the flexibility to make these determinations at any given point in time in the way that it believes best to provide appropriate leadership for the Company at that time. The Board evaluates the leadership structure annually, and it will continue to do so as circumstances change, including if a new chief executive officer is elected. Currently, Mr. Tompkins serves as executive chairman of the Board and Mr. Rosenthal serves as lead independent director.

Risk Oversight

The Board has three standing committees with separate chairs – Audit, Compensation, and Nominating and Governance. Our Audit Committee is responsible for overseeing risk management and at least annually reviews and discusses with management policies and systems pursuant to which management addresses risk, including risks associated with our audit, financial reporting, internal control, disclosure control, legal and regulatory compliance, and investment policies. Our Audit Committee also serves as the contact point for employees to report corporate compliance issues. Our Audit Committee regularly reviews with our Board any issues that arise in connection with such topics. Our full Board regularly engages in discussions of risk management to assess major risks facing the Company and review options for their mitigation. Each of our Board committees also considers the risk within its area of responsibilities. For example, our Compensation Committee periodically reviews enterprise risks to ensure that our compensation programs do not encourage excessive risk-taking and our Nominating and Governance Committee oversees risks related to governance issues.

Board Meetings and Committee Meetings

During 2023, the Board held nine meetings. Each incumbent director who was a director in 2023 attended at least 75% of the aggregate of the total number of meetings of the Board and meetings of the committees on which such director served that occurred while such director served on the Board or the committees. Our Board and its committees set schedules to meet throughout the year and also can hold special meetings and act by written consent from time to time, as appropriate. Our Board has delegated various responsibilities and authority to its committees as generally described below. The committees regularly report on their activities and actions to the Board.

Audit Committee

The Audit Committee, which has been established in accordance with Section 3(a)(58)(A) of the Exchange Act, assists the Board in its general oversight of our financial reporting, internal controls, and audit functions, and is directly responsible for the appointment, compensation and oversight of the work of our independent registered public accounting firm. As of December 31, 2023, the members of the Audit Committee are Brent D. Rosenthal and David I. Chemerow. Each member of the Audit Committee is independent under Nasdaq’s independence standards for audit committee members and within the meaning of Rule 10A-3 of the Exchange Act. The Board has determined that Brent D. Rosenthal and David I. Chemerow are each an “audit committee financial expert”, as defined by the rules of the SEC. The charter of the Audit Committee is available on our website at www.ricebrantech.com/investors/annual-meeting. The Audit Committee met four times in 2023. Each then-current member of the Audit Committee attended at least 75% of these meetings during the period that the director was a committee member.

Compensation Committee

The Compensation Committee establishes our executive compensation policy, determines the salary and bonuses of our executive officers and recommends to the Board share-based compensation grants for our executive officers. The members of the Compensation Committee are Brent D. Rosenthal and David I. Chemerow, and each member is independent under Nasdaq’s independence standards for compensation committee members. The Compensation Committee may from time to time delegate some or all of its duties or responsibilities to subcommittees or to one member of the Compensation Committee. Our executive chairman often makes recommendations to the Compensation Committee and the Board concerning compensation of other executive officers. The Compensation Committee seeks input on certain compensation policies from the executive chairman. The charter of the Compensation Committee is available on our website at www.ricebrantech.com/investors/annual-meeting.

In fulfilling its duties and responsibilities, the Compensation Committee seeks periodic input, advice and recommendations from various sources, including our Board and our executive officers. The Committee at all times exercises independent discretion in its executive compensation decisions. In 2023, all members of the board were on all committees, and the entire board met for compensation committee matters.

Table of Contents

Nominating and Governance Committee

The Nominating and Governance Committee is responsible for matters relating to the corporate governance of our Company and the nomination of members of the Board and committees thereof. The members of the Nominating and Governance Committee are Brent D. Rosenthal and David I. Chemerow and each member is independent under Nasdaq’s independence standards. The charter of the Nominating and Governance Committee is available on our website at www.ricebrantech.com/investors/annual-meeting. In 2023, all members of the board were on all committees, and the entire board met for nominating and governing committee matters.

Nomination Process

In evaluating potential candidates for membership on the Board, the Nominating and Governance Committee may consider such factors as it deems appropriate. These factors may include judgment, skill, diversity, integrity, experience with businesses and other organizations of comparable size, the interplay of the candidate’s experience with the experience of other Board members and the extent to which the candidate would be a desirable addition to the Board and any committees of the Board. While the Nominating and Governance Committee has not established any specific minimum qualifications for director nominees, the Nominating and Governance Committee believes that demonstrated leadership, as well as significant years of service in an area of endeavor such as business, law, public service, related industry or academia, is a desirable qualification for service as our director. Upon the identification of a qualified candidate, the Nominating and Governance Committee selects, or recommends for consideration by the full Board, the nominee for the election of directors to the Board.

We are committed to diversity and inclusion. Although we do not have a formal policy in place, we consider diversity, among other factors, to identify our nominees for the Board. We view diversity broadly to include diversity of experience, skills and viewpoint. In sum, we strive to assemble a diverse Board that is strong in its collective knowledge and that also consists of individuals who bring a variety of complementary attributes and skills to the Board such that the Board, taken as a whole, has the necessary and appropriate skills and experience to provide an enriched environment. The needs of the Board and the factors that the Nominating and Governance Committee considers in evaluating candidates are reassessed on an annual basis, when the committee’s charter is reviewed. The charter of the Nominating and Governance Committee is available on our website at www.ricebrantech.com/investors/annual-meeting.

The Nominating and Governance Committee will consider nominees recommended by shareholders. Any shareholder may make recommendations to the Nominating and Governance Committee for membership on the Board by sending a written statement of the qualifications of the recommended individual to: Secretary, RiceBran Technologies, 25420 Kuykendahl Rd., Suite B300, Tomball, Texas 77375. Such recommendations should be received no later than twenty days prior to the annual meeting for which the shareholder wishes his or her recommendation to be considered; provided, however, that in the event that less than thirty days’ notice or prior public disclosure of the date of the meeting is given or made to shareholders, notice by the shareholder to be timely must be received no later than the close of business on the tenth day following the day on which such notice of the date of the meeting was mailed or such public disclosure was made. Such shareholder’s notice must set forth all of the information required by, and comply with, our articles of incorporation and bylaws, including the following: (a) as to each person whom the shareholder proposes to nominate for election or re-election as a director: (i) the name, age, business address and residence address of such person, (ii) the principal occupation or employment of such person, (iii) the class and number of shares of the Company which are beneficially owned by such person, (iv) any other information relating to such person that is required by law to be disclosed in solicitations of proxies for election of directors, and (v) such person's written consent to being named as a nominee and to serving as a director if elected; and (b) as to the shareholder giving the notice: (i) the name and address, as they appear on the Company's books, of such shareholder, (ii) the class and number of shares of the Company which are beneficially owned by such shareholder, and (iii) a description of all arrangements or understandings between such shareholder and each nominee and any other person or persons (naming such person or persons) relating to the nomination. The Board will evaluate candidates recommended by shareholders on the same basis as it evaluates other candidates, including the following criteria:

●

Directors should be of the highest ethical character and share values that reflect positively on themselves and us.

●

Directors should have reputations, both personal and professional, consistent with our image and reputation.

●

Directors should be highly accomplished in their respective fields, with superior credentials and recognition.

Table of Contents

The fact that a proposed director nominee meets some or all of the above criteria will not obligate the Nominating and Governance Committee to nominate or recommend the candidate for election to the Board.

Code of Business Conduct and Ethics

Our Board has adopted a Code of Business Conduct and Ethics that applies to all of our directors, officers and employees. Any waivers of any provision of this code for our directors or officers may be granted only by the Board or a committee appointed by the Board. Any waivers of any provisions of this code for an employee or a representative may be granted only by our executive chairman or chief financial officer. We will provide any person, without charge, a copy of this code. Requests for a copy of the code may be made by writing to RiceBran Technologies at 25420 Kuykendahl Rd., Suite B300, Tomball, Texas 77375, Attention: Secretary. The Code of Business Conduct and Ethics is also available on our website at www.ricebrantech.com/investors/annual-meeting.

Our Board has not adopted any practices or policies regarding the ability of our employees or directors, or any of their designees, to engage in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of our securities.

Communication Policy

Shareholders and other interested parties may send communications to the Board or individual members of the Board by writing to them, care of Secretary, RiceBran Technologies, 25420 Kuykendahl Rd., Suite B300, Tomball, Texas 77375, who will forward the communication to the intended director or directors. If the shareholder wishes the communication to be confidential, then the communication should be provided in a form that will maintain confidentiality.

Attendance of Directors at Annual Meetings of Shareholders

We have a policy of encouraging, but not requiring, directors to attend our annual meeting of shareholders. All of our current directors who were directors at the time of the 2023 Annual Meeting of Shareholders attended such meeting.

ITEM 11. EXECUTIVE COMPENSATION

~~The~~We ~~information~~are ~~required~~currently byconsidered ~~Item~~a 11“smaller reporting company” for purposes of ~~Part~~the ~~III~~SEC’s isexecutive ~~incorporated~~compensation bydisclosure ~~reference~~rules. toIn ~~our~~accordance ~~definitive~~with ~~proxy~~such ~~statement~~rules, we are required to beprovide ~~filed~~a ~~within~~summary ~~120~~compensation ~~days~~table ofand ~~our~~an outstanding equity awards at fiscal year end table, oras ~~will~~well beas ~~included~~limited innarrative andisclosures. ~~amendment~~Further, our reporting obligations extend only to ~~this~~the ~~Form~~individuals ~~10-K~~serving as our principal executive officer, who was our executive chairman, and our two other most highly compensated executive officers other than our principal executive officer, if any. For 2023, our “named executive officers” were:

●

Eric Tompkins, Director and Executive Chairman; and

●

William J. Keneally, Interim Chief Financial Officer and Secretary; and

●

Peter G. Bradley, Former Director and Executive Chairman; and

●

Todd T. Mitchell, Former Chief Operating Officer and Chief Financial Officer.

Compensation Philosophy

Our Compensation Committee is charged with the evaluation of the compensation of our named executive officers and to assure that they are compensated effectively in a manner consistent with our compensation strategy and resources, competitive practice, and the requirements of the appropriate regulatory bodies.

Our compensation philosophy has the following basic components: (i) establish competitive base salaries to attract qualified talent, and (ii) evaluate performance and grant performance-based bonuses that may include equity and cash components. Our goal is to establish executive compensation levels to allow us to remain competitive in our industry and to attract and retain executives of a high caliber. Similarly, we strive to align components of annual compensation to performance and achievement of our business objectives in an effort to retain highly motivated executives who are focused on performance. We review other public reports and consider the compensation paid to executives at similarly situated companies, both within and outside of our industry, when determining and evaluating our compensation philosophy and compensation levels. Our performance, including, but not limited to, earnings, revenue growth, cash flow, and continuous improvement initiatives, is a significant part of our evaluation and determination of compensation levels.

Table of Contents

Summary Compensation Table

The following table sets forth all compensation awarded, earned or paid to our named executive officers for services rendered to us in all capacities during 2023 and 2022.

						Stock		Option
		Salary		Bonus		Awards		Awards		Total
Name and Principal Position (1)	Year	($)		($)		($) (2)		($) (3)		($)

Eric Tompkins, Director and Executive Chairman	2023		300,000		100,000		-		-		400,000
	2022		200,000		-		57,000		-		257,000

William J. Keneally, Interim Chief Financial Officer and Secretary	2023		405,266		-		-		72,830		478,096
	2022		-		-		-		-		-

Peter G. Bradley, Former Director and Executive Chairman	2023		31,196		-		27,968		-		59,164
	2022		235,000		-		628,882		-		863,882

Todd T. Mitchell, Former Chief Operating Officer and Chief Financial Officer	2023		126,160		-		-		-		126,160
	2022		275,000		-		449,513		-		724,513

(1)

Reflects the positions held by our named executive officers as of December 31, 2023. Mr. Tompkins was appointed executive chairman of the Company in June 2023, and Mr. Keneally was appointed interim chief financial officer in April 2023.

(2)

Amounts in this column reflect the grant date fair value of share and share-based awards granted to the named executive officers, calculated in accordance with FASB ASC Topic 718 and the SEC rules. The assumptions underlying these calculations are described in Note 10 to the accompanying consolidated financial statements.

(3)

Amounts in this column reflect the grant date fair value, calculated in accordance with FASB ASC Topic 718 and the SEC rules of equity and equity-based awards granted to the named executive officers. The assumptions underlying these calculations are described in Note 10 to the accompanying consolidated financial statements.

Narrative Disclosure to the Summary Compensation Table

The following is a brief description of the compensation arrangements we had with each of the named executive officers and the other compensation received by the named executive officers during 2023. All Common Stock, stock option, and RSU grants (including DSU grants) described below were made pursuant to the 2014 Plan.

Eric Tompkins, Executive Chairman

Mr. Tompkins was initially employed by us when he was appointed executive chairman of the Board effective June 13, 2023. Mr. Tompkins’ employment is at-will, and his employment continues until either the Company or Mr. Tompkins elects to separate from the Company.

Mr. Tompkins is entitled to receive an annual cash salary of $300,000. Whether any bonus award is earned by Mr. Tompkins is determined in the complete discretion of the Board. We do not maintain a formal bonus plan, but historically, the Board has considered both individual and Company performance in determining whether annual bonuses have been earned. The Board determined that a retention bonus of $100,000 was earned by Mr. Tompkins for 2023.

William J. Keneally, Interim Chief Financial Officer

Mr. Keneally, on behalf of CXO Partners, entered into a consulting services agreement with us and was appointed interim chief financial officer in April 2023. Under the consulting services agreement, Mr. Keneally is entitled to receive a monthly consulting fee of $45,000. Whether any bonus award is earned by Mr. Keneally is determined in the complete discretion of the Board. We do not maintain a formal bonus plan, but historically, the Board has considered both individual and Company performance in determining whether annual bonuses have been earned. In July 2023, the Board granted Mr. Keneally 100,000 vested stock options.

Table of Contents

Peter G. Bradley, Former Executive Chairman

Mr. Bradley was initially employed by us when he was appointed executive chairman of the Board effective August 14, 2020. He served as a non-employee director of our Board from July 2019 until August 14, 2020. We entered into an offer letter with Mr. Bradley on August 12, 2020, governing the terms of his employment as our executive chairman (Offer Letter). Pursuant to the Offer Letter, the nature of Mr. Bradley’s employment was at-will and his employment continued until either the Company or Mr. Bradley elected to terminate the Offer Letter. Mr. Bradley resigned in June 2023.

Under the Offer Letter, Mr. Bradley was entitled to receive an annual cash salary of $180,000, an annual cash bonus award and stock grants under the 2014 Plan with a value of $10,000 for each month of his service. Whether any bonus award was earned by Mr. Bradley was determined in the complete discretion of the Board. We do not maintain a formal bonus plan, but historically, the Board has considered both individual and Company performance in determining whether annual bonuses have been earned. The Board determined that no annual bonus was earned by Mr. Bradley for 2023 or 2022. Effective February 1, 2022, Mr. Bradley’s annual cash salary increased from $180,000 to $240,000 and the monthly stock grant value decreased from $10,000 to $5,000. Additionally, Mr. Bradley was eligible under the Offer Letter to participate in the benefit plans and programs we made available to similarly situated employees from time to time.

The monthly stock grant Mr. Bradley received was in the form of DSUs for his service. Each DSU award was fully vested on the applicable date of grant. The number of shares of underlying DSUs was determined based on the weighted average closing price of our Common Stock for the ten (10) trading days prior to the applicable date of grant.

Mr. Bradley received awards of RSUs and DSUs during 2022 in addition to the stock awards granted pursuant to the Offer Letter as described above. In March 2022, the Board granted Mr. Bradley 36,585 RSUs contingent upon shareholders approving an increase in the shares available for issuance under the 2014 Plan. Half of the RSUs vested on March 4, 2023, and the remainder were to vest on March 4, 2024, subject to Mr. Bradley’s continued employment through the applicable vesting date. In March 2022, the Board also granted Mr. Bradley 100,000 DSUs contingent upon shareholders approving an increase in the shares available for issuance under the 2014 Plan. The DSUs vested as to 20% of the units March 4, 2023, and were to vest on March 4^th of each of 2024, 2025, 2026 and 2027, subject to Mr. Bradley’s continued employment through the applicable vesting date. In July 2022, as compensation for his services as a director, the Board granted Mr. Bradley 13,158 DSUs which were to vest on the earlier of July 14, 2023, or one day prior to the next annual meeting of shareholders, subject to Mr. Bradley’s continued employment, or board service, through the vesting date.

Shareholders approved the increase in shares available under the 2014 Plan on July 14, 2022, and the grant date fair value reflected in the Summary Compensation Table above with respect to the awards granted contingent upon the increase was on July 14, 2022, the date the contingency was resolved under FASB ASC Topic 718.

Todd T. Mitchell, Former Chief Operating Officer and Chief Financial Officer

Mr. Mitchell was initially employed by us in May 2019, appointed chief financial officer effective July 1, 2019, and appointed chief operating officer effective December 7, 2021. We entered into an employment agreement with Mr. Mitchell on May 28, 2019, governing the terms of his employment (Employment Agreement). Pursuant to the Employment Agreement, the term of Mr. Mitchell’s employment renewed automatically for successive one-year terms unless either party notified the other party in writing at of the then-effective term of such party’s intention not to renew the agreement. Mr. Mitchell resigned in April 2023.

Under the Employment Agreement, Mr. Mitchell was entitled to receive an annual base salary of $275,000. Mr. Mitchell was eligible to participate in any bonus program that we adopted applicable to our senior officers. Mr. Mitchell was eligible to earn an annual cash bonus of up to 40% of his annual base salary based upon satisfaction of corporate and individual goals as determined by our Compensation Committee. The Compensation Committee determined that no bonus was earned by Mr. Mitchell during 2022.

Table of Contents

In December 2022, we entered into a retention agreement with Mr. Mitchell (Retention Agreement) under which he was eligible to receive a cash bonus payment of $137,500, if he remained employed through June 30, 2023, or if he was terminated without cause prior to June 30, 2023.

Under the Employment Agreement, Mr. Mitchell was eligible to receive equity awards at the discretion of the Board or the Compensation Committee. In March 2022, the Board granted Mr. Mitchell 18,293 RSUs contingent upon shareholders approving an increase in the number of shares available for issuance under the 2014 Plan. As noted above, such increase was approved by the shareholders on July 14, 2022. Half of the RSUs vested on March 4, 2023, and the remainder were to vest on March 4, 2024, subject to Mr. Mitchell’s continued employment through such date.

Equity Compensation Arrangements – 2014 Plan

The Board originally adopted the 2014 Plan in June 2020, after it was approved by our shareholders. As of December 31, 2023, the total shares of Common Stock authorized for issuance under the 2014 Plan, as amended, was 1,230,000 shares. Under the terms of the 2014 Plan, we may grant stock options, shares of Common Stock and other share-based awards to officers, directors, employees or consultants providing services on such terms as are determined by the Board. The Board administers the plan, determines vesting schedules on plan awards and may accelerate the vesting schedules for award recipients. The options granted under the 2014 Plan have terms of up to 10 years. As of December 31, 2023, awards for the issuance or purchase of 1,230,000 shares of Common Stock had been granted and remain outstanding (including common stock options, Common Stock, RSUs (including DSUs)) and no shares of Common Stock were reserved for future grants under the 2014 Plan.

401(k) Plan

Our named executive officers employed by the Company were eligible to participate in a defined contribution retirement plan qualified under subsection 401(k) of the Internal Revenue Code (401(k) Plan) in 2023. Named executive officers participating in the 401(k) Plan did not receive contributions from the Company into the 401(k) Plan in 2023. None of our named executive officers employed by the Company are currently covered by any other pension plan or other similar benefit plan that provides for payments or other benefits at, following, or in connection with retirement.

Nonqualified Deferred Compensation

None of our named executive officers employed by the Company are covered by a defined contribution or other plan that provides for the deferral of compensation on a basis that is not tax-qualified.

Outstanding Equity Awards at Fiscal Year End

The following table provides information as of December 31, 2023, regarding outstanding equity awards held by each of our named executive officers.

			Option Awards
			Number of Securities Underlying Unexercised Options		Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options		Option Exercise Price		Option Expiration
			(# Exercisable)		(#)		($/sh)		Date
Eric Tompkins	(1	)		1,422		-		35.20	4/4/2029
	(2	)		2,853		-		12.30	1/28/2030
William J. Keneally	(3	)		100,000		-		1.05	7/10/2028
Peter G. Bradley				-		-		-	-
Todd T. Mitchell				-		-		-	-

(1)

Options vested and became exercisable 25% on April 4^th of each 2020, 2021, 2022 and 2023.

(2)

Options vested and became exercisable 25% on January 28^th of each 2021, 2022, 2023 and 2024..

(3)

Options vested and became exercisable on July 10, 2023.

Table of Contents

Termination and Change in Control Arrangements

Mr. Tompkins and Mr. Keneally are not party to any contract, agreement, plan or arrangement that provides for payment at, following, or in connection with the resignation, retirement or other termination of employment or a change in control.

Upon Mr. Bradley’s resignation, he received 100,743 shares of common stock underlying the vested DSUs he was previously awarded according to the terms of such award agreements.

Mr. Mitchell did not receive any compensation upon resignation from the Company.

Director Compensation

Our Compensation Committee adopted a comprehensive director compensation program to attract and retain qualified non-employee directors who are critical to our future value, growth and governance. For 2023, annual compensation for non-employee directors consisted of the following amounts: $10,000 to each member of the Audit Committee, and $4,000 to each member of the Nominating and Governance Committee and the Compensation Committee.

For 2023, the Compensation Committee approved payment of the annual retainer amounts in quarterly installments, under the 2014 Plan. The Compensation Committee elected to pay such installments in the form of grants of immediately-vested DSUs. The number of shares of Common Stock subject to these regular board fee DSUs was determined based on the closing price of our Common Stock on the last day of the applicable quarter. We reimburse all directors for travel required in connection with their service on the Board and other necessary business expenses incurred in the performance of director services and extend coverage to them under our directors and officers indemnity insurance policies.

2023 Director Compensation

The following director compensation table sets forth summary information concerning the compensation paid to our non-employee directors in 2023. The compensation paid to our employee directors during 2023 in respect of their service on the Board is reflected in the Summary Compensation Table above under “Executive Compensation.”

	Stock Awards		All Other Compensation		Total
Name	($) (1) (2)		($)		($)
Will T. Black		22,083		-		22,083
David I. Chemerow		58,906		-		58,906
Jean M. Heggie		23,850		-		23,850
Brent D. Rosenthal		52,892		-		52,892

(1)

Amounts shown in this column reflect the grant date fair value, determined in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (FASB ASC Topic 718), of DSUs granted for 2023 services under the 2014 Plan. For additional information regarding the assumptions underlying this calculation please see Note 1 and Note 10 of “Notes to Consolidated Financial Statements”.

(2)

As of December 31, 2023, the aggregate number of outstanding stock awards held by each of our non-employee directors with respect to vested DSUs for which settlement is deferred, 193,727 by David I. Chemerow and 189,167 by Brent D. Rosenthal. There were no outstanding equity awards held by Mr. Bradley, Mr. Black and Ms. Heggie as of December 31, 2023. There were no outstanding equity awards held by Mr. Bradley, Mr. Black and Ms. Heggie as of December 31, 2023.

Table of Contents

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

The following table sets forth certain information ~~required~~regarding bybeneficial ~~Item~~ownership 12of our Common Stock as of ~~Part~~March ~~III~~29, 2024, by (i) each person or entity who is ~~incorporated~~known by ~~reference~~us to own beneficially more than 5% of the outstanding shares of that class or series of our ~~definitive~~stock, ~~proxy~~(ii) ~~statement~~each of our directors and director nominees, to(iii) beeach ~~filed~~of ~~within~~the ~~120~~named ~~days~~executive officers, and (iv) all directors and current executive officers as a group. For purposes of this section, “named executive officers” shall mean: (i) each person who served as our ~~fiscal~~principal ~~year~~executive ~~end~~officer during 2023; (ii) the two (2) most highly compensated executive officers other than the principal executive officer who were serving as executive officers as of December 31, or2023, ~~will~~if beany; ~~included~~and (iii) up to two (2) additional individuals for whom disclosure would have been provided in anthe ~~amendment~~table tobelow, ~~this~~but ~~Form~~for ~~10-K~~the fact that such persons were not serving as executive officers as of December 31, 2023.

The table is based on information provided to us or filed with the SEC by our directors, executive officers and principal shareholders. Beneficial ownership is determined in accordance with the rules of the SEC and includes voting and investment power with respect to shares. Shares of Common Stock issuable upon exercise or conversion of options and warrants that are currently exercisable or are exercisable within sixty days after March 29, 2024, and shares underlying RSUs (including DSUs) vesting within sixty days after March 29, 2024, are deemed outstanding for purposes of computing the percentage ownership of the person holding such securities but are not deemed outstanding for computing the percentage of any other shareholder. Unless otherwise indicated, the address for each shareholder listed in the following table is c/o RiceBran Technologies, 25420 Kuykendahl Rd., Suite B300, Tomball, Texas 77375.

	Common Stock Beneficially Owned
Name and Address of Beneficial Owner	Number		Percentage (1)
Eric Tompkins (2)		45,618		*	%
David I. Chemerow (3)		220,250		2.20	%
William J. Keneally (4)		100,000		1.00	%
Brent D. Rosenthal		230,734		2.31	%
James P. Flynn		-		*	%
Georgina Russell		-		*	%
All directors and executive officers as a group (5 persons) (5)		596,602		5.96	%
* less than 1%

(1)

The applicable percentage of ownership is based on 10,002,902 shares of our Common Stock outstanding as of March 29, 2024.

(2)

Includes 4,275 shares issuable upon exercise of options.

(3)

Includes 26,033 shares held by the David I. Chemerow 1992 Trust.

(4)

Includes 100,000 shares issuable upon exercise of options.

(5)

Includes 104,275 shares issuable upon exercise of options.

Table of Contents

Equity Compensation Plan Information

The following table sets forth, as of December 31, 2023, certain information with respect to the 2014 Plan:

	Number of securities to be issued upon exercise of outstanding options, warrants and rights		Weighted average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column a)
Plan Category	(a)		(b)		(c)
Equity compensation plans approved by shareholders		104,275	$	1.83		-
Equity compensation plans not approved by shareholders		-		-		-
Total		104,275	$	1.83		-

~~The information required by Item 13 of Part III is incorporated by reference to our definitive proxy statement~~Review, toApproval beor ~~filed~~Ratification ~~within 120 days~~ of ~~our~~Transactions ~~fiscal~~with ~~year~~Related ~~end,~~Parties ~~or will be included in an amendment to this Form 10-K.~~

As provided in our Audit Committee charter, our Audit Committee reviews and approves, unless otherwise approved by our Compensation Committee, any transaction or series of similar transactions to which we were or are to be a party in which the amount involved exceeds the lesser of (a) $120,000 or (b) one percent of the average of our total assets at the end of our last two completed fiscal years, and in which any director, director nominee, executive officer or holder of more than 5% of any class of our capital stock, or members of any such person’s immediate family (as the term is defined by Item 401 of Regulation S-K), had or will have a direct or indirect material interest (each such transaction, a Related Party Transaction). Each Related Party Transaction that occurred since January 1, 2021, if any, has been approved by our Board, Audit Committee or Compensation Committee.

Related Party Transactions

Other than compensation described above in “Executive Compensation,” “Director Compensation” and “Director Compensation Table”, we believe that there have been no Related Party Transactions since January 1, 2021.

Director Independence

Our Board annually determines the independence of each director, based on the independence criteria set forth in the listing standards of the Marketplace Rules of Nasdaq. In making its determinations, the Board considers all relevant facts and circumstances brought to its attention as well as information provided by the directors and a review of any relevant transactions or relationships between each director or any member of his or her family, and the Company, its senior management or our independent registered public accounting firm. Based on its review, the Board determined that the following directors, director nominees and former directors are each independent under the Nasdaq’s criteria for independent board members: Brent D. Rosenthal, David I. Chemerow, James P. Flynn and Georgina Russell.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

~~The~~Fees ~~information~~Billed ~~required~~ by ~~Item~~Independent 14Registered ofPublic ~~Part~~Accounting ~~III is incorporated by reference to our definitive proxy statement, to be filed within 120 days of our fiscal year end, or will be included in an amendment to this Form 10-K.~~Firms

The following table presents fees for professional services rendered by our independent registered public accounting firm Withum Smith+Brown, PC for 2023 and our former independent registered public accounting firm for 2022, RSM US LLP, Houston, Texas.

	2023		2022
Audit fees	$	261,202	$	370,000
Audit-related fees		-		26,000
Tax fees		-		-
All other fees		-		-
Total	$	261,202	$	396,000

Table of Contents

Audit fees

Audit fees consist of fees billed for professional services rendered for the audit of our year-end consolidated financial statements and the review of our financial statements included in our quarterly filings on Form 10-Q, as well as services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings.

Audit-related fees

Audit-related fees in 2023 and 2022 relate to consents and comfort letters provided in connection with filings on Form S-1 and Form S-3.

Tax fees

There were no tax fees in 2023 or 2022.

All other fees

There were no other fees in 2023 or 2022.

Pre-Approval Policies

Our Audit Committee is responsible for appointing, setting compensation and overseeing the work of the independent auditors. In recognition of this responsibility, the Audit Committee pre-approves all audit and non-audit services provided by our independent registered public accounting firm prior to the engagement of the independent registered public accounting firm for such services. All fees reported under the headings Audit fees, Audit-related fees, Tax fees and All other fees above were approved by the Audit Committee before the respective services were rendered, which concluded that the provision of such services was compatible with the maintenance of the independence of the firm providing those services in the conduct of its auditing functions.

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

See Exhibit Index attached hereto.

The Financial Statements are included under Item 8.

4256

Table of Contents

EXHIBIT INDEX

		Incorporated by Reference
Exhibit Number	Exhibit Description	Form	File No.	Exhibit Number	Filing/Effective Date	Filed Herewith
3.01.01	Restated and Amended Articles of Incorporation filed with the Secretary of State of California on December 13, 2001	10-KSB	000-32565	3.3	April 16, 2002
3.01.02	Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of California on August 4, 2003	SB-2	333-129839	3.01.1	November 21, 2005
3.01.03	Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of California on October 31, 2003	10-QSB	000-32565	3.4	November 19, 2003
3.01.04	Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of California on September 29, 2005	SB-2	333-129839	3.03	November 21, 2005
3.01.05	Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of California on August 20, 2007	10-Q	000-32565	3.1	August 14, 2007
3.01.06	Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of California on June 30, 2011	8-K	000-32565	3.1	July 5, 2011
3.01.07	Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of California on July 12, 2013	10-Q	000-32565	3.1	August 14, 2013
3.01.08	Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of California on May 30, 2014	S-3	333-196541	3.01.088	June 5, 2014
3.01.09	Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of California on February 15, 2017	S-3	333-217131	3.1.9	April 04, 2017
3.01.10	Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of California on June 18, 2020	10-Q	001-36245	3.1	August 12, 2020
3.01.11	Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of California on August 25, 2022	8-K	000-32565	3.1	August, 25, 2022
3.02	Certificate of Designation of the Rights, Preferences, and Privileges of the Series A Preferred Stock filed with the Secretary of State of California on December 13, 2001	SB-2	333-89790	4.1	June 4, 2002
3.03	Certificate of Determination, Preferences and Rights of Series B Convertible Preferred Stock filed with the Secretary of State of California on October 4, 2005	8-K	000-32565	3.1	October 4, 2005
3.04	Certificate of Determination, Preferences and Rights of Series C Convertible Preferred Stock filed with the Secretary of State of California on May 10, 2006	8-K	000-32565	3.1	May 15, 2006
3.05	Certificate of Determination, Preferences and Rights of the Series D Convertible Preferred Stock, filed with the Secretary of State of California on October 17, 2008	8-K	000-32565	3.1	October 20, 2008
3.06	Certificate of Determination, Preferences and Rights of the Series E Convertible Preferred Stock, filed with the Secretary of State of California on May 7, 2009	8-K	000-32565	3.1	May 8, 2009

4357

Table of Contents

EXHIBIT INDEX

			Incorporated by Reference
Exhibit Number		Exhibit Description	Form	File No.	Exhibit Number	Filing/Effective Date	Filed Herewith
3.07		Certificate of Determination, Preferences and Rights of the Series F Convertible Preferred Stock, filed with the Secretary of State of California on February 18, 2016	8-K	001-36245	3.1	February 23, 2016
3.08		Form of Certificate of Determination of Preferences and Rights of Series G Convertible Preferred Stock, filed with the Secretary of State of California on February 9, 2017	8-K	001-36245	3.1	February 15, 2017
3.09.1		Bylaws	SB-2	333-134957	3.05	June 12, 2006
3.09.2		Amendment of Bylaws, effective June 19, 2007	8-K	000-32565	3.1	June 25, 2007
3.09.3		Amendment of Bylaws, effective December 4, 2009	8-K	000-32565	3.1	December 10, 2009
3.09.4		Amendment of Bylaws, effective as of February 13, 2017	S-3	333-217131	3.9.4	April 04, 2017
3.09.5		Amendment to Bylaws, effective July 30, 2019	8-K	001-36245	3.1	August 5, 2019
3.10		Certificate of Ownership dated October 3, 2012	8-K	000-32565	3.01	October 10, 2012
4.01		Form of Warrant (Private Placement)	8-K	001-36245	4.1	September 13, 2021
4.02		Form of Prefunded Warrant (Private Placement)	8-K	001-36245	4.2	September 13, 2021
4.03		Description of Registrant’s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended					X
4.04		Form of Pre-Funded Warrant (Registered Direct Offering and Private Placement)	8-K	001-36245	4.1	October 20, 2022
4.05		Form of Private Placement Warrant (Registered Direct Offering and Private Placement)	8-K	001-36245	4.2	October 20, 2022
4.06		Form of Wainwright Warrant (Registered Direct Offering and Private Placement)	8-K	001-36245	4.3	October 20, 2022
10.01	*	Employment Agreement with Todd T. Mitchell dated May 28, 2019	10-Q	001-36245	10.2	May 5, 2020
10.02	*	Amended and Restated 2014 Equity Incentive Plan, as amended on June 17, 2020	8-K	001-36245	10.2	July 17, 2020
10.03	*	Form of Award of Deferred and Restricted Stock Units for 2014 Equity Incentive Plan	8-K	001-36245	10.3	July 17, 2020
10.04	*	Form of Stock Option Agreement for 2014 Equity Incentive Plan	10-K	001-36245	10.72	March 31, 2015

Incorporated by Reference

Exhibit

Number

Exhibit Description

Form

File No.

Exhibit

Number

Filing/Effective Date

Filed

Herewith

3.07		Certificate of Determination, Preferences and Rights of the Series F Convertible Preferred Stock, filed with the Secretary of State of California on February 18, 2016	8-K	001-36245	3.1	February 23, 2016
3.08		Form of Certificate of Determination of Preferences and Rights of Series G Convertible Preferred Stock, filed with the Secretary of State of California on February 9, 2017	8-K	001-36245	3.1	February 15, 2017
3.09		Certificate of Determination of Series H Junior Preferred Stock	10-Q	001-36245	3.1	December 20, 2023
3.09.1		Bylaws	SB-2	333-134957	3.05	June 12, 2006
3.09.3		Amendment of Bylaws, effective December 4, 2009	8-K	000-32565	3.1	December 10, 2009
3.09.4		Amendment of Bylaws, effective as of February 13, 2017	S-3	333-217131	3.9.4	April 04, 2017
3.09.5		Amendments to Bylaws, effective August 30, 2023	8-K	001-36245	3.1	August 30, 2023
3.10		Certificate of Ownership dated October 3, 2012	8-K	000-32565	3.01	October 10, 2012
4.01		Form of Warrant (Private Placement)	8-K	001-36245	4.1	September 13, 2021
4.02		Form of Prefunded Warrant (Private Placement)	8-K	001-36245	4.2	September 13, 2021
4.04		Form of Pre-Funded Warrant (Registered Direct Offering and Private Placement)	8-K	001-36245	4.1	October 20, 2022
4.05		Form of Private Placement Warrant (Registered Direct Offering and Private Placement)	8-K	001-36245	4.2	October 20, 2022
4.06		Form of Wainwright Warrant (Registered Direct Offering and Private Placement)	8-K	001-36245	4.3	October 20, 2022
4.07		Form of Funicular Warrant	8-K	001-36245	4.1	December 6, 2023
4.08		Form of Sabby Warrant	8-K	001-36245	4.2	December 6, 2023
10.01	*	Employment Agreement with Todd T. Mitchell dated May 28, 2019	10-Q	001-36245	10.2	May 5, 2020
10.02	*	Amended and Restated 2014 Equity Incentive Plan, as amended on June 17, 2020	8-K	001-36245	10.2	July 17, 2020
10.03	*	Form of Award of Deferred and Restricted Stock Units for 2014 Equity Incentive Plan	8-K	001-36245	10.3	July 17, 2020

Table of Contents

EXHIBIT INDEX

			Incorporated by Reference
Exhibit Number		Exhibit Description	Form	File No.	Exhibit Number	Filing/Effective Date	Filed Herewith
10.05	*	Form of Restricted Stock Award Agreement for 2014 Equity Incentive Plan	10-K	001-36245	10.73	March 31, 2015
10.06	*	Form of Restricted Stock Unit Award Agreement for 2014 Equity Incentive Plan	8-K	001-36245	10.1	October 3, 2018
10.07	*	Employee Agreement (Offer Letter) with Peter G. Bradley dated August 12, 2020	10-K	001-36245	10.21	February 25, 2021
10.08	*	Amendment No. 1 to Restricted Stock Unit Award Grant Notice and Award Agreement with Todd T. Mitchell, effective December 15, 2021	10-K	001-36245	10.08	March 17, 2022
10.09	*	Form of Indemnification Agreement for Officers and Directors	10-Q	000-32565	10.2	May 12, 2011
10.10	*	Form of Award of Contingently Granted Deferred and Restricted Stock Units for 2014 Equity Incentive Plan	10-K	001-36245	10-24	March 17, 2022
10.11		Agreement for Purchase and Sale with Republic Business Credit, LLC dated October 28, 2019	8-K	001-36245	10.1	November 1, 2019
10.12		Purchase Agreement dated December 17, 2019 (Public Offering)	8-K	001-36245	1.1	December 19, 2019
10.13		Form of Securities Purchase Agreement dated September 9, 2021 (Private Placement)	8-K	001-36245	10.1	September 13, 2021
10.14		Form of Registration Rights Agreement dated March 7, 2019	8-K	001-36245	10.3	March 13, 2019
10.15		At Market Issuance Sales Agreement with B Riley FBR, Inc	8-K	001-36245	10.1	March 30, 2020
10.16		Promissory Note dated as of April 15, 2020 (Paycheck Protection Program)	8-K	001-36245	10.1	April 16, 2002
10.17		Mortgage Agreement and Amendment for Purchase and Sale with Republic Business Credit, LLC, dated July 10, 2020	8-K	001-36245	10.1	July 17, 2020
10.18		Mortgage Agreement and Amendment for Purchase and Sale with Republic Business Credit, LLC, dated December 6, 2021	8-K	001-36245	10.1	December 10, 2021
10.19		Mortgage Agreement and Amendment for Purchase and Sale with Republic Business Credit, LLC, dated January 12, 2023	8-K	001-36245	10.1	January 19, 2023
10.20		Form of Securities Purchase Agreement (Registered Direct Offering and Private Placement)	8-K	001-36245	10.1	October 20, 2022
21		List of Subsidiaries					X
23.1		Consent of Independent Registered Public Accounting Firm					X
24.1		Power of Attorney – Power of Attorney (incorporated by reference to the signature page of this Annual Report on Form 10-K.)

Incorporated by Reference

Exhibit

Number

Exhibit Description

Form

File No.

Exhibit

Number

Filing/Effective Date

Filed

Herewith

10.04	*	Form of Stock Option Agreement for 2014 Equity Incentive Plan	10-K	001-36245	10.72	March 31, 2015
10.05	*	Form of Restricted Stock Award Agreement for 2014 Equity Incentive Plan	10-K	001-36245	10.73	March 31, 2015
10.06	*	Form of Restricted Stock Unit Award Agreement for 2014 Equity Incentive Plan	8-K	001-36245	10.1	October 3, 2018
10.07	*	Employee Agreement (Offer Letter) with Peter G. Bradley dated August 12, 2020	10-K	001-36245	10.21	February 25, 2021
10.08	*	Amendment No. 1 to Restricted Stock Unit Award Grant Notice and Award Agreement with Todd T. Mitchell, effective December 15, 2021	10-K	001-36245	10.08	March 17, 2022
10.09	*	Form of Indemnification Agreement for Officers and Directors	10-Q	000-32565	10.2	May 12, 2011
10.10	*	Form of Award of Contingently Granted Deferred and Restricted Stock Units for 2014 Equity Incentive Plan	10-K	001-36245	10-.24	March 17, 2022
10.11		Agreement for Purchase and Sale with Republic Business Credit, LLC dated October 28, 2019	8-K	001-36245	10.1	November 1, 2019
10.12		Purchase Agreement dated December 17, 2019 (Public Offering)	8-K	001-36245	1.1	December 19, 2019
10.13		Form of Securities Purchase Agreement dated September 9, 2021 (Private Placement)	8-K	001-36245	10.1	September 13, 2021
10.14		Form of Registration Rights Agreement dated March 7, 2019	8-K	001-36245	10.3	March 13, 2019
10.15		Registration Rights Agreement, dated as of December 1, 2023, by and between RiceBran Technologies and Funicular Funds, LP	8-K	001-36245	10.2	December 6, 2023
10.16		At Market Issuance Sales Agreement with B Riley FBR, Inc	8-K	001-36245	10.1	March 30, 2020
10.17		Promissory Note dated as of April 15, 2020 (Paycheck Protection Program)	8-K	001-36245	10.1	April 16, 2002
10.18		Secured Promissory Note, dated as of December 1, 2023, by and among RiceBran Technologies, Funicular Funds, LP, as holder, Golden Ridge Rice Mills, Inc., as guarantor, and MGI Grain Incorporated, as guarantor	8-K	001-36245	10.6	December 6, 2023
10.19		Mortgage Agreement and Amendment for Purchase and Sale with Republic Business Credit, LLC, dated July 10, 2020	8-K	001-36245	10.1	July 17, 2020
10.20		Mortgage Agreement and Amendment for Purchase and Sale with Republic Business Credit, LLC, dated July 10, 2020	8-K	001-36245	10.1	July 17, 2020

Table of Contents

EXHIBIT INDEX

Incorporated by Reference

Exhibit Number

Exhibit Description

Form

File No.

Exhibit Number

Filing/Effective Date

Filed Herewith

31.1

Certification by CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification by CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification by CEO and CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Incorporated by Reference

Exhibit

Number

Exhibit Description

Form

File No.

Exhibit

Number

Filing/Effective Date

Filed

Herewith

10.21	Mortgage Agreement and Amended Amendment for Purchase and Sale with Republic Business Credit, LLC, dated January 12, 2023	8-K	001-36245	10.1	January 19, 2023
10.22	Fifth Amendment, Consent and Waiver to the Agreement for Purchase and Sale, dated as of December 1, 2023, by and among RiceBran Technologies, Golden Ridge Rice Mills, Inc. and MGI Grain Incorporated, as sellers, and Republic Business Credit, LLC, as purchaser	8-K	001-36245	10.7	December 6, 2023
10.23	Form of Securities Purchase Agreement (Registered Direct Offering and Private Placement)	8-K	001-36245	10.1	October 20, 2022
10.24	Securities Purchase Agreement dated as of December 1, 2023, by and between RiceBran Technologies and Funicular Funds, LP	8-K	001-36245	10.1	December 6, 2023
10.25	Asset Purchase Agreement with Stabil Nutrition LLC, dated as of June 23, 2023	8-K	001-36245	2.1	June 28, 2023
10.26	Letter Agreement with Continental Republic Capital LLC d/b/a Republic Business Credit, dated as of June 23, 2023	8-K	001-36245	10.1	June 28, 2023
10.27	Consulting Services Agreement with CXO Partners dated as of April 6, 2023	S-1/A	001-36245	10.1	April 11, 2023
10.28	Tax Benefits Preservation Plan, dated as of July 6, 2023, with American Stock Transfer & Trust Company, LLC, as Rights Agent	8-K	001-36245	4.1	July 6, 2023
10.29	Agreement for Purchase And Sale with Republic Business Credit, LLC (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on November 1, 2019)	8-K	001-36245	10.1	September 14, 2023
10.30	Letter from RSM US LLP to the Securities and Exchange Commission, dated August 23, 2023	8-K	001-36245	16.1	August 23, 2023
10.31	Exchange Agreement, dated as of December 1, by and between RiceBran Technologies and Cove Lane Master Fund LLC	8-K	001-36245	10.3	December 6, 2023
10.32	Exchange Agreement, dated as of December 1, by and between RiceBran Technologies and Sabby Volatility Warrant Master Fund, Ltd.	8-K	001-36245	10.4	December 6, 2023
10.33	Exchange Agreement, dated as of December 1, by and between RiceBran Technologies and Hudson Bay Master Fund Ltd.	8-K	001-36245	10.5	December 6, 2023
21	List of Subsidiaries					X
23.1	Consent of Independent Registered Public Accounting Firm List of Subsidiaries					X
23.2	Consent of Independent Registered Public Accounting Firm List of Subsidiaries					X

Table of Contents

EXHIBIT INDEX

Incorporated by Reference

Exhibit

Number

Exhibit Description

Form

File No.

Exhibit

Number

Filing/Effective Date

Filed

Herewith

24.1

Power of Attorney – Power of Attorney (incorporated by reference to the signature page of this Annual Report on Form 10-K.)

31.1

Certification by CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002Power of Attorney – Power of Attorney (incorporated by reference to the signature page of this Annual Report on Form 10-K.)

31.2

Certification by CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.Certification by CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification by CEO and CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.Certification by CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104101.PRE

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*	Indicates a management contract or compensatory plan, contract or arrangement in which any Director or any Executive Officer participates.

@ ~~iXBRL~~XBRL (~~Inline~~ Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

4661

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	RICEBRAN TECHNOLOGIES
Date: March 16, 2023	By:	/s/ Peter G. Bradley
Date: March 29, 2024	By:	/s/ Eric Tompkins
		Name: Peter G. Bradley
		Name: Eric Tompkins
		Title: Director and Executive Chairman

Power of Attorney

Each person whose signature appears below constitutes and appoints ~~Peter~~William GJ. ~~Bradley~~Keneally, true and lawful attorney-in-fact, with the power of substitution, for him/her in any and all capacities, to sign amendments to this Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.

Signature	Title	Date
Principal Executive Officer:
/s/ Peter G. Bradley	Director and Executive Chairman	March 16, 2023
/s/ Eric Tompkins	Director and Executive Chairman	March 29, 2024
Peter G. Bradley
Eric Tompkins
Principal Financial Officer and Principal Accounting Officer:
/s/ Todd T. Mitchell	Chief Financial Officer and Chief Operating Officer	March 16, 2023
/s/ William J. Keneally	Interim Chief Financial Officer and Secretary	March 29, 2024
Todd T. Mitchell
William J. Keneally
Additional Directors:
/s/ Will T. Black	Director	March 16, 2023
/s/ James P. Flynn	Director	March 29, 2024
Will T. Black
James P. Flynn
/s/ David I. Chemerow	Director	March 1629, ~~2023~~2024
David I. Chemerow
/s/ Jean M. Heggie	Director	March 16, 2023
/s/ Georgina Russell	Director	March 29, 2024
Jean M. Heggie
Georgina Russell
/s/ Brent D. Rosenthal	Director and Chairman	March 1629, ~~2023~~2024
Brent D. Rosenthal

4762

Filing Compare · RiceBran Technologies